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Osteoarthritis is a debilitating and irreversible disease afflicting the synovial joints. It is char-
acterized by pain and hindered mobility. Given that osteoarthritis has no cure, current treatments
focus on pain management. Ultimately, however, a patient’s pain and immobility necessitates joint
replacement surgery. An attractive alternative to this treatment paradigm, tissue engineering is a
promising strategy for resurfacing the osteoarthritis-afflicted cartilage surface with a biochemically
and biomechanically similar tissue to the healthy native cartilage tissue. The most successful car-
tilage tissue engineered systems to date can repeatably grow constructs ≈4 mm in diameter with
native proteoglycan and compressive mechanical properties. Unfortunately, as symptomatic carti-
lage typically presents only once lesions span large regions of the joint (≈25 mm in diameter), these
small construct are of limited use in clinical practice.
Numerous attempts to simply grow a construct large enough to span the size of an osteoarthritic
lesion have shown that the growth of large engineered tissues develop heterogeneous properties, em-
phasizing the need for culture protocols to enhance tissue homogeneity and robustness. In particular,
as nutrient limitations drive heterogeneous growth in engineered cartilage, developing strategies to
improve nutrition throughout the construct are critical for clinical translation of the technology. To
this end, our lab has successfully supplemented nutrient channels within large engineered cartilage
constructs to improve the functional properties of developing tissue. However, it is unknown what
the optimal nutrient channel spacing is for growing large cartilage constructs of anatomical scale.
Additionally, the fundamental factors and mechanisms which drive tissue heterogeneity have not
been implicated, making the results of channel-spacing optimizations difficult to translate across
different systems.
Computational models of growth, faithful to the physics and biology of engineered tissue growth,
may serve as an insightful and efficient tool for optimally designing culture protocols and construct
geometries to ensure homogeneous matrix deposition. Such computational tools, however, are not
presently available, owing to the unresolved mechanical and biological growth phenomena within
developing engineered cartilage. This dissertation seeks to develop and implement computational
models for predicting the biochemical and biomechanical growth of engineered tissues and apply
these models to optimizing tissue culture strategies. These models are developed in two stages:
1) based on our recent characterization of the nutrient demands of engineered cartilage, models
are developed to simulate the spatial biochemical deposition of matrix within tissue constructs and,
subsequently, 2) based on models of biochemical matrix deposition we develop models for simulating
the mechanical growth of tissue constructs.
To accomplish these tasks, we first develop models simulating glucose availability within large
tissue constructs using system-specific modeling based on our recent characterization of the glucose
demands of engineered cartilage. These models led to early insight that we had to enhance the supply
of glucose within large tissue constructs to ensure maximal matrix synthesis throughout culture.
Experimental validations confirmed that increasing glucose supply enhanced matrix deposition and
growth in large tissue constructs.
However, even despite the increased glucose supply, increasing the size of constructs demon-
strated that severe matrix heterogeneities were still present. Subsequent nutrient characterization
led to the finding that TGF-β transport was significantly hindered within large tissue constructs.
Incorporating the influence of glucose and TGF-β into the computational model growth kinetics.
Using both nutrients, models recreated the heterogeneous matrix deposition evident in our earlier
work and could account for the role of cell seeding density and construct geometry on tissue growth.
The insights gathered from this modeling analysis led to important changes in our culture proto-
cols: we could reduce the dose of TGF-β from 10 ng mL−1 to 1 ng mL−1 for constructs cultured
with channels, saving considerable expense while still maintaining a high level of matrix synthesis
throughout the construct.
In the presence of sufficient nutrition, we witnessed an unprecedented level of matrix deposition
and physical growth of the constructs. In fact, by using developmentally physiologic cell seeding
densities (120 million cells mL−1) and providing adequate nutrition, constructs physically grew
to 9-times their originally cast size. Despite such encouraging growth, tissue function properties
plateaued at sub-physiologic levels. For insight into the connection between matrix deposition
and tissue mechanics, we extended the computational growth models to consider the mechanisms
underlying physical growth. Interestingly, we found that a large matrix synthesis mismatch between
proteoglycans and collagen gave rise to the excessive tissue swelling. Computational models of this
matrix synthesis mismatch predicted the high tissue swelling displayed experimentally only when
a damage-able collagen fiber material was implemented. Together, the experimental and modeling
evidence suggested a new mechanism of cartilage growth: the high proteoglycan deposition creates
a swelling pressure within the nascent tissue which outcompetes the restraining force of newly
deposited collagens; this rapid tissue swelling disrupts a functional collagen network from forming.
Subsequent analysis suggested that the disruption of the collagen network prevented the formation
of collagen crosslinks, stymieing the development of native functional properties.
Based on this insight into the mechanisms of cartilage growth, we developed a culture systems
to improve tissue functional properties. Modeling analysis indicated two novel routes for improving
tissue mechanics: either through 1) reducing the swelling response (synthesis and deposition) of
proteoglycans or 2) enhancing and reinforcing the newly synthesized collagen to prevent disruptions
brought on by tissue swelling. We developed a cage culture system for resisting the swelling pres-
sure of deposited proteoglycans and reenforcing the deposition of new collagens. Using this cage
system, we grew tissue constructs with enhanced functional properties using two separate scaffold
systems – agarose and a cartilage-derived matrix hydrogel – suggesting this mechanism of growth
is fundamental to engineered cartilage development.
This work has generated a novel paradigm towards engineering cartilage constructs using
biomimetic strategies. Performing simulations with the validated, computational growth models
allowed anatomically-sized cartilage constructs to grow into the largest, homogeneous cartilage
constructs grown to date. Models presented a new level of insight into the nutrient demands of
developing tissues, allowing for the first time the successful development of large tissue constructs
grown with developmentally physiologic cell seeding densities. In this way, tissue constructs growth
followed a biomimetic approach, based on the high cell densities and cartilage canals and vascu-
lature present during fetal cartilage development. Adequate nutrition led to high levels of tissue
growth not previously experienced in vitro, a result of adequately nourishing primary chondrocytes,
a cell type which preferentially deposits proteoglycans over collagen. We therefore developed a
cage-based growth system to resist the proteoglycan-induced tissue swelling in a manner similar
to the fetal development of cartilage where the resident cells synthesize more collagens than pro-
teoglycans. Together, the use of nutrient growth models, high cell seeding densities, and culture
systems to strengthen the collagen-framework of de novo cartilage proved beneficial for engineering
anatomically-sized cartilage constructs. The fundamental mechanisms identified here are likely to
be universal across a number of engineered cartilage systems and will be adapted to more clinically-
relevant cell sources in future our work.
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Cartilage tissue engineering (CTE) is a promising cell-based therapy where a biochemically and
biomechanically functional cartilage construct is engineered to replace and resurface the degener-
ative cartilage. CTE research has been ongoing for nearly two-decades and has made enormous
strides recently in the repeatability and performance of small engineered constructs which match
the mechanical and biochemical properties of native articular cartilage. Despite these advances,
however, future success of the field is largely contingent on the ability to translate these promising
strategies from the research lab to clinical practice.
Achieving this translation is contingent on addressing two primary limitations in current engi-
neered tissue culture. The first challenge is the ability to grow large, anatomically-sized constructs
by scaling up current tissue engineered construct culture. The second challenge is growing tissues
which match all of the unique and robust functional mechanical properties typical of native cartilage.
A background on the field of tissue engineering is first introduced. We then introduce the
overarching specific aims of this dissertation in the context of the work’s significance. Lastly, more
detailed specific aims are itemized.
1.1 Background
1.1.1 Cartilage structure and function
Articular cartilage is an avascular and aneural connective tissue lining our diarthrodial joints. The
dense extracellular matrix of cartilage imparts the tissue with unique mechanical properties ide-
ally suited for its function as a dynamically loaded tissue (Mow et al. , 1984; Park et al. , 2004;
Kempson, 1980; Ateshian et al. , 1997). In addition to being resistant to high dynamic and static
loads, cartilage has a very low coefficient of friction (Krishnan et al. , 2004; Jones et al. , 2015) and
good wear properties (Radin et al. , 1982; Oungoulian et al. , 2015); the biochemical composition
and structural organization of cartilage confer the tissue with all of these functional properties.
Cartilage is able to withstand the loading environment of activities of daily living often without
problems for >80 years. This is essential as the tissue’s dense matrix, lack of vasculature, and low
cell content limit the natural repair capacity of the tissue, critically-sized defects therefore evolve
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into larger defects.
The two predominant structural molecules of native cartilage are proteoglycans, consisting of
hyaluronan chains lined with polymeric glycosaminoglycans (GAGs), and collagen (chiefly type II
in mature cartilage) (McDevitt, 1973; Kuettner, 1992). The GAGs and collagens play opposing
mechanical forces that together provide the robust mechanical properties. Collagen makes up ~80%
dw of the extracellular matrix constituents and provides a dense fibrillar network within the tis-
sue to prevent expansive forces (Chahine et al. , 2004; Wilson et al. , 2004). These fibrils buckle
under compressive loading. Conversely, the GAGs within cartilage are negatively charged and
impart a high fixed-charge density to the tissue (Maroudas, 1976; Eisenberg & Grodzinsky, 1985;
Lai et al. , 1991; Setton et al. , 1998; Chahine et al. , 2005). This fixed-charge density of nearly -
300 mEq L−1, among the highest in the body, attracts ions from the interstitial fluid to balance
the fixed charges and ensure electoneutrality. The steep ion gradient subsequently attracts the
interstitial water into the tissue and the high osmotic pressure that develops causes the tissue to
swell and resist compressive deformation. Together, the restraining collagen and expansive GAG
mechanical contributions give rise to cartilage’s unique non-linear tension-compression properties
where the tensile (collagen-dominated) modulus is nearly two orders of magnitude greater than the
compressive (GAG- and osmotic-dominated) modulus (Chahine et al. , 2004).
Cartilage’s high tensile modulus directly effects the frictional and dynamic modulus properties of
the tissue, two important measures for cartilage due to its biomechanical role (Krishnan et al. , 2003;
Krishnan et al. , 2004). Under routine compressive loading conditions, cartilage deforms around the
loaded tissue. This expansive deformation is resisted by the collagen and high tensile modulus of
the tissue (Chahine et al. , 2004). Therefore, the external compressive loads are translated into a
tensile loading response of the tissue, much like the way a water ballon, when squeezed (compressed),
expands in its lateral directions. Furthermore, in the instantaneous loading response, cartilage’s
interstitial fluid pressurizes (being resisted primarily by the collagen framework), and supports
much of the load. This is critical to maintaining cartilage’s low friction properties (µ ! 10−2).
Ultimately, an engineered tissue replacement would replicate this dense biochemical composition of
native cartilage (both the dense collagen and GAG networks – as both are essential for the unique
mechanical properties of native cartilage) .
Apart from the unique biochemical composition of articular cartilage, the tissue’s GAG and
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collagen networks are arranged heterogeneously from the superficial to deep zones and further influ-
ence mechanical properties of the tissue (Chahine et al. , 2004; Buckley et al. , 2008; Clark, 1990;
Shirazi et al. , 2008). The highest level of organization is the arcade collagen network, where col-
lagen fibrils are nearly perpendicular to the subchondral bone in the deep zones and then cross
over to become parallel to the articular surface in the superficial zone. The “superficial” zone of
cartilage is defined as having preferentially parallel collagen fibers relative to the articular surface.
The “middle” zone then begins where the collagen fibers begin to cross over and assume a more
random orientation. The “deep” zone extends below the middle zone to the subchondral bone and
consists mostly of collagen fibers in an aligned direction, perpendicular to the subchondral bone and
upper, articulating cartilage surface. This preferential directionality influences mechanical proper-
ties significantly, but it is still a debated issue on whether the directed collagen orientation plays a
critical role in cartilage’s mechanical response once the tissue is dynamically loaded under normal
in situ loading states (Jones et al. , 2016).
1.1.2 Cartilage development, maintenance, and degeneration
Though mature cartilage has no vasculature and a low cell content, developmental carti-
lage is highly vascularized and consists of an extremely high cell density as the early pre-
cursor mesenchymal cells condense to eventually form bone, the joint space, and the carti-
lage anlage (Strayer Jr, 1943; Gardner & Gray, 1950; Gardner & O’Rahilly, 1968; Mitrovic, 1977;
Doskocil, 1984; Oreja et al. , 1995; Bland & Ashhurst, 1996). In the earliest investigated states
of the developing cartilage, the tissue consists nearly entirely of cells with little extracellu-
lar matrix aside from early, mostly unsulfated hyaluronan deposition (Edwards et al. , 1994;
Pitsillides et al. , 1995). The cells of the early joint, responding to both signaling molecules and
mechanical cues, begin to align and define an articular surface on opposing sides of the joint
surface. Simultaneously, collagen deposition begins to occur. At this early state collagen types
I, II, III, and V are the predominant forms which locate to superficial, deep, and pericellular
zones (Bland & Ashhurst, 1996; Craig et al. , 1987; Mundlos et al. , 1990; Treilleux et al. , 1992;
Evans et al. , 1983). Expansion of the joint at this level (prenatal) is believed to occur mostly
from cellular proliferation which continues to develop the long bones, and chondrocytes are highly
aligned still in this state. After birth, collagen synthesis and cellular proliferation still occur and
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sulfated GAGs are slowly synthesized into the matrix. This is the first significant level of colla-
gen cross linking to occur too, perhaps in response to the tissue becoming increasingly hypoxic
(Moriguchi & Fujimoto, 1978; Makris et al. , 2014a). Development of cartilage continues to pro-
ceed as the subchondral bone below the cartilage begins to ossify. Cartilage canals, a vasculature
network stemming from the highly vascularized bone, play a critical role in chondrocyte nutrition
until complete ossification and allows the tissue matrix to continue to develop and deposit during
the last days of development (Stockwell, 1971b; Wilsman & Van Sickle, 1972; Olstad et al. , 2008;
Albro et al. , 2011).
At the time of skeletal maturation, the subchondral bone becomes fully sealed off from the artic-
ular cartilage. The cartilage canals, which to this point have supplied the tissue with vital nutrition
fill with matrix. As nutrients are now only accessible from the superficial surface of the tissue,
primarily through diffusion, the cell content drop precipitously (Stockwell, 1971a; Stockwell, 1967;
Klein et al. , 2007). Measurements of developmental cartilage have found the cell content to be 100-
300 million cells mL−1. Mature cartilage, on the other hand, has a cell content closer to 5-30 million
cells mL−1 (Stockwell, 1971a; Temple-Wong et al. , 2009). This population of cells that do persist
within cartilage have a limited role in the tissue’s maintenance. After reaching tissue maturity, stud-
ies have found collagen deposition ceases completely in human cartilage (Heinemeier et al. , 2016).
Similar studies find that proteoglycans, which are not covalently bound within the tissue as the
cross-linked collagen network is, slowly diffuse out through the articular surface of the cartilage,
suggesting these cells are capable of a continued level of GAG synthesis and deposition within the
tissue.
While healthy cartilage can be maintained without damage for many decades, the limited nat-
ural repair capacity prevents the joint from rebounding from minor defects or destabilizing effects
including aberrant growth factor signaling and mechanical loading. Therefore the small-sized de-
fects that may occur grow into large-sized defects (Ding et al. , 2007). Unfortunately, the lack of
cartilage innervation means defects go unnoticed until they develop into a size sufficiently large for
altered joint kinematics to cause aberrant loading of either the subchondral or surrounding joint
capsule soft tissues (Dieppe & Lohmander, 2005). Moreover, these defects lead to bone-on-cartilage
and bone-on-bone wear which can further aggravate the delicate equilibrium of the joint. The first
radiographic signs of OA are typically focal swelling within the cartilage, but to date the etiology of
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OA is unclear. Specifically, while measurements find both focal collagen denaturation and increases
GAG deposition near focal damage sites, the initiating event is often unknown.
1.1.3 Cartilage repair in the clinic
Due to the limited regenerative and healing capacity of native cartilage, defects must be
repaired or replaced to enable continued mobility and limit pain. Typical current treat-
ments include microfracture surgery, osteochondral allograft, and autologous chondrocyte
transplantation (ACI) (McDermott et al. , 1985; Steadman et al. , 1997; Steadman et al. , 2003;
Jakob et al. , 2002; Knutsen et al. , 2004; Peterson et al. , 2010). None of these treatments, how-
ever, can be used to treat the large-sized defects which arise in osteoarthritis, often leaving this
sizable population to wait until a total joint replacement is appropriate.
To this end, cartilage tissue engineering has emerged as a promising regenerative medicine
approach to treating small and large sized defects with a tissue construct which is biochemically and
biomechanically similar to the native articular cartilage. However, despite several clinical trials of
cartilage tissue engineering products, their utility and treatment scope has been limited (primarily
by cartilage defect size) (Huang et al. , 2016a). Of the eleven (11) cartilage tissue engineering
products which have undergone clinical trials, four (4) of these are ongoing, seven (7) have no
future development plans, and two (2) have led to products available in Europe only (with no plans
for US clinical trials). These limitations of current engineered cartilage products are the subject of
continued research.
1.1.4 Cartilage tissue engineering
To generate a cartilage tissue construct, a typical CTE strategy isolates and cultures a chondro-
genic cell source within a biocompatible scaffold (Butler et al. , 2000). Using modern tissue culture
techniques (i.e. a chemically-defined, serum-free media formulations and growth factor supplemen-
tation to stimulate matrix production and ensure a chondrogenic phenotype), our lab and a few
others have shown that small tissue constructs can routinely be grown to achieve native compressive
properties. The growth of engineered constructs is modulated by the culture system used, which is
where biomedical engineers can act to develop more functional tissue replacements. There are three
important culture factors to consider for system optimization: 1) cell source, 2) scaffold type, and 3)
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media formulation and culture configuration with the objective of producing large tissue constructs
with functional mechanical properties.
1.1.4.1 Cell source Originally, cell source for cartilage tissue engineering was primary chondro-
cytes harvested directly from native cartilage and digested out of the matrix (Benya & Shaffer, 1982;
Buschmann et al. , 1995). Primary chondrocytes are fully differentiated, ensuring matrix synthesis
similar to native cartilage. As primary cells are taken directly from the tissue there are limitations on
the number of harvestable cells, particularly from a tissue with as low a cellularity as cartilage. Cell
passaging is a technique whereby adherent cells can be plated into a two-dimensional environment
and allowed to multiply, a method routinely used for enhancing the supply of cells. Two-dimensional
(2D) culture, being unnatural for most cells, can lead to “de-differentiation,” a phenomenon were a
cell phenotype is altered to a non-native state. For chondrocytes, early work suggested that limit-
ing the length of time the cells are cultured in 2D, returning the cells to a three-dimensional (3D)
environment to culture, and using growth factors and specific nutrients can help prevent deleterious
de-differentiation (Benya & Shaffer, 1982; Bonaventure et al. , 1994; Darling & Athanasiou, 2005).
In addition to chondrocytes, adult stem cells are a widely researched cell source of developing en-
gineered cartilage constructs (Tuan et al. , 2002; Guilak et al. , 2004; Caplan, 2007; He et al. , 2009).
Adult stem cells have the ability to be transformed into an number of different cells, and are located
in adult fat (adipose-derived stem cells), bone marrow (bone marrow stem cells), synovial tissue
(synovial derived stem cells), and other connective tissues. Adult stem cells have the advantage of
being readily available such that high cell contents can be easily obtained. A challenge to using adult
stem cells is first converting them to chondrocytes necessary for synthesizing the matrix molecules
required for the structure and mechanical properties of the engineered cartilage construct. Recent
advances in adult stem cell techniques, however, have shown great strides in controlling bone marrow
derived stem cells into robust engineered cartilage (Mauck et al. , 2006; Erickson et al. , 2012).
1.1.4.2 Scaffold type Scaffold selection of an engineered tissue is an equally delicate
challenge with options including: biologically derived scaffolds, synthetic scaffolds, and scaf-
foldless strategies. Biologically derived scaffolds include both the agarose and alginate
(marine-derived) scaffolds with little biological activity in mammals (Lee & Mooney, 2001;
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Benya & Shaffer, 1982; Buschmann et al. , 1995; Mauck et al. , 2000), and cartilage derived matrix
scaffolds (Cheng et al. , 2012; Garrigues et al. , 2014; Burnsed et al. , 2016; Rowland et al. , 2016),
in which native cartilage is devitalized and cleaned of immunogenic material before breaking the
matrix up for use as a scaffold. These scaffolds were originally chosen as a convenient system for
homogeneously encapsulating the isolated cell population and maintaining proper cell phenotype.
Scaffoldless approaches consist of seeding cells to coalesce and create highly-cellularized constructs
which lack the geometrical constraint of a traditional scaffold material (Elder & Athanasiou, 2009;
Bhumiratana et al. , 2014; Yamashita et al. , 2015; DuRaine et al. , 2015). Agarose as a scaffold
has played a fundamental role in studies of both chondrocyte biology and in early tissue engineer-
ing work, as the scaffold retains a high proportion of the synthesized matrix molecules and readily
encapsulates chondrocytes and other cells. Both cartilage derived and scaffoldless approaches have
gained much attention in recent years and several small clinical trials are ongoing for each system.
1.1.4.3 Culture conditions Culture conditions of engineered cartilage were originally carefully
titrated and validated in earlier works to ensure and enhance nutrient (oxygen and glucose) availabil-
ity (Vunjak-Novakovic et al. , 1998; Obradovic et al. , 1999; Freed et al. , 1993). Most of these cul-
ture systems have been replaced with orbital shaking or perfusion platforms (Sittinger et al. , 1994),
although sufficiency of nutrient availability in most systems is often not interrogated.
Media formulations, originally supplemented with fetal bovine serum (FBS), are now chemically-
defined and supplemented with growth factors (Mauck et al. , 2003; Van der Kraan et al. , 2002).
This change has enhanced reproducibility and tissue properties within the field. It is a seldom
addressed issue, but one of great importance as engineers design larger sized constructs. Most
modern systems utilize a formula consisting of at least glucose, insulin, amino acids, ascorbic acid,
glucocorticoids (dexamethasone), and antibiotics/anti-mycotic (to prevent bacterial and mycotic
growth) (Cigan et al. , 2013). The most notable growth factor administered is TGF-β which has
been a fundamental simulator of matrix synthesis and helps maintain the chondrogenic phenotype
of not fully differentiated stem cells.
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1.1.5 Computational growth models
Interestingly, computational models played a large role in early studies of tissue engineered cartilage.
Early models were used to assess the hydrodynamics, media perfusion, and cell seeding efficiency
on early scaffolds where cell adherence could not be presumed (Vunjak-Novakovic et al. , 1998;
Vunjak-Novakovic et al. , 1999). Subsequent analysis of the critical nutrient oxygen led to
early growth models of the GAG content within the scaffolds based on oxygen availability
(Obradovic et al. , 2000). This study was followed with an extension which also monitored ra-
dial tissue swelling over time (Nikolaev et al. , 2010). These seminal studies have illustrated the
potential utility of a modeling framework which can examine how culture conditions translate to a
tissue’s functional properties. Furthermore, the authors illustrated the complex ecosystem in which
biological growth phenomena occur. Despite their novelty, these computational models lacked the
generalizability required to gain insights on culture conditions as they were fit and validated on
the same data sets, had key parameters (such as GAG synthesis behavior, cell proliferation, and
infinite supply nutrient concentration boundary conditions) coded directly into the equations, and
were developed in a framework which only permitted a two-dimensional, cylindrical analysis. These
models also illustrate two distinct classes of computational models which can be applied to engi-
neered tissue growth: those that examine biochemical content only, and those that also predict the
evolution of mechanical properties.
1.1.5.1 Biochemical models Biochemical models, the most commonly performed, often focus
on using a prototypical nutrient (such as oxygen) to predict the levels of matrix synthesis within
a tissue (Sengers et al. , 2004; Sengers et al. , 2005a; Zhou et al. , 2008; Soares & Sacks, 2016).
The synthesized soluble matrix products then undergo reversible binding to the engineered scaf-
fold (Wilson et al. , 2002; DiMicco & Sah, 2003; Klein & Sah, 2007; van Donkelaar et al. , 2011).
More generalized models have focused on the dynamic role of cellular proliferation within en-
gineered cartilage, leading to a potentially more faithful model of the evolving tissue system
(Galban & Locke, 1999b; Galban & Locke, 1999a). Importantly, and in part due to the original
experimental studies, matrix synthesis models are coded with a pre-set level of matrix content, at
which matrix synthesis ceases.
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1.1.5.2 Mechanical models Mechanical models are typically based on compositional mod-
els of native cartilage and have been used to investigate matrix compositional proper-
ties and the individual roles of different matrix molecules and collagen fiber orientation
(Wilson et al. , 2004; Kelly & Prendergast, 2006; Nagel & Kelly, 2012; Khoshgoftar et al. , 2011;
Khoshgoftar et al. , 2013a; Khoshgoftar et al. , 2013c). To bridge biochemical and mechanical mod-
els, some mechanical modeling approaches have used temporal deposition of material, although the
role of growth has yet to be elucidated (Khoshgoftar et al. , 2013b).
1.1.5.3 Systems biology models Despite the sophistication of these biochemical and mechan-
ical models, the utility of such model lie in the ability to depict the underlying physics of growth.
In modern tissue culture systems, however, growth phenomena are often controlled ultimately by
both the cells and growth factor administration schedules. Such advances in tissue culture have
left the traditional computational models unable to meet the growth kinetics seen. To this end,
recent advances in the field of systems biology have developed faithful models, but these work at
the small scale of individual cells. Most notably for this work, TGF-β signaling models develop
interesting insight into the modes by which cells respond to it (Zi et al. , 2011; Nicolás et al. , 2004;
Dubrulle et al. , 2015). Such models, while only predictive of intracellular signaling cascades, are
illuminating in that 1) the stimulation by TGF-β and other growth factors can be titrated and
diminished over time and 2) stimulatory doses are influenced over a wide range of concentrations.
1.1.6 Unanswered questions in cartilage tissue engineering
While modern CTE techniques can now routinely engineer small cartilage constructs with native
GAG and compressive modulus properties, challenges persist limiting the translation of this tech-
nology to clinical treatments. Of these, addressing two key challenges would immediately promote
the acceptance of CTE into the clinic: 1) adequate scaling up of culture systems to develop large
sized tissue replacements and 2) the development of robust mechanical properties in engineered
cartilage constructs to match the native biomechanical environment of the tissue.
Due to the promising advances in CTE systems which approach native mechanical properties in
small systems, several recent studies have worked to grow constructs in the shape of entire anatomical
articular layers. However, without proper understanding of the nutrient demands within the tissue,
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these constructs have exhibited significant matrix heterogeneities. Increased nutrient availability
within these large tissues is a critical step for translating these systems to a state of clinical readiness.
On this note, our lab’s recent efforts to grow large constructs through the assembly of smaller
pieces, while a potentially interesting technique for developing constructs of different tissue sizes,
were performed irrespective of the high nutrient demands of the tissue. The heterogeneous matrix
deposited played a detrimental role as tissue constructs failed at ≈0.2 MPa failure stress from the
incomplete matrix deposition within the tissue. Native cartilage has a failure stress of greater than
10 MPa, suggesting that constructs would fail soon after implantation and under normal loading.
Overall, the point should be stressed that current tissue engineering protocols are promising enough
that overcoming the matrix heterogeneities within large constructs will be a significant advance
towards moving constructs to the clinic.
To this end the unique and robust mechanical properties of native cartilage play a significant role
in the proper function of the tissue. The high tensile modulus relative to compressive modulus is an
essential part of the tissue having such low friction properties. For the engineered tissue constructs
to be adequate, long-term replacements, they should best match these native cartilage functional
properties. Thus an enduring goal of CTE has been developing native tensile mechanical properties
within the tissue and coaxing resident cells into preferentially synthesizing a robust collagen network.
Ultimately, the ability to engineer large, anatomically-sized cartilage constructs with native
tensile and compressive mechanical properties will be a major transition point towards moving
more promising CTE technologies forward into clinical practice to address the clinical pains and
problems which patients face.
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1.2 Significance and Specific Aims
Osteoarthritis is degenerative disease of the articular cartilage that manifests itself once defects in the
cartilage matrix become large enough to stimulate nerves in both the subchondral bone, ligaments,
fat pads, and other soft tissues of the capsule in response to altered mechanical loading of the joint.
The unique nature of cartilage, notably featuring a dense network of structural molecules to support
the high loading environment, also give rise to a tissue which is avascular, aneural, and has a low
resident cell population ultimately limiting the regenerative capacity of the tissue to small defects
(Maroudas et al. , 1975; Stockwell, 1971a). When this limited repair capability fails, these small
defects eventually erode into the large defects typical of symptomatic osteoarthritis (OA). To date,
there are no widely-available clinical treatments to repair or resurface these large defects which are
the source of much disability. Presently, the gold standard treatment is to manage the pain until
the patient can no longer function, followed by a total joint replacement with an artificial joint.
Cartilage tissue engineering (CTE) is a promising cell-based therapy where a biochemically and
biomechanically functional cartilage construct is engineered to replace and resurface the degen-
erative cartilage (Vacanti & Langer, 1999; Butler et al. , 2000). Seminal CTE studies nearly two
decades ago produced the first promising proof-of-concept results for the engineering and develop-
ment of a native cartilage analog for replacing defects of symptomatic OA (Benya & Shaffer, 1982;
Freed et al. , 1993; Buschmann et al. , 1995).
Since this early work, an emphasis has been placed on using engineering and computational
analyses to develop tissues more similar to native articular cartilage. In the early days of cartilage
tissue engineering, the use of serum-based media produced tissues with heterogeneous levels of ma-
trix synthesis and variable success rates. Recent biotechnology advances have improved the success
rates and consistency of tissue engineering studies with quantitative and defined culture protocols
that repeatedly produce similar results across multiple studies and labs. This level of consistency
is encouraging and makes the application of quantitative computational models a suitable solution
to addressing a complex, but reproducible, system.
Today’s modern CTE techniques successfully engineer small-sized constructs with native GAG
content and equilibrium compressive mechanical properties (Byers et al. , 2008; Lima et al. , 2007).
While OA degeneration begins as small-sized defects, OA becomes symptomatic to patients only
11
once defects exceed ≈5 cm2(Moisio et al. , 2009), limiting the utility and application of such small
constructs into clinical practice. To this end, our lab and others have utilized nutrient channels to
enhance matrix synthesis within large-sized constructs (Bian et al. , 2009a; Buckley et al. , 2009;
Miller et al. , 2012; Sheehy et al. , 2014; Sheehy et al. , 2011). Our early work demonstrated that
channels improve mechanical properties of constructs, although biochemical content was not en-
hanced with nutrient channels (Bian et al. , 2009a). At the same time, other labs were observ-
ing that large construct properties were not influenced by the incorporation of nutrient channels
(Buckley et al. , 2009). Understanding the optimal spacing of channels and the modes by which
engineered cartilage growth are influenced by channels therefore became an important milestone as
engineers worked to grow large, anatomically-sized cartilage constructs. Too few channels would
not allow adequate nutrient availability while too many channels would remove the tissue essen-
tial for cells to deposit matrix and develop the structural properties necessary to match native
cartilage. Moreover, understanding the influence of enhanced nutrient availability and more homo-
geneous tissue properties is a critical task for enhancing engineered cartilage mechanical (functional)
properties.
The specific aims of this work are focused around the paradigm of developing, informing, and
using computational growth models to improve and optimize engineered cartilage culture protocols
and using experiments to inform, validate, test, and confirm computational models and predictions.
Experiments and models first address the development of computational growth models of the
biochemical growth in engineered cartilage constructs. Based on the success of these results and
experimental outcomes, models and experimental focus on the mechanical implications of de novo
cartilage growth. The specific aims are divided into two distinct, but coordinated, tasks. Specific
Aims 1.2, 1.2, and 1.2 (Part I) examine the nutrient conditions within developing engineered cartilage
constructs and their influence on the evolving biochemical composition of the tissue. Specific Aims
1.2 and 1.2 (Part II) then utilize the understanding of the biochemical environment from Aims 1.2,
1.2, and 1.2 to develop computational models of evolving mechanical properties within developing
tissues, and to enhance culture protocols that improve tissues’ functional properties.
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Specific Aim 1: Assess critical nutrient availability within engineered cartilage
constructs
Specific Aim 1 experimentally characterizes the growth of small engineered tissues and monitors the
transport properties of the critical nutrients identified for the [bovine chondrocyte]-[agarose gel] tis-
sue engineering system, being predominately glucose and active TGF-β3. Although these nutrients
were identified in previous studies to be critical for growth, using computational models to assess
their availability for our own system-specific construct geometries and culture conditions allows us
to answer the question of “how best can we ensure adequate nutrient availability.” Moreover, as
TGF-β plays a transformational role in the nutrient demands of the tissues, further experiments
were performed with oxygen and inorganic sulfate to investigate whether TGF-β increases demands
of these nutrients as well.
Specific Aim 2: Assess matrix deposition rates and binding characteristics within
engineered cartilage constructs
In light of a more fundamental understanding of the critical nutrients of concern in our engineered
tissue system, Specific Aim 2 interrogates how matrix synthesis is governed in response to both
adequate and inadequate nutrient availability. In small constructs with sufficient nutrition, the
critical structural proteins of engineered cartilage are determined and their characteristic deposition
behaviors are extracted. This, for the first time, allows us to investigate our prior experimental
attempts at growing large-sized anatomical patella constructs.
Specific Aim 3: Develop and validate relations between the key nutrients glucose and
active TGF-β3 and the cellular proliferation and matrix synthesis within engineered
cartilage. Use models for optimizing the arrangement of nutrient channels within
engineered cartilage constructs.
Specific Aim 3 begins constructing the first comprehensive finite element growth models based
on the modern, standardized, engineered cartilage culture protocols. This work builds off the
nutrient models of Specific Aim 1 and the matrix deposition models of Specific Aim 2. As a
first step we grew small constructs with varying TGF-β doses to investigate the various growth
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mechanisms behind TGF-β supplementation. Based on the culmination of these previous works,
we implemented and developed both matrix synthesis and cellular proliferation models based on
the TGF-β availability. While not examined in most models of cartilage growth, the influence of
cellular proliferation and initial cell seeding density proved influential in the predictive power of
the computational models. This work represents a significant advance in our ability to predictively
assess the success of engineered tissue culture based on matrix deposition within constructs of
various cell densities and geometries.
Specific Aim 4: Experimentally measure and computationally model mechanisms of
the growth underlying engineered cartilage maturation and mechanical growth.
Building off these biochemical growth models, Specific Aim 4 develops physical growth models of
engineered cartilage. As cartilage constructs will ultimately be required to undergo implantation in
the dynamically loaded joint environment, it is a critical step to determine how culture conditions
influence the mechanical properties of the developing tissue in addition to the biochemical content.
However, no engineered cartilage growth models had been proposed in the prior literature. The work
of this aim therefore presents the first set of experimental and computational models to support
a mechanism of matrix synthesis mismatch between GAG synthesis and collagen deposition to
explain the large swelling seen in our engineered cartilage. This work further provides the first
set of fundamental, generalized modeling for the biological growth of engineered tissues through a
mixture of structural constituents. This provides us with a level of modeling sophistication which
can now anticipate the developing mechanical properties in engineered cartilage during growth.
Specific Aim 5: Develop and utilize a constraint-based culture system (cage) to
improve the functionality of engineered cartilage; test the cage approach in both
agarose scaffolds and also cartilage devitalized matrix hydrogel scaffold.
The growth and remodeling insights into engineered cartilage which the computational models of
Specific Aim 4 afforded us, presented us with a direct and fundamental target to improve the
mechanical properties of engineered cartilage through enhanced support of the developing collagen
framework. Specific Aim 5 developed and experimentally cultured constructs within a cage system
in the presence of sufficient nutrition to improve the collagen stability of growing tissues. As the
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fundamental theories on which a supportive cage was developed are contingent only on the mismatch
of GAG and collagen, both agarose and cartilage derived matrix hydrogels were tested within the
cage systems. Constructs cultured in cages with both scaffolds had improved mechanical properties
and enhanced collagen cross-linking. This suggests the cage system will be a promising advance in
the future of cartilage tissue engineering technology.
15
1.3 Detailed Specific Aims
Specific Aim 1: Assess critical nutrient availability within engineered cartilage
constructs
Over a decade ago, a strong translational effort in our lab was made to engineer the first anatomical
patella cartilage construct. While an achievement for the time, the study was instructive on the
physical limitations of engineering large-sized, engineered cartilage tissues. The purported culprit
hindering this initial attempt of engineering an anatomically-sized construct was the inability of
critical nutrients to reach within the interior of the constructs. Notably, the patella construct
(with an articular layer thickness of up to 7 mm) was significantly larger than any prior cartilage
constructs and the tissue displayed severe matrix heterogeneities, with matrix deposition occurring
predominantly near the tissue periphery and little deposition occurring within the center of the
construct.
In a subsequent effort, coring a single ! 1 mm channel in a ! 4 mm construct or three ! 1
mm channels within a ! 10 mm construct could improve functional tissue properties. Moreover,
previous efforts using both serum-based and chemically-defined media formulations had demon-
strated increases in functional properties when tissues were cultivated with adequate nutrient sup-
ply. Together, these studies suggested that nutrient limitations can be overcome with channels and
understanding the precise nutrient deficiencies within large engineered tissues.
To this end, this aim examines the role and availability of such “critical” nutrients and develops
computational models based on the consumption of the critical nutrients to determine whether these
nutrients are limiting in the culture of large tissue constructs. Based on our experimental work up
to this point, we have characterized the role of both glucose and TGF-β for their growth-limiting
roles and have characterized the critical internalization (consumption) rates and the growth-limiting
concentration of glucose (Cigan et al. , 2013; Nims et al. , 2015; Albro et al. , 2016).
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Specific Aim 1.1: Develop and implement computational models based on
culture conditions, construct geometries, and consumption kinetics of glucose.
Specific Aim 1.2: Alter culture conditions (glucose supply) to identify a
media volume at which glucose will always be at concentrations that
promotes growth.
Specific Aim 1.3: Building from Specific Aim 1.2, develop computational
models based on the transport and binding of active TGF-β to investigate
transport within engineered cartilage.
Specific Aim 1.4: Experimentally measure the dependence of matrix growth
on oxygen and sulfate.
Completing these sub-aims will advance our understanding of how the critical nutrients are
distributed during engineered cartilage growth and how their availability can be enhanced through
culture conditions.
Specific Aim 2: Assess matrix deposition rates and binding characteristics within
engineered cartilage constructs
Developing computational growth models further requires models of the matrix synthesis and depo-
sition behaviors within the engineered tissues. For computational efficiency, like the nutrient models
previously, modeling only the critical structural molecules for engineered cartilage deposition is es-
sential. In native cartilage the structural molecules are negatively charged proteoglycans (made
up of glycosaminoglycans, GAG, chains) and type II collagen. Minor structural proteins however,
such as cartilage oligomeric matrix protein (COMP), lubricin, pyridinoline, and hyaluronan, are
purported to further play a role in the mechanics of engineered cartilage.
We first struck out to examine the deposition of extracellular matrix proteins and which proteins
play a critical role in the developing mechanics of the tissue. The binding and deposition charac-
teristics were then fit according to a computational model description of reversible matrix binding
throughout construct culture. Such models can be implemented with the descriptions of glucose
availability, a simple relation based on the work of Specific Aim 1.2, to develop computational
models of the interactive dependence of glucose availability and matrix deposition.
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Specific Aim 2.1: Experimentally characterize the deposition and matrix
release profiles of GAG, collagen, and COMP within small engineered
cartilage constructs.
Specific Aim 2.2: Computationally fit the matrix deposition and release
profiles to a reversible reaction kinetics model of the developing cartilage
constructs.
Specific Aim 2.3: Experimentally characterize dependence of correlations of
matrix deposition on cell density and hyaluronan content within small
engineered constructs.
Specific Aim 2.4: Develop computational models of the interactions between
glucose availability (developed and validated in Specific Aim 1) and matrix
deposition in an anatomical construct.
Completing these sub-aims will advance our understanding of the critical matrix molecules of
engineered cartilage that must be modeled for growth and how simple nutrient availabilities dictate
the spatial deposition of matrix growth.
Specific Aim 3: Develop and validate relations between the key nutrients glucose and
active TGF-β3 and the cellular proliferation and matrix synthesis within engineered
cartilage. Use models for optimizing the arrangement of nutrient channels within
engineered cartilage constructs.
Based on the system identification parts in Specific Aims 1.2 and 1.2, we can develop comprehensive
computational models for the developing constructs in the presence of glucose and TGF-β via the
biochemical deposition and maturation of GAG and collagen within the tissue. While the bulk of
the parameters will be built from the models of the first two aims, a relation between the growth
of engineered cartilage and the availability of TGF-β remains unknown.
The first investigations into the stimulatory role of TGF-β were crucial in establishing the
dose dependence of TGF-β (Byers et al. , 2008), but in light of the severe heterogeneity of the
tissue, an increased range of TGF-β supplementation levels is required for modeling the differential
stimulation of TGF-β. Moreover, based on the experimental channel studies of (Nims et al. , 2015)
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and (Cigan et al. , 2016c), there are contradicting experimental results which may indicate a strong
dependence of the channel-spacing optimization on the initial cell seeding densities of the constructs.
Models must therefore the able to examine the influence of cell density and proliferation on the
growth kinetics of the developing tissue. Once validated, models can be used to assess how different
cell culture factors and tissue geometries influence the growth of tissue development.
Specific Aim 3.1: Experimentally investigate the role of a wide range of
active TGF-β3 concentrations on cellular proliferation, GAG and collagen
deposition, and construct growth.
Specific Aim 3.2: Develop and implement computational models based on the
matrix synthesis and binding and nutrient consumption and transport models
to link the availability of active TGF-β3 and glucose to cellular proliferation
and matrix synthesis. Fit model growth parameters to experiments of
Specific Aim 3.1.
Specific Aim 3.3: Using the matrix synthesis and cellular proliferation models
of Specific Aim 3.2, validate models against previously published channel
studies using channel-specific finite element model geometries and adapting
models to reflect: construct geometry, culture conditions (media bath
volume, nutrient concentration, and media resupply rate), and initial cell
seeding density.
Specific Aim 3.4: Simulate the growth of engineered constructs using a
variety of engineered construct geometries and initial cell seeding densities to
observe optimal construct geometries to maximize matrix deposition.
Completing these sub-aims will advance our understanding of the complex interactions between
the developing biochemical content of engineered tissues with the culture conditions, construct
geometry, and cell seeding density of the tissues.
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Specific Aim 4: Experimentally measure and computationally model mechanisms of
the growth underlying engineered cartilage maturation and mechanical growth.
In both native and engineered cartilage, the biochemical and mechanical properties develop hand
and hand with the maturation of the the tissue. To withstand the robust mechanically-loaded
environment within the joint, engineered cartilage must match the functional properties of the na-
tive tissue. While tissue engineering efforts have been successful in matching the GAG content of
native cartilage, it is unclear how the deposition of newly synthesized GAGs and collagens influ-
ence the mechanical properties of developing engineered cartilage. Traditional structural models of
cartilage, which approximate the mechanical roles of both GAG and collagen, have been validated
only for native, mature cartilage in which the tissue has reached a steady-state metabolism with
little turnover. Engineered cartilage, however, experiences a rapid level of growth that cannot be
adequately explained by these former models.
In Specific Aim 1.2, we will experimentally grow engineered constructs to examine the growth
kinetics underlying their mechanical and physical changes. Interestingly, in our prior experiments
of Specific Aims 1.2, 1.2, and 1.2, constructs supplied with sufficient nutrition begin to expand
and grow when supplied with sufficient nutrition. This swelling is matched by a plateauing in
mechanical properties in a phenomenon which the literature deems as “tissue maturation.” Despite
this “maturation,” however, constructs continue to expand and grow under the continued synthesis
of matrix proteins. The mechanisms underlying this growth are yet unknown and uncharacterized.
This aim examines the physics of the continued growth using both experimental measures of
matrix turnover and changes and computational models to quantitatively describe and validate such
changes.
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Specific Aim 4.1: Experimentally investigate the role of elevated cell seeding
density (120 million cells mL−1) on constructs growth under both untreated
and chondroitinase ABC treated constructs.
Specific Aim 4.2: Develop and implement computational damage models
based on the experimental matrix synthesis of Specific Aim 4.1 to fit the
physical growth (tissue swelling ratio, SR, and unconfined compressive
modulus, EY ). Validate models according to the chondroitinase ABC studies
according to SR and EY .
Specific Aim 4.3: Synthesize the validated physical growth models with the
validated biochemical growth models to develop a comprehensive model
informed by culture conditions and construct geometry and predictive of
mechanical properties and tissue growth.
Completing these sub-aims will advance our understanding of the mechanism of growth within
engineered cartilage constructs.
Specific Aim 5: Develop and utilize a constraint-based culture system (cage) to
improve the functionality of engineered cartilage; test the cage approach in both
agarose scaffolds and also cartilage devitalized matrix hydrogel scaffold.
The experimental findings of Specific Aim 1.2 illustrate that the high and rapid synthesis of GAG
relative to the restraining force of deposited collagen can disrupt the deposition of new collagen
within the construct and leads to the plateauing of mechanical properties despite continued matrix
synthesis and deposition. To enhance the collagen framework during engineered cartilage develop-
ment we propose using a mechanical restraint (“cage”) system to maintain the mechanical integrity
of the nascent collagen framework.
We further suspect that due to the predominance of excess GAG synthesis, relative to collagen
synthesis, across the field of tissue engineering, that this method is readily translatable to a num-
ber of different engineered cartilage systems. To test this, we apply the cage system to a tissue
engineering system using a cartilage derived matrix hydrogel (CDMH) scaffold system. CDMH
scaffolds are gaining in popularity as the tissue engineering field looks to match the cellular niche
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which chondrocytes typically occupy for improving the properties of developing tissues.
To investigate the use of a cage system to improve functional tissue properties, the following
two specific aims are performed.
Specific Aim 5.1: Experimentally culture engineered cartilage constructs
using an agarose scaffold in a mechanical constraining cage assembly and
under free-swelling (control) conditions to assess the mechanical property
enhancement when the collagen framework develop is enhanced through
cages.
Specific Aim 5.2: Experimentally culture engineered cartilage constructs
using a cartilage derived matrix hydrogel scaffold in a mechanical
constraining cage assembly and under free-swelling (control) conditions to
assess the mechanical property enhancement when the collagen framework
develop is enhanced through cages.
Completing these sub-aims will advance our understanding of how experimental methodologies
based on the fundamental growth mechanisms of engineered cartilage can produce superior tissues
across a range of cartilage tissue engineering systems.
22
Part I
Biochemical Growth Models and Experiments
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Chapter 2 Models of glucose availability in channeled tissue
constructs and remediation with increased glucose
supply
2.1 Abstract
Cartilage tissue engineering is a promising approach to resurfacing osteoarthritic joints. Existing
techniques successfully engineer small-sized constructs with native levels of extracellular matrix
(glycosaminoglycans (GAG) or collagen). However, a remaining challenge is the growth of large-sized
constructs with properties similar to those of small constructs, due to consumption and transport
limitations resulting in inadequate nutrient availability within the interior of large constructs. This
study employed system-specific computational models for estimating glucose requirements of large
constructs, with or without channels to enhance nutrient availability. Based on glucose requirements
for matrix synthesis in cartilage constructs, computational simulations were performed to identify
the media volume (MV) and the number of nutrient channels (CH) needed to maintain adequate
glucose levels within tissue constructs over the three-day period between media replenishments.
In Study 1, the influence of media volume (MV: 5, 10, 15 mL/construct) and number of nutrient
channels (CH: 0, 3, 7, 12 per construct) on glucose availability was investigated computationally
for ∅10 mm × 2.34 mm cylindrical constructs. Results showed that the conventionally used MV
5 led to deleterious glucose depletion after only 40 h of culture, and that MV 15 was required to
maintain sufficient glucose levels for all channel configurations. Study 2 examined experimentally
the validity of these predictions, for tissue constructs cultured for 56 days. Matrix elaboration was
highest in MV 15/CH 12 constructs (21.6±2.4 %/ww GAG, 5.5±0.7 %/ww collagen, normalized
to wet weight (ww) on day 0), leading to the greatest amount of swelling (3.0±0.3 times day-
0 volume), in contrast to the significantly lower matrix elaboration of conventional culture, MV
5/CH 0 (11.8±1.6 %/ww GAG and 2.5±0.6 %/ww collagen, 1.6±0.1 times day-0 volume). The
computational analyses correctly predicted the need to increase the conventional media levels three-
fold to support matrix synthesis in large channeled engineered constructs. Results also suggested
that more elaborate computational models are needed for accurate predictive tissue engineering
simulations, which account for a broader set of nutrients, cell proliferation, matrix synthesis, and
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swelling of the constructs.
2.2 Introduction
Osteoarthritis (OA) is a debilitating, degenerative disease that degrades the articular cartilage
of diarthrodial joints, compromising its low-friction, load bearing function (Krishnan et al. , 2004;
Mow et al. , 1984; Stockwell, 1979). OA often becomes symptomatic only after large focal de-
fects (≈5 cm2) have appeared, eventually progressing to encompass most of the articular surface
(Moisio et al. , 2009). Cartilage tissue engineering (CTE) is a promising technique for the treat-
ment of OA. In our vision, a tissue replacement would be cultured first in vitro to develop a robust
native matrix prior to in vivo implantation into the large focal defects (Hunziker, 2002).
While conventional culture techniques can successfully engineer small constructs (≈0.1
cm2) approaching native levels of glycosaminoglycans (GAG) and collagen (Lima et al. , 2007;
Byers et al. , 2008), culturing large constructs for resurfacing clinically relevant defect sizes
remains a challenge (Hung et al. , 2003; Hung et al. , 2004). Consumption by cells in the con-
struct’s peripheral regions hinders the transport of nutrients critical for matrix synthesis in
the inner regions, limiting the size to which functional constructs can be grown. To overcome
transport limitations, several strategies have been employed for enhancing nutrient availability.
Heywood et al. demonstrated that increasing media volume in cultures of small [primary
bovine chondrocyte]-[alginate] constructs enhanced extracellular matrix (ECM) elaboration and
homogeneity (Heywood et al. , 2006b; Heywood et al. , 2006a). More recently, our lab and others
have incorporated nutrient channels into large constructs. This reduction in nutrient path
length within large constructs produced tissues with higher compressive mechanical properties
and improved matrix distribution over channel-free constructs, although differences in total
matrix content were insignificant (Bian et al. , 2009a; Buckley et al. , 2009; Cigan et al. , 2016c).
Despite these advances, our limited understanding of the specific nutrient requirements for
construct synthesis compromises the application of culture strategies to larger constructs. This
notion is supported by the variability of media supply rates found in the literature (Table 1)
(Heywood et al. , 2004; Hu & Athanasiou, 2006; Buschmann et al. , 1992; Buckley et al. , 2009;
Vunjak-Novakovic et al. , 1996; Obradovic et al. , 1999; Davisson et al. , 2002b;
Kisiday et al. , 2002; Mauck et al. , 2002; Nims et al. , 2014).
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The aim of our study was to formulate and validate system-specific computational models for
estimating the nutrient supplies needed to engineer large tissues, with or without nutrient channels.
These models may account for system-specific ECM synthesis and nutrient consumption. This study
focused specifically on the supply of glucose in the [juvenile bovine chondrocyte]-[agarose gel] CTE
system. In our recent experimental study of cellular glucose consumption and matrix synthesis in
small constructs (∅4 mm × 2.34 mm), a glucose concentration of 12.5 mM was identified as the
nutrient threshold below which the ECM synthesis ceased (Nims et al. , 2014; Cigan et al. , 2013).
This threshold represented half the initial glucose concentration of 25 mM in standard cell culture
media, suggesting that such standard conditions may easily lead to nutrient depletion in tissue
engineering studies when the media/cell ratio is inadequate. Indeed, preliminary simulations con-
ducted for this study suggested that our standard culture conditions fail to supply larger (∅10 mm
× 2.34 mm) constructs with adequate glucose levels for ECM elaboration. Consequently, placing
nutrient channels into constructs would be ineffective under those conditions, potentially leading to
confounding results if nutrient levels were not accounted for.
Motivated by these insights, we investigated whether computational models, informed by this
critical glucose threshold and experimentally characterized glucose consumption rates, can identify
adequate levels of media volume per construct to ensure optimal matrix synthesis during tissue
culture for a variety of channel configurations. To this end, finite element (FE) models were first
used to simulate the influences of media volume and nutrient channel density on the glucose con-
centrations within large constructs (Study 1); in this manner, the theoretical conditions required
for sufficient glucose availability were identified. Informed by Study 1, large constructs were ex-
perimentally cultured for 8 weeks under these computationally predicted suboptimal and optimal
conditions, and their mechanical properties and biochemical composition were assessed (Study 2).
2.3 Methods
2.3.1 Nutrient simulations
Nutrient supply and consumption models were performed in FEBio (www.febio.org) to simulate the
glucose concentration in tissue constructs and their surrounding bath throughout a three-day culture










Buschmann, 1992 4.0 2 1 12.4
Vunjak-Novakovic, 1996 7.0 3 1 10.7
Obradovic, 1999 5.0 5 3 8.3
Mauck, 2002 1.7 0.5 3 2.4
Davisson, 2002 20 12.5 3 5.2
Kisiday, 2002 76.8 12 2 1.9
Heywood, 2004 200 20 3 0.7
Hu, 2006 5.5 0.5 1 2.27
Buckley, 2009 3.75 3 3 18.4
Nims, 2014 0.88 0.5 3 4.7
This work 11.0 15 3 11.3
Table 1: Culture conditions were used to calculate the daily media replenishment volume per million
cells and the daily moles of glucose replaced per million cells. All media was based on 25 mM glucose
except Heywood, 2004.
framework that accounts for chemical reactions, simulating glucose transport from the bath into
the construct, glucose diffusion within the construct, and glucose consumption by chondrocytes
(Nims et al. , 2014). Chondrocytes were not modeled explicitly, but their consumption of glucose
was described by a ‘sink’ rate uniformly distributed across the construct geometry to represent a
similarly homogeneous cell-seeding density. In the standard 2-2-3-day media change schedule, the
three-day period simulated here represented the longest duration without nutrient replenishment.
Based on the system-specific experimental parameters (glucose threshold and glucose consumption
rate (Nims et al. , 2014; Cigan et al. , 2013), simulations were performed to identify the culture
conditions that prevent the glucose concentration throughout the construct from dropping below
the glucose threshold for ECM synthesis.
Constructs were modeled as being suspended within a well-stirred bath, boundary conditions
representative of the experimental configuration (Cigan et al. , 2013). The bath was modeled explic-
itly and well-stirred conditions were simulated using glucose diffusivity one thousand times higher
than in the construct (Nims et al. , 2014). FE model geometries and meshes (CUBIT, Sandia Na-
tional Laboratory) matched the geometries of several candidate channel and bath configurations
(Figure 2.1): constructs (∅10 mm × 2.34 mm) suspended within a media bath volume of 5, 10, or
15 mL (MV: 5, 10, and 15) and configured with either 0, 3, 7 or 12 channels (CH: 0, 3, 7, 12), gener-
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ating a total of 12 culture conditions. CH groups represent triangular packing arrangements of ∅1
mm channels that may be inscribed symmetrically within a ∅10 mm construct; the MV groups were
selected such that the lowest (5 mL/construct) represented a typical media/cell ratio employed in
CTE experiments (Table 1), while the highest (15 mL/construct) was predicted to supply adequate
glucose according to the nutrient threshold. As these geometries exhibited both axial and radial
symmetries, symmetrical representative regions (CH 0, 3, 12: 60°, CH 7: 30°; all: half-thickness)
were modeled with symmetry planes (zero-flux boundaries) shown in Figure 2.1 (bottom).
To examine how an infinitely large (or continuous) supply of fresh media would influence con-
struct glucose concentrations, simulations were also run with a fixed 25 mM glucose concentration
prescribed at the construct surface (group MV∞).
Glucose was modeled as an uncharged solute with a constant free diffusivity, Do = 9.2 × 10−4
mm2 s−1, and mixture diffusivity 8.7 × 10−4 mm2 s−1 (Sengers et al. , 2005a); the constructs had
solid volume fractions of 2%, typical of freshly cast constructs. Glucose transport and supply were








where cglu is the glucose concentration and ĉglu is the glucose supply resulting from chemical reac-
tions. A nominal construct cellularity of 60 million cells mL−1 was utilized to inform the glucose
consumption rates of the construct material. To account for variability in the cell glucose consump-
tion rates, simulations for each culture condition were based on the mean, 1.24 × 10−13 mol h−1
cell−1, and 95% confidence interval (CI) limits, 0.69 – 1.81 × 10−13 mol h−1 cell−1, of the glucose
consumption rate for this culture system (Nims et al. , 2014). Cellular glucose consumption was




where V glumax is
the maximal glucose consumption rate of the tissue (with mean value of 2.07 µM s−1 and 95% CI
limits of 1.15 – 3.03 µM s−1) and Km is the Michaelis constant, 0.35 mM (Johnson & Goody, 2011;
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Windhaber et al. , 2003). The initial glucose concentration in both the media and construct mate-
rials was 25 mM, based on high-glucose Dulbecco’s Modified Eagle Media. Models simulated a 72 h
period during which glucose consumption occurred in the construct and glucose transport from the
surrounding bath occurred via passive diffusion through the construct. After the culture simulation,
the minimum glucose concentration within the construct was determined.
2.3.2 Experimental culture and analysis
Experimental culture is described in both (Cigan et al. , 2014) and (Nims et al. , 2015). Constructs
were cultured as idealized by the models with either 0, 3, or 12 nutrient channels (CH0, 3, 12) and
in either 5, 10, or 15 mL media per construct (MV 5, 10, 15).
2.4 Results
2.4.1 Nutrient simulations
Glucose consumption by the cells within constructs caused the projected glucose concentrations
to drop throughout the construct and bath substantially below the initial concentration (25 mM),
with glucose levels varying spatially throughout the constructs (Figure 2.2). Channels enabled the
maintenance of more homogeneous glucose concentrations, whereas channel-free constructs exhibited
large concentration gradients between the construct surface and center. The temporal evolution of
the minimum glucose concentration (at the construct center) is presented in Figure 2.3, based on
average cellular consumption rate. These results show that at low media supply (MV 5), glucose
concentrations were below the 12.5 mM threshold for all CH configurations as early as 40 h for CH
0 and 50 h for CH 12 after medium change. Conversely, for MV 15, glucose concentrations exceeded
the threshold level throughout the 72 h of culture for all CH groups. The MV 10 group maintained
the glucose levels slightly above the threshold for all CH groups at 72 h. However, when examining
the effect of cell consumption rate variability (Figure 2.4), results show that the MV 10 groups
mostly straddle the critical threshold concentration, especially for CH 0 and CH 3. Only the MV
15 group consistently exceeded the glucose concentration threshold for all channel configurations.
On average, the minimum construct glucose concentration increased by 8.4 mM between the
MV 5 and MV 10 groups, and by 2.7 mM between the MV 10 and MV 15 groups (Figure 2.3). For
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Figure 2.1: Experimental configuration. Theoretical models were developed for channeled constructs
suspended in a well-mixed bath. Constructs (with 0, 3, 7, and 12 channels each) were modeled
according to the available symmetry (axial and radial). Models featured a finite media bath, either 5,
10, or 15 mL; constructs then had either a media bath boundary conditions (lateral, top, and channel,
if present, surfaces) or no flux boundary conditions (sagittal cut edges and bottom transverse plane);
as shown is CH 3/MV 5 configuration.
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Figure 2.2: Model-predicted influence of channels (0, 3, 7, and 12 channels per construct) and media
volume (MV 5, 10, 15 mL per construct) on glucose profiles within constructs after 72 h of culture.
a given MV, the minimum glucose concentration within the construct increased by an average of
0.6 mM between each CH level (i.e. 0 to 3, 3 to 7, or 7 to 12). The MV∞ group further elevated
minimum glucose concentrations; minimum construct glucose concentration of the CH 0, 3, 7 and
12 constructs were 23.2, 23.4, 23.8 and 24.4 mM, respectively, at 72 h. From these predictions, it
became evident that increasing MV led to diminishing returns in glucose availability; a MV of 15 was
sufficient to elevate all CH groups with 95% confidence above the 12.5 mM threshold (Figure 2.4).
Therefore, this MV was selected as the highest media volume for experimental culture.
2.4.2 Experimental results
Experimental results are described in depth in both (Cigan et al. , 2014) and (Nims et al. , 2015)
(Figure 2.5). Briefly, construct mechanical properties were similar between all groups, although
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Figure 2.3: Theoretical predictions of the minimum glucose concentration within the construct over
the 72 h culture period. Trend lines represent the mean level of glucose consumption for the different
channel configurations (dotted line: CH 0; dashed line: CH 3; dot-dashed line: CH 7; line-through
dots: CH 12) and media supplementation volumes (light grey: MV 5; dark grey: MV 10; black: MV
15). Horizontal dashed line denotes the critical glucose threshold for matrix synthesis (12.5 mM).
Figure 2.4: Theoretical predictions of the minimum glucose concentration within the construct
after the 72 h culture period. Bar value represents mean glucose consumption level; high error bar
represents the low 95%-CI consumption level; low error bar represents the high 95%-CI consumption
level. Dotted line denotes initial glucose concentration (25 mM); dashed line denotes the critical
glucose threshold for matrix synthesis (12.5 mM).
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swelling was significantly higher with additional media supply. When normalized to the current
day (day 56) wet weight, biochemical contents were similar for all culture groups. Conversely, when
normalized to the day-0 (initial) wet weight, constructs grew significantly more with additional
channels and media supply.
2.5 Discussion
The objective of this study was to formulate and validate system-specific computational models
for estimating nutrient supplies needed to culture large engineered tissues, with or without nutrient
channels. Based on our recent investigations, which reported the glucose threshold necessary for ma-
trix synthesis and a representative glucose consumption rate in our CTE system (Nims et al. , 2014;
Cigan et al. , 2013), we focused on the availability of glucose as an essential nutrient. Predictions
from the simulations indicated that standard media/cell ratios used in studies of smaller constructs
(Table 1) may be inadequate for culturing larger constructs, and that channel incorporation alone
would not ameliorate this nutrient depletion. According to the models, higher media volumes would
be required for maximal matrix elaboration and greater effectiveness of nutrient channels, as related
to glucose.
With this guidance, constructs (CH 0, 3, 12) were experimentally cultured at standard (MV
5 per ∅10 mm × 2.34 mm construct) or elevated (MV 10 and 15) media volumes, to investigate
the validity of computational predictions. Prior investigations of this culture system with con-
structs of this size or smaller have demonstrated that chondrocytes maintain their morphology
throughout the construct (Cigan et al. , 2013; Benya & Shaffer, 1982; Aydelotte & Kuettner, 1988;
Lee & Bader, 1997; Dimicco et al. , 2007). When examining total matrix elaboration, as repre-
sented by D0ww-normalized compositional measures in Figure 2.5, increasing MV produced sig-
nificantly greater ECM deposition (GAG and collagen, Figure 2.5D, F). Nutrient channels further
increased ECM deposition, with the most dramatic CH-induced enhancements evident in the pres-
ence of high MV (Figure 2.5D & F). These experimental results supported the model predictions that
standard media/cell levels produced sub-optimal matrix synthesis and that channels at standard
media levels do not demonstrate much effectiveness for larger constructs.
While GAG and collagen content normalized by D0ww illustrated differences in ECM synthesis
as a function of MV and CH, these differences were not evident when using the more conventional
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Figure 2.5: Mechanical and biochemical construct properties (day 56), (A) EY (kPa), (B) SR, (C)
GAG (%/D56ww), (D) GAG (%/D0ww), (E) collagen (%/D56ww), (F) collagen (%/D0ww), (G)
cell density (cell (D56 mL)-1), (H) cell density (cell (D0 mL)-1). *: significance of CH within given
MV (p < 0.05); +: significance of CH for different MV (p < 0.05); **: significance of indicated
factors (CH, MV, and/or CH × MV or groups ; p < 0.05). Dashed lines (G, H) depict mean day-0
cellularity (99.4 million cells (D0 mL)-1).
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normalization to wet weight on the last day of culture (D56ww). Indeed, though greater matrix
synthesis was observed with increasing MV and CH, EY showed no significant differences among
the groups (Figure 2.5A), presumably because their variable swelling (Figure 2.5B) maintained the
fixed-charge density of GAGs at a nearly uniform level (Figure 2.5C).
In prior studies, we have noted that our CTE system is able to produce GAG at native levels
(≈6% ww for immature bovine cartilage), but that collagen remains significantly below native values
(≈10% ww), as was also observed here (≈7% D56ww GAG in Figure 2.5C and ≈1.5% D56ww
collagen in Figure 2.5E). Interestingly, day-0 normalizations suggest that the amount of collagen
actually synthesized (almost ≈6% D0ww in Figure 2.5F for the MV 15/CH 12 group) could produce
weight ratios closer to native levels, were it not for the substantial swelling (Figure 2.5B) driven by
the Donnan osmotic pressure from charged GAG (Eisenberg & Grodzinsky, 1985; Lai et al. , 1991;
Mow et al. , 1998). These results support the value of strategies using exogenous treatments with
lysyl oxidase, to strengthen the collagen network by increasing collagen cross-link precursors, to
prevent the swelling evident in this study (Athens et al. , 2013).
In prior studies of this model system (Bian et al. , 2009b), it had been suggested that the higher
deposition of GAG might inhibit collagen deposition, possibly due to a steric effect. Histological
stains from this study support this hypothesis (Cigan, 2016), especially around channel edges, where
a greater proportion of synthesized GAGs may diffuse into the channel due to their natural time
constant for binding with the scaffold (Nims et al. , 2014), allowing for a more intense ring of
deposited collagen. This hypothesis had previously motivated alternative strategies for enhancing
collagen deposition by using chondroitinase ABC to enzymatically remove GAG and quell construct
swelling (O’Connell et al. , 2014).
The amount of glucose available in the culture media was adjusted by changing the media vol-
ume per construct instead of modifying the glucose concentration. This choice was motivated by the
desire to maintain glucose concentration at the standard 25 mM of high-glucose DMEM, and the
concern that large changes in concentration might produce confounding effects due to alterations in
osmolality and pH (Heywood et al. , 2006a; Zhou et al. , 2008). Another potential concern is that
large numbers of channels may compromise the construct mechanical integrity, possibly leading
to stress concentrations and cracking under loading. No cracking was observed during mechani-
cal testing on day 56, though the possibility that such damage may occur at physiological load
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magnitudes should not be discounted. In native cartilage, the network of channels that irrigates
the tissue during development and through adolescence eventually disappears. A process whereby
channels completely occlude at the time of construct maturation would be similarly beneficial; by
day 56 of this study, channels filled by ≈75% (data presented in (Nims et al. , 2015)), suggesting
that complete filling may occur at a later time point. Depending on the level of elaboration of
functional properties in the construct, ensuring free flow of media in the channels for longer culture
durations may require periodic material removal. Alternatively, strategies may be needed, such as
the injection of cell-seeded agarose, to completely fill channels prior to implantation.
The computational model employed herein builds from earlier efforts to model engineered
cartilage nutrient consumption (Lin et al. , 2013; Sengers et al. , 2005a; Nikolaev et al. , 2010;
Obradovic et al. , 2000; Zhou et al. , 2008; Galban & Locke, 1999b) and served as a critical step
to develop system-specific models for assessing the culture of the characterized CTE systems.
Models may similarly guide future studies by identifying the most promising experimental cul-
ture conditions for a given construct geometry and cell density, eliminating less promising ones,
and reducing the need for labor- and cost-extensive experimental parametric studies. While the
models here did provide insight on the culture of large constructs, subsequent models may be
considerably improved in future implementations. Under the current framework, the model pre-
dicted that all CH groups within the MV 15 group should produce similar matrix levels. Ex-
perimental results, however, demonstrated that for MV 15 groups, CH was a significant fac-
tor influencing ECM content, suggesting that additional factors may need to be modeled to
account for these observations (Nikolaev et al. , 2010; Sengers et al. , 2005a). Channels also in-
creased the total construct cell content (Figure 2.5H), implying that channels in constructs may
act to both increase nutrient availability and enhance the synthesis capacity of the constructs.
Thus, cellular proliferation may need to be incorporated into future growth models when sim-
ulating multiple weeks of culture (Lemon & King, 2007; Sengers et al. , 2005b). Additionally,
early matrix synthesis models implicated oxygen as a limiting nutrient (Nikolaev et al. , 2010;
Obradovic et al. , 1999; Obradovic et al. , 2000) and recently our lab has shown that active TGF-β
binds extensively to the native ECM suggesting potential transport limitations within engineered
constructs (Albro et al. , 2013). Therefore, the transport, binding, consumption, and biosynthetic
influence of oxygen and TGF-β may need to be included explicitly in future models. Construct
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swelling, resulting from ECM synthesis and Donnan osmotic pressure, may also need to be modeled
to better reproduce observed phenomena (Figure 2.5B, H). With these improved models, it will
become possible to optimize the placement and density of channels for growing full-sized engineered
cartilage layers, recognizing the competition between increasing the number of channels to enhance
nutrient access and reducing the number of cells available for matrix synthesis.
In summary, computational models are becoming increasingly valuable tools for designing ef-
fective culture conditions for engineering large tissue constructs. This study specifically addressed
the amount of glucose in our [juvenile bovine chondrocyte]-[agarose gel] CTE system, as a wide
range of media and glucose supply rates have been employed in prior studies (Table 1), illustrating
the lack of consensus on adequate amounts of this fundamental nutrient. It was found computa-
tionally that conventional culture conditions provide inadequate glucose levels for culturing larger
constructs, obviating the benefits of nutrient channels. Experimental results demonstrated that sig-
nificantly enhanced matrix deposition in channeled constructs could be achieved when using higher
media volume supplementation (Figure 2.5D, F). This agreement between model prediction and
subsequent experimentation encourages further development and validation of predictive models,
including models that account for a broader set of nutrients, cell proliferation, matrix synthesis,
and swelling of the constructs. These more sophisticated models may be subjected to more strin-
gent quantitative validations of a variety of measures, including matrix composition, mechanical
properties and dimensional changes.
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Chapter 3 TGF-β transport, binding, and consumption within
engineered constructs
3.1 Abstract
Transforming growth factor-β (TGF-β) transport within engineered cartilage is critically hindered,
causing steep gradients throughout even small tissue constructs. In addition to diffusion and con-
sumption, TGF-β undergoes reversible binding with the acellular agarose scaffold, encapsulated
cells, and developing extracellular matrix, leading to transport limitations in both immature and
mature tissue constructs. We have previously reported the transport kinetics of TGF-β based on
bulk tissue properties (i.e.. mixtures of cells + scaffold and cells + scaffold + matrix), but charac-
terizing the binding coefficients of the individual constituents (the cells and matrix) has not been
examined. The individual binding rates of the agarose, cells, and matrix is essential for building
models of long-term culture conditions with evolving matrix compositions and for extending models
to different cell seeding densities. To this end, the current study characterizes and validates the
individual binding characteristics of the cell constituent within a freshly-seeded construct. We pro-
vide the equations for this separation and a simulation comparing the binding of TGF-β with one
partner (implicit, partner = scaffold + cells) to two partners (explicit, partner 1 = scaffold, partner
2 = cells). Simulations display similar behavior of both models. These results grant us the ability
to change TGF-β binding capacity to a freshly-seeded construct on the basis of a construct’s cell
seeding density.
3.2 Introduction
Using a mixture framework to model tissue growth will be a significant advance of the current
approaches to modeling growth which typically use kinematic and morphometric data to inform
the growth of tissues without examining the specific mechanism underlying growth. Conversely, the
mixture framework uniquely model the growth of the salient constituents within a tissue and can
model growth through chemical kinetic modeling of the constituents. While an attractive framework
for a mechanistic understanding of growth, challenges arise in how to accurately model the evolution
of the constituents and relate each chemical reaction all available constituents.
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Our previous work characterized TGF-β binding as dependent on both agarose, cells, and ma-
trix within immature (cultured for 3 days) and mature (cultured for 28 days) engineered tissue
constructs (Albro et al. , 2016). These models characterized the binding kinetics against the con-
struct as a whole (henceforth referred to as the “mixture” binding parameters) (Albro et al. , 2013;
Albro et al. , 2016). As our ongoing goal for engineered cartilage growth models is to understand the
role of cell seeding density in developing constructs, the goal of the present study was to characterize
the individual binding kinetics of TGF-β to cell content.
The mixtures investigated in our earlier work consisted of an acellular agarose scaffold, a freshly
seeded construct (acellular agarose scaffold + 60 million cells mL−1), and a mature construct (acel-
lular agarose scaffold + 60 million cells mL−1 + 6% GAG). Computational models of the evolving
and spatially heterogeneous tissue construct require models of the individual binding kinetics of the
construct constituents (agarose, cells, and GAG) with TGF-β.
The present work identifies the specific binding characteristics of agarose and chondrocytes based
on the previous measures of binding characteristics determined for the mixtures of acellular, freshly
seeded, and mature tissue constructs.
3.3 Methods
We begin with the generalized equation of a reversible reaction
A+Bi " Ci



























Acellular agarose 60 ng mL−1 1.8 ×10−6 s mL ng−1 2.7 ×10−5 s−1 6.67×10−2 mL ng−1
Fresh construct 200 ng mL−1 2.7 ×10−6 s mL ng−1 2.5 ×10−5 s−1 1.1×10−1 mL ng−1
Mature construct 370 ng mL−1 1.6 ×10−6 s mL ng−1 8.3 ×10−5 s−1 1.9×10−2 mL ng−1
Table 2: Effective binding rates for freshly seeded constructs from (Albro et al. , 2016).
using conservation of binding sites (B),
N i = Bi + Ci
and conservation of ligand (A),
Atot = A+ C
1 + C2.
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where we have Keffeq , Atot, N eff from (Albro et al. , 2016) as the mixture constants for the agarose +
cellular (freshly-seeded construct in Table 2). Taking the physical root for a presumed configuration
of a 1 mm × 1 mm × 1 mm cube with an assumed initial concentration of 10 ng mL−1, we find at
equilibrium Ceff = {210, 9.54} ng mL−1, taking the second root due to the physics of the problem.
We can now determine the binding properties of the agarose and cellular constituents individually
based on the assumption that the properties of agarose remain constant (all i = 1 terms are known).
The equations simplify as
kefff (N
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and we find that k2f = 3.09 × 10










Agarose 60 ng mL−1 1.8 ×10−6 s mL ng−1 2.7 ×10−5 s−1 6.67×10−2 mL ng−1
Cells 140 ng mL−1 3.09 ×10−6 s mL ng−1 2.42 ×10−5 s−1 1.27×10−1 mL ng−1
Table 3: Constituent-specific binding rates for freshly seeded constructs.
















f (Atot − C
eff) + k2f
) = C2
and therefore, k2r = 2.42 × 10
−5 s−1.
3.4 Results
Constituent-specific rates are found in Table 3. It should be noted, that because these binding
rates are dependent upon the constituents themselves, then agarose parameters are specific for 2%
gel and cell parameters are specific for a new cell seeding density of 60 million cells mL−1 (based
on a 2% agarose gel). The agreement between a freshly seeded construct (parameters based on
(Albro et al. , 2016)) and the mixture constituents of agarose and cells calculated here is modeled
in a simple configuration (assuming a 1 mm × 1 mm × 1 mm homogeneous cube with initial TGF-β
concentration =10 ng mL−1) Figure 3.1. Initial, transient, and equilibrium responses of the mixture
and the two constituents combined are in agreement.
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3.5 Discussion
This work identified the binding rates of the individual cell constituents within a freshly seeded
engineered construct (Table 3). These values will be part of future comprehensive growth models for
generalizing models to various cell seeding densities through both normalized nutrient consumption
values (i.e. using nutrient consumption per cell multiplied by the local, present density of cells) and
the cellular binding interactions as identified here.
Importantly, both agarose and the cellular phase were identified. While it is unlikely we will
change the concentration of agarose, alterations in cell density, both during growth and through
changes in initial cell seeding density are common. Calculating the ratio of available TGF-β binding
sites per cell, based on this work, comes out to 2.33 ng mL−1 TGF-β per million cells mL−1. This
ratio can be used for developing models with alterations in cell density from the 60 million cells
mL−1 of our previous work. The constituent forward and reverse binding rates will be held constant
for future work based on the assumption they reflect the actual inherent interactions between TGF-β
and the respective constituents (agarose, cells, GAG).
As the aims for the current set of models is to model the agarose + juvenile bovine chondrocyte
model, we characterized only the binding coefficients of agarose and cells in this work. In this
set-up, little matrix is deposited during the first two weeks of TGF-β administration. Our future
efforts to model the growth of mature chondrocytes from canine cartilage will likely require the
binding relations between TGF-β and matrix as TGF-β supplementation is delivered continuously
throughout culture and once a significant matrix has developed, likely accentuating the transport
limitations of TGF-β.
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Chapter 4 Synthesis and binding kinetics within developing
engineered constructs
4.1 Abstract
Large engineered cartilage constructs typically suffer from inhomogeneous extracellular matrix de-
position due to insufficient nutrient availability. Computational models of nutrient consumption
and tissue growth can be utilized as an efficient alternative to experimental trials for optimizing the
culture of large constructs; such models require system-specific growth and consumption parame-
ters. To inform the modeling of the [bovine chondrocyte]-[agarose gel] system, total synthesis rate
(matrix accumulation rate in construct + matrix release rate to media) and matrix retention frac-
tions of glycosaminoglycans (GAG), collagen, and cartilage oligomeric matrix protein (COMP) were
measured either in the presence (continuous or transient) or absence of TGF-β3 supplementation.
Reversible binding kinetics parameters were then characterized using computational models. These
results were combined with our recent nutrient supplementation work to computationally simulate
the culture of a human patella-sized tissue construct, reproducing the experimental results from
(Hung et al. , 2003). Transient TGF-β3 supplementation produced the highest total GAG synthe-
sis rate, highest GAG retention ratio, and highest binding affinity; collagen synthesis was elevated
in growth factor supplementation groups over control, with the highest binding affinity observed in
the transient supplementation group; both COMP synthesis and retention were lower than those
for GAG and collagen. Using these results to inform the modeling of GAG deposition within the
large patella construct, computational predictions were consistent with the previous experimental
findings without further adjustments to modeling parameters. These results suggest that these
nutrient consumption and matrix synthesis models are an attractive alternative for optimizing the
culture of large-sized constructs.
4.2 Introduction
Osteoarthritis (OA) is a debilitating disease causing significant pain and immobility as the cartilage
of the diarthrodial joints degrades to expose the underlying bone. The low cellularity and avascular
nature of adult articular cartilage contribute to the limited capacity of the tissue to heal from minor
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injuries and defects, eventually developing into symptomatic OA (Stockwell, 1979). Cartilage tissue
engineering (CTE) is a promising strategy targeting the replacement of defective native cartilage
with mechanically and biochemically similar engineered cartilage. In CTE, systems usually consist of
a cell species (typically chondrocytes, mesenchymal stem cells, or embryonic stem cells) embedded
in a biocompatible polymeric scaffold (Kuo et al. , 2006). The scaffold maintains the cells in a
3D environment with access to a nutrient rich culture media and retains the extracellular matrix
(ECM) products synthesized by the cells. In particular, agarose is a well-characterized, bio-inert
scaffold that shows great promise in CTE systems as chondrocytes elaborate a functional ECM when
cultured in the three-dimensional agarose environment, reaching native levels of glycosaminoglycans
(Benya & Shaffer, 1982; Buschmann et al. , 1995; Lima et al. , 2007; Byers et al. , 2008).
A remaining challenge in CTE is the development of clinically relevant-sized tissue constructs,
which are required to repair the large surface defects (>5 cm2) present in symptomatic OA
(Hung et al. , 2003; Moisio et al. , 2009). Engineered constructs of this size suffer from inhomo-
geneous ECM deposition as the transport of critical nutrients to the interior of the construct is
hindered by consumption of cells along the periphery. Lacking a homogenous and structural ECM,
these constructs are unable to support physiologic loads and are therefore unlikely to function suc-
cessfully upon implantation. In an effort to reduce ECM heterogeneity, strategies for enhancing nu-
trient transport have been employed such as direct media perfusion, dynamic mechanical loading,
and the introduction of nutrient channels into the tissue (Bian et al. , 2009a; Lima et al. , 2007;
Mauck et al. , 2000; Buckley et al. , 2009; Davisson et al. , 2002b; Davisson et al. , 2002a). How-
ever, quantitative predictive methods for optimizing the culture of large-sized constructs of various
sizes remain unexplored.
An overarching aim of our research is to develop and implement continuum growth models to
optimize tissue culture protocols for growing large-sized constructs with sufficient nutrient avail-
ability and ECM deposition throughout the interior. Such models may prove insightful and effi-
cient in analyzing how nutrient distribution and ECM deposition are affected by culture conditions
(Nikolaev et al. , 2010; Obradovic et al. , 2000; Sengers et al. , 2005a; Zhou et al. , 2008). Accu-
rate, system-specific, CTE modeling requires knowledge of: 1) the nutrient(s) essential for cell
viability and concentrations of the nutrient(s) necessary for tissue growth, 2) consumption rates of
the nutrient(s), 3) matrix constituents critical to mechanical integrity, and 4) synthesis rate and
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binding kinetics for each essential constituent. Previously, we have identified that tissue growth
is diminished at a glucose concentration of 7.5 mM as compared to 25 mM in the [bovine chon-
drocyte] – [agarose gel] system (Cigan et al. , 2013). The present study, therefore, focuses on the
remaining tasks: experimentally measuring ECM synthesis and retention to determine the matrix
binding kinetics consistent with the measured levels of matrix retention, measuring the rate of
glucose consumption for this system, and refining the glucose concentration threshold required for
ECM synthesis. To investigate the utility of these parameters, we model the growth of a human
patella-sized construct as was performed experimentally by (Hung et al. , 2003), by incorporating
glucose transport from a periodically refreshed bath, cellular glucose consumption, matrix synthesis
as a function of glucose availability, and binding and release of matrix products.
In cartilage, proteoglycans (PGs) and type II collagen are the major ECM structural com-
ponents. PGs, predominantly consisting of aggregated glycosaminoglycans (GAG), contribute
to the compressive stiffness while the fibrillar collagen network contributes to the tensile behav-
ior (Jurvelin et al. , 1988; Kempson, 1980). Pyridinoline cross-links between collagen fibrils act
to retain and strengthen the PG-collagen network (Eyre & Wu, 2005; Williamson et al. , 2003b;
Williamson et al. , 2003a). In addition, cartilage oligomeric matrix protein (COMP) is a high
molecular weight (500 kDa) matrix protein that may play a structural role in cartilage given its
high concentration (0.4% ww) in the tissue and binding affinity for both PGs and type II colla-
gen (Chen et al. , 2007; Rosenberg et al. , 1998; Di Cesare et al. , 1996). Here, we experimentally
examined the influence of GAG, collagen, COMP and pyridinoline on CTE construct mechanical
properties, due to their suggested mechanical roles in native cartilage. An experimentally de-
termined retention fraction was also calculated for GAG, collagen and COMP, and a reversible
binding model of each ECM constituent was then used to determine its binding kinetics, similar
to prior analyses of native cartilage and CTE constructs (DiMicco & Sah, 2003; Klein & Sah, 2007;
Sengers et al. , 2004). Due to the earlier success of using transforming growth factor β3 (TGF-β3)
on the culture of the [bovine chondrocyte]-[agarose gel] system, the synthesis rates, retention frac-
tions, and binding constants of GAG, collagen, and COMP were examined in the continuous and
temporary (2 week) presence, as well as absence, of TGF-β3 (Byers et al. , 2008; Lima et al. , 2007).
To preclude the confounding influence of heterogeneous nutrient availability present in large con-
structs, the experimental work of this study is performed with small constructs.
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4.3 Methods
4.3.1 Cellular isolation and construct culture
Primary chondrocytes were isolated from articular cartilage of bovine calf (2 months old) car-
pometacarpal joints digested with type IV collagenase (activity = 747 U/g) in high glucose Dul-
becco’s Modified Eagle’s Medium (hgDMEM) (Invitrogen, Carlsbad, CA) supplemented with 5%
fetal bovine serum (Invitrogen), amino acids, buffering agents, and 1% antibiotic-antimycotic (Invit-
rogen) at 37 °C on a shaker for 6 hours (Lima et al. , 2007). Cells were encapsulated in 2% agarose
(type VII-A) at a density of 30 × 106 cells mL−1. Constructs were cored from the cell-agarose mix-
ture (!4 mm × 2.3 mm thick) and cultured under static conditions for 45 days in chemically-defined,
chondrogenic media (hgDMEM, 100 nM dexamethasone, 100 μg/mL sodium pyruvate, 50 μg/mL
L-proline, 1% ITS+ premix (Becton Dickinson, Sparks, MD), 1% antibiotic-antimycotic, and 173
nmol/mL ascorbic acid 2-phosphate) at 37 °C under 5% CO2 tension. Media were supplemented
with 10 ng/mL TGF-β3 (R&D Systems, Minneapolis, MN) for either the entire culture period (β3+
group) or for only the first 14 days of culture (β3− group). A control group was cultured with-
out TGF-β3 supplementation. Media were changed three times per week and conditioned media
aliquots were taken at each media change. Constructs were removed and characterized after 14, 28,
and 45 days (n = 4 per group, time point).
4.3.2 Mechanical characterization
At each time point, constructs were mechanically tested in a custom device using unconfined com-
pression with impermeable metal loading platens. Sample thickness and diameter were measured
prior to loading. Samples were equilibrated under a creep load in a bath of phosphate buffered
saline for 400 s. A stress relaxation test was then performed by ramping the displacement at a con-
stant rate to 10% of the original thickness over 300 s, then relaxing for 1500 s. The stress relaxation
data was curve-fitted to extract mechanical properties similar to previous work (Huang et al. , 2012;
Cigan et al. , 2013). This optimization analysis, performed in FEBio (febio.org), models the CTE
constructs as a biphasic material consisting of both an intrinsically incompressible fluid and porous,
solid matrix. Here, the solid matrix is modeled as a mixture of a neo-Hookean ground material
(e.g., representing the scaffold material and GAGs) and a continuous fiber distribution material
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(representing collagen) where fibers sustain tension only, with a linear variation of stress with strain
(Ateshian et al. , 2009). These fits are able to able to extract the equilibrium compressive modulus
EY , the hydraulic permeability k, and the fiber modulus ξ. The optimization results fit the exper-
imental data with R2 = 0.95 ± 0.05 (for all samples), a result consistent with prior results with
similar engineered tissue constructs.
Since fiber recruitment in a continuous fiber distribution model depends on the state of strain, the
parameter ξ does not represent the actual tensile modulus of the construct. Therefore, the construct
tensile modulus, ET , was determined by modeling the equilibrium response to a homogeneous
tensile deformation of a material with the same EY and ξ determined from the curve-fitting of the
unconfined stress-relaxation response. In a prior study (Huang et al. , 2012), it was shown that this
method for predicting ET from unconfined compression stress-relaxation experiments produced a
value statistically not different from tensile test measurements.
4.3.3 Biochemical characterization
After mechanical testing, constructs were radially halved and both halves were weighed. The con-
struct masses were used to normalize the biochemical content and to calculate the swelling ratio for
each group where
swelling ratio =
average construct mass at time point
average construct mass at day 0
.
One half was digested with proteinase K (MP Biomedical, Santa Ana, CA) and the other half was
digested with guanidine. Samples were lyophilized prior to the proteinase K digestion (0.5 mg/ml) as
previously described (Hollander et al. , 1994). Guanidine digestion was performed with 4 M guani-
dine HCl at 4 °C for 16 hours. GAG, collagen, and pyridinoline content were measured from the
proteinase K digests. GAG content was assayed using the 1,9 dimethylmethylene blue dye-binding
(DMMB) assay (Farndale et al. , 1986). Collagen and pyridinoline content were assayed after acid
hydrolysis of the digests using an ortho-hydroxyproline (OHP) assay (Stegemann & Stalder, 1967)
and a pyridinoline specific enzyme linked immunosorbent assay (ELISA; Quidel Corperation, San
Diego, CA), respectively. Pyridinoline content was not measured on day 0 due to the low colla-
gen content (≈0). A 1:7.6 OHP:total collagen mass ratio was used to determine collagen content
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(Hollander et al. , 1994). COMP was measured from the guanidine digests with a COMP specific
ELISA (MDBiosciences, St. Paul, MN). GAG and COMP were measured in the conditioned media
samples directly, without digestion, using the DMMB assay and COMP ELISA, respectively. Media
samples were pooled between two media changes for the COMP assay and the mass of COMP re-
leased into the media was averaged over the span of the two sequential media changes. Collagen me-
dia concentrations were assayed via the OHP assay of acid-hydrolyzed media samples. Pyridinoline
content is presented both as a concentration and a molar fraction to collage: mol pyridinoline/mol
collagen triple helix (collagen triple helix MW = 285 kDa) (Grant & Prockop, 1972).
4.3.4 Synthesis rates and retention fractions
For each ECM constituent examined (GAG, collagen, COMP) two distinct rates were measured:
(A) the rate at which the constituent accumulated within the scaffold and (B) the rate at which the
constituent was released into the media. The scaffold mass accumulation rate, mc, was the slope of
the linear regression of the mass of matrix within each construct (normalized to the construct day
0 reference volume) over the culture period (typical data set and linear regression shown in Figure
4.1A). The media mass release rate, mm, was the slope of the linear regression of the mass of matrix
released into the media (normalized to the construct day 0 volume) over the culture period (typical
data set and linear regression shown in Figure 4.1B). The linear regressions for the β3+ and control
groups were calculated over the entire 45-day culture period (days 0 to 45) and the regressions for
the β3− group were calculated after discontinuing TGF-β3 supplementation (days 14 to 45). The
total synthesis rate was the sum of mc and mm. The retention ratio, Rc, of each matrix constituent





The uncertainties of both the total synthesis rates and retention ratios were calculated according
to standard uncertainty analysis from the standard deviations associated with the linear regression
fits.
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Figure 4.1: Representative synthesis profiles for (A) matrix accumulation in the construct and (B)
cumulative matrix release in the media. Synthesis rates were calculated from the slope of the linear
regression.
Figure 4.2: (A) Schematic for the experimental set-up idealized in the matrix-binding-diffusion
model. (B) A representative result of the bound matrix spatial distributions within the tissue phase
of the construct (GAG accumulation in the β3− group).
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4.3.5 Binding parameters
The reversible binding kinetics of each matrix constituent were assessed based on the following
assumptions: the synthesis rate was based on experimental results; each constituent is synthesized
in soluble form and binds reversibly according to the law of mass action; when in soluble form,
matrix products undergo Fickian transport with a diffusivity negligibly altered by matrix deposition;
soluble matrix products diffuse out of the construct into a well-mixed bath; electric charge effects are
neglected; construct swelling as a result of matrix growth is also neglected. All model simulations
were performed in the open-source finite element code FEBio (www.febio.org), customized for this
application (Ateshian, 2007; Maas et al. , 2012). Models consisted of a construct (∅4 mm × 2.3
mm thick, cell density: 30 million cells mL−1) in a 0.5 mL bath, similar to the day 0 experimental
conditions (Figure 4.2). The governing equation for soluble matrix product was the mass balance
relation in the presence of chemical reactions,
∂c
∂t
+ div j = ĉ
where c is the solute molar concentration and j = −Dgradc is the molar flux of the solute relative
to the construct solid matrix, with D representing the diffusivity. Here, ĉ is the net rate of mo-
lar supply to the soluble constituent from chemical reactions, combining synthesis and reversible
binding according to ĉ = ĉsyn + ĉrb, where ĉsyn the synthesis rate is prescribed from experimental
measurements and was computed assuming a molar mass of 513 Da for GAG, 500 kDa for collagen,
and 524 kDa for COMP. The reversible binding rate is
ĉrb = kf [(c+Kd) cb −Ntc] .
Here, kf is the forward reaction rate, Kd =
kr
kf
is the dissociation constant and kr is the reverse
reaction rate, Nt is the total binding site concentration, and cb is the concentration of bound matrix
product whose temporal evolution is given by dcbdt = ĉrb, with initial condition cb(t = 0) = 0. Values
were taken from the literature for DGAGand Dcoll (for table see (Nims et al. , 2014)) for GAG and
collagen diffusivities, respectively, (Silver & Trelstad, 1980; DiMicco & Sah, 2003) and for COMP
was estimated from 500 kDa dextran (Leddy et al. , 2004). The synthesis rate was evaluated from
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Figure 4.3: (A) Finite element mesh and geometric model of the anatomical patella construct
supported on the porous, chondral scaffold, with an intermediary interface layer and (B) a cross
sectional image of the construct surrounded within the 75 mL bath.
ĉsyn = (mc + mm)/M where M is the molar mass. Nt for GAG and collagen were set roughly
equal to the average day 45 concentration of the supplementation group with the highest GAG and
collagen content, respectively; Nt for COMP was equal to 10 times the day 45 concentration of the
group with the highest COMP concentration; at these levels the matrix accumulated in a linear
fashion, as observed experimentally. With these parameters taken as constants, kr and kf for each
constituent were determined by a custom MATLAB optimization wrapper code that matched the
experimental matrix release pattern over 45 days to the computationally predicted matrix release.
4.3.6 Human patella-sized construct
As an example of the applicability of the binding and synthesis constants, we attempted to reproduce
the results of previous studies of culture of a human patella-sized construct, which analyzed the
spatial GAG deposition over 35 days of culture (Hung et al. , 2003; Hung et al. , 2004). The details
of this analysis are included below.
4.3.6.1 Computational anatomical model Three-dimensional finite element models of the
patella construct were constructed from the anatomical human patella surfaces obtained using
stereophotogrammetry (Ateshian et al. , 1991; Ateshian et al. , 1992; Hung et al. , 2003). The cel-
lular construct was modeled atop an acellular, porous scaffold, similar to the experimental protocol
and a 1 mm thick ‘interface region’ was included (Figure 4.3). The gel construct was seeded at 60
million cells mL−1; this cell density informs both the matrix synthesis and nutrient consumption
rates. The model was analyzed with the FEBio finite element software which incorporates transport
mechanics and chemical kinetics.
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4.3.6.2 Culture conditions The construct was surrounded within a bath containing 75 mL of
media (Figure 4.3b). The media was changed three times per week (in a 2-2-3 day manner) over the
35 day culture. Media changes consisted of ‘replacing’ the conditioned media (glucose concentration
< 25 mM and soluble ECM concentration > 0 mM) with fresh media (glucose concentration = 25
mM and soluble ECM concentration = 0 mM). As this experiment was performed in the absence of
TGF-β supplementation, the synthesis and binding parameters for the ‘control’ case were used.
4.3.6.3 Matrix synthesis and glucose consumption Three chemical reactions were mod-
eled in this finite element analysis. (1) Glucose uptake by cells was based on Michaelis-Menten
kinetics; here the maximal cellular glucose consumption rate was experimentally determined (be-
low) and the Michaelis constant, = 0.35 mM, was taken from previous experiments on chondrocytes
(Windhaber et al. , 2003). (2) Soluble GAG synthesis was based on Michaelis-Menten type kinetics
where the maximal synthesis rate was taken from our experimental synthesis results (scaled ap-
propriately for the increased cellularity) and the Michaelis constant was the same as the glucose
consumption reaction. Additionally, based on our earlier findings that low levels of glucose results
in no significant ECM deposition (Cigan et al. , 2013), a nutrient threshold level was added into
the synthesis equation, such that ECM synthesis was turned off within regions where the glucose
concentration was below the threshold level. (3) GAG deposition was modeled using standard re-
versible binding kinetics of the soluble GAG with the extracellular matrix, based on the parameters
curve-fitted to the experimental data of this study. The following additional experiments were per-
formed to identify the remaining necessary parameters (cellular glucose consumption rate and ECM
nutrient threshold) for this system.
4.3.6.4 Glucose consumption rate Glucose consumption on various weeks is discussed in
(Cigan, 2016). The results of this work demonstrate that the glucose consumption rate through 7
weeks of culture of the system average 1.24× 10−13 ± 3.4× 10−14 mol cell−1 hr−1, in line with prior
work.
4.3.6.5 ECM nutrient threshold ECM nutrient threshold was determined in the previous
study (Cigan, 2016). The results of this work demonstrate a critical glucose concentration of 12.5
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mM is required to sustain matrix deposition.
4.3.7 Statistics
The biochemical concentrations, equilibrium compressive modulus, EY , hydraulic permeability, k,
equilibrium tensile modulus, ET , and swelling ratio of the constructs were compared with a two-way
analysis of variance (ANOVA) using Tukey’s HSD post hoc test (α = 0.05). Synthesis rates were
compared with an analysis of covariance of the cumulative mass per construct released to the media
and the mass accumulated in the scaffold over the culture time (day 0 to 45 for the control and
β3+ groups and day 14 to 45 for the β3− group) (Rohlf & Sokal, 1995). Retention fractions for
each matrix constituent were compared using an ANOVA of each group’s mean, uncertainty, and
n (total number of constructs and media aliquots for each supplementation group) (Cohen, 2002).
Data are reported as mean ± standard deviation (for GAG, collagen, mechanical properties, and
swelling ratio, n = 4; for COMP and pyridinoline, n = 3). For each group and constituent, the fit
between the experimental and binding kinetics model was determined by nonlinear regression for
both the construct matrix (sum of bound and soluble matrix within the construct) and cumulative
matrix media release.
4.4 Results
4.4.1 Mechanical characterization and biochemical composition
Constructs cultured over the 45-day period developed EY values that were highest in the β3− group
(Figure 4.4A; p < 0.001), consistent with previous studies (Byers et al. , 2008; Lima et al. , 2007); k
was affected by both the course of culture and supplementation (Figure 4.4B; p < 0.001), as was ET
(Figure 4.4C; p < 0.001); by day 42, the swelling ratio of the constructs was significantly influenced
by TGF-β3 (Figure 4.4D; p < 0.001) with the most swelling occurring in the β3− group (p < 0.05).
GAG was highest in the β3− group (Figure 4.5A; p ≤ 0.022) and collagen levels in the β3− and
β3+ groups were higher than the control on days 28 and 45 (Figure 4.5B; p ≤ 0.002). Collagen
concentration was statistically similar between the β3− and β3+ groups (p = 0.619). Levels of
COMP were similarly affected by TGF-β3 supplementation (Figure 4.5C; p < 0.001), with the
highest construct COMP concentration observed on day 45 in the β3− group (p ≤ 0.003), and the
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highest overall COMP concentration observed in the β3+ group on day 28 (p ≤ 0.028). Cessation of
TGF-β3 supplementation influenced total pyridinoline concentration (Figure 4.5D; p < 0.001) and
pyridinoline per collagen was influenced by the presence of TGF-β3 (Figure 4.5E; p < 0.001).
4.4.2 Experimental Synthesis Rates and Retention Fractions
GAG, collagen, and COMP levels in constructs and media increased nearly linearly over time
(Figure 4.1), as assessed with the coefficient of determination of the linear regression (R2; for table
see (Nims et al. , 2014)). Scaffold accumulation rates and media release rates for these constituents
were evaluated from the slope of the linear regression. Matrix release into the media generally
exhibited a higher R2 than the scaffold accumulation. The lowest coefficient of determination was
the COMP scaffold accumulation for the β3+ group (R2 = 0.37).
Synthesis rates varied with TGF-β3 supplementation (Figure 4.6). GAG scaffold accumulation
rate was highest in the β3− group (p < 0.001) and GAG media release rates were similar between
the three supplementation groups (p = 0.429). Collagen scaffold accumulation rate was highest in
the β3− and β3+ groups compared with the control (p < 0.001) and collagen media release rate
was lowest in the β3− group (p = 0.002). Overall, COMP synthesis was lower compared to the
synthesis of the GAG and collagen (on the order of 102 µg ml−1 day−1 compared with 1 mg ml−1
day−1). The β3+ group had the highest COMP media release rate (p < 0.001) and the β3− group
had the highest COMP scaffold accumulation rate (p ≤ 0.021).
For all matrix constituents (Figure 4.7), the β3− group had the highest retention ratio (p <
0.001). GAG retention reached a high level (Rc = 90 ± 2%) in the β3− group. COMP retention
was lowest in the β3+ group (Rc = 7 ± 2%; p < 0.001).
4.4.3 Theoretical Model Binding Kinetics
The finite element models of the CTE constructs resulted in matrix accumulation and media release
profiles that were similar to the experimental set-up over the 45 day culture of the system (repre-
sentative profile in [FIG] 6), showing mostly high correlations (R2construct and R
2
media ,for table see
(Nims et al. , 2014)). The binding constants for a single constituent varied little with supplemen-
tation type compared with the variations among the different constituents. The reversible binding
parameters in these models produce bound constituent concentrations that are reduced at the pe-
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Figure 4.4: Curve-fit mechanical properties (A) EY (kPa), (B) k (mm4 N−1 s−1), (C) ET (kPa)
and (D) the experimentally determined swelling ratio of constructs over the course of culture. *
denotes group significantly differ from indicated group(s) at same time point (p < 0.05); + denotes
group significantly differ from day 0 properties (p < 0.05); # denotes the indicated groups differ
significantly (p < 0.05).
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Figure 4.5: Biochemical properties of constructs over the culture period: (A) GAG concentration
(%ww), (B) collagen concentration (%ww), (C) COMP concentration (μg/ml), (D) pyridinoline
concentration (nmol/ml), and (E) pyridinoline to collagen ratio (mol/mol). * denotes group signif-
icantly differ from indicated group(s) at same time point (p < 0.05); § denotes group significantly
differ from previous time point (day 7 control and β3+ compared to day 0; day 28 β3+ and β3−
compared to day 14 β3+).
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Figure 4.6: Synthesis rates of GAG (mg ml−1day−1), collagen (mg ml−1day−1), and COMP (102
µg ml−1day−1). The total synthesis (total column) is divided between media release rate (light,
bottom) and construct accumulation rate (dark, top). * denotes significant differences between
media and construct synthesis rates (p < 0.05); upper case letters denote groups of significance
of construct accumulation for each matrix constituent (p < 0.05) and lower case letters denote
groups of significance of media release for each matrix constituent (p < 0.05); thus for each matrix
constituent, groups with the same upper or lower case letters had statistically similar construct
matrix accumulation or matrix media release, respectively.
Figure 4.7: Retention ratio of the matrix constituents COMP, collagen, and GAG for each of the
TGF-β3 culture treatments: control (light), β3+ (medium), and β3− (dark). Upper case letters
denote groups of significance (p < 0.05); thus for each matrix constituent: groups with different
capital letters were statistically different.
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Figure 4.8: Representative (A) cumulative media release and (B) construct accumulation experimen-
tal data (circles) and the theoretical model results (line) of the GAG constituent in the β3− group.
The inflection at day 14 in (B) reflects changes in synthesis rate and binding kinetics associated
with ending TGF-β3 supplementation.
riphery and homogenous within the interior of the tissue (representative result in Figure 4.2B of
bound GAG in the β3− group).
4.4.4 Human Patella-Sized Construct
When modeling both nutrient consumption and nutrient-dependent GAG synthesis the models pre-
dict glucose concentration profiles with interior glucose concentrations below the 12.5 mM threshold
both before (Figure 4.9A, C) and immediately after (Figure 4.9B) a media change. Due to this lack
of glucose availability, bound GAG develops solely in the periphery (Figure 4.9D, E, F). These
ECM profiles are fundamentally different than the small construct models where ECM accumu-
lation is highest in the interior of the construct. This human patella-sized simulation agrees well
with our previous experimental findings (compare Figure 4.9F from this study to Figure 4.9H from
(Hung et al. , 2004)).
4.4.5 Correlations Between Mechanical Properties and Biochemical Composition
EY showed a high correlation with GAG concentration (Figure 4.10A; R2 = 0.74). Relatively low
correlations were found for EY versus collagen or COMP (Figure 4.10B; R2 = 0.31 and Figure 4.10C;
R2 = 0.32, respectively). EY was moderately correlated to pyridinoline concentration (Figure 4.10D;
R2 = 0.47). The swelling ratio displayed a high correlation to GAG concentration (Figure 4.10E; R2
= 0.74), a moderate correlation to collagen concentration (Figure 4.10F; R2 = 0.48), a poor correla-
tion to COMP (Figure 4.10G; R2 = 0.27), and a moderate correlation to pyridinoline (Figure 4.10H;
R2 = 0.56). ET was moderately correlated with GAG and pyridinoline (Figure 4.10I; R2 = 0.49 and
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Figure 4.9: Model simulations results (sagittal plane, G) of the glucose concentration distributions
(A, B, C) and bound GAG distribution (D, E, F) in patella-sized CTE construct (cellular gel
region, “g”, gel and acellular bone scaffold interface, “i”, and the acellular scaffold, “b”) after 35 days
of culture. Images were taken either 3 hours (A, D) and immediately before (C, F) a media change
and immediately after (B, E) a media change throughout the culture (1 wk: A, D; 3 wk: B, C; 5 wk:
C, F). The previous experimental results of GAG accumulation (H) are provided for comparison to
the model simulations (F) of this study. Figure 4.9H from (Hung et al. , 2004)(figure 7) with kind
permission from Springer Science and Business Media.
Figure 4.10L; R2 = 0.50, respectively) and poorly correlated with collagen and COMP (Figure 4.10J;
R2 = 0.20 and Figure 4.10K; R2 = 0.33, respectively).
4.5 Discussion
Engineering cartilage constructs large enough to replace defects seen in symptomatic OA requires
scaling up the current size of constructs. Presently, thicker and wider constructs experience heteroge-
neous matrix deposition as steep gradients in nutrient availability develop between the construct’s
periphery and interior due to cellular consumption and diffusion limitations (Bian et al. , 2009a;
Hung et al. , 2003; Leddy et al. , 2004). Computational modeling of the culture conditions may
serve as an essential and cost-effective method for determining the efficacy of techniques aimed
at enhancing the functional ECM homogeneity. This study measured the synthesis and binding
parameters of small [bovine chondrocyte]-[agarose gel] constructs cultured with sufficient media,
thereby obviating potentially severe nutrient heterogeneity within the construct. These results were
then combined with our prior work that identified glucose as a critical nutrient for this CTE system
to model the culture of a human patella-sized construct (Cigan et al. , 2013; Hung et al. , 2003).
The synthesis rates of all the molecules examined were affected by TGF-β3 supplementation
(Figure 4.6). GAG synthesis was elevated by supplementation of TGF-β3 versus control levels,
and was further boosted by terminating the supplementation (TGF-β release) after 14 days (β3−
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Figure 4.10: Correlations between the mechanical properties EY (A-D), swelling ratio (E-H) and
ET (I-L) and the biochemical concentrations of GAG (A, E, I), collagen (B, F, J), COMP (C, G,
K) and pyridinoline (D, H, L).
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group). This withdrawal not only increased the total synthesis rate of GAG, as shown previously
(Byers et al. , 2008; Lima et al. , 2007), but also increased GAG retention over the continuous treat-
ment group (≈90% retention in the β3− compared with ≈75% retention in the β3+ group). This
trend in retention was similar to the trend in the dissociation constants (0.14 µM for the β3− group
and 10 µM for the control). A similar experimental (0.22 µM) has been reported for reversible bind-
ing between aggrecan and hyaluronate (Watanabe et al. , 1997). Previous models of GAG binding
kinetics in cartilage have been primarily focused on the binding and degradation of PGs in native
cartilage (DiMicco & Sah, 2003). These studies used an experimentally determined binding rate
between PGs and hyaluronate (Sandy & Plaas, 1989). The two measures of GAG binding affinity
(this study: 2 – 73 × 10−9 mM−1s−1; previously: 1.2 × 10−5 s−1 ;(DiMicco & Sah, 2003) can be
reconciled, however, by multiplying the rate constant by the density of binding sites (300 mM).
This ‘effective forward binding rate’ ( 6 – 222 × 10−7 s−1) is similar between this and the previous
work. It should also be noted that this study assumed reversible binding as suggested by prior
work on the binding of aggrecan and hyaluronate (Watanabe et al. , 1997), while previous models
of PG deposition have utilized a model in which bound PG is only re-solubilized by degradation
and therefore cannot participate in re-binding (DiMicco & Sah, 2003).
TGF-β3 increased collagen synthesis over control, although termination of supplementation did
not subsequently alter the total synthesis rate. This observation suggests that TGF-β primes the
chondrocytes for greater collagen synthesis but is not needed continuously, as chondrocytes retain a
memory of this exposure; similar behavior has been observed in fibroblasts. Both supplementation
groups also have a high retention ratio (84% and 77% for the β3− and β3+ groups, respectively, com-
pared with 44% retention in the control) potentially due the synthesis of small PGs, such as decorin
and fibromodulin, which are also upregulated with TGF-β supplementation and which promote col-
lagen fibril formation (Burton-Wurster et al. , 2003). Prior studies have analyzed the binding of PGs
with collagen (ÖBrink, 1973a; ÖBrink, 1973b; Öbrink et al. , 1975); specifically, of the collagen-PG
interaction is on the order of 30-1000 nM under low osmotic conditions (Öbrink et al. , 1975). This
study predicts between 0.2 - 387 nM. As reaching native levels of collagen remains a problem in
CTE, these results suggest that increasing construct collagen content will be more greatly impacted
by techniques that increase total collagen synthesis (Eleswarapu & Athanasiou, 2013) rather than
those which solely increase construct retention.
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COMP synthesis was stimulated by TGF-β3. In contrast to GAG and collagen, COMP syn-
thesis does not appear to retain a memory of past exposure to TGF-β3 and was elevated only in
the presence of exogenous TGF-β3; these results are similar to studies of superficial chondrocyte
monolayers where COMP expression and synthesis are upregulated in response to TGF-β supple-
mentation (Motaung et al. , 2011; Recklies et al. , 1998). Despite the high COMP synthesis of the
β3+ group, retention was much lower than that of GAG and collagen, resulting in much of the
COMP (≈93%) to be released into the media. Earlier studies have shown that COMP binds to
both aggrecan and chondroitin sulfate under Ca2+ concentrations similar to those present in the
culture media used in this study (≈73 nM when binding with heparin, >10 μM when binding to
keratan sulfate, and ≈102 nM when binding to chondroitin sulfates (Chen et al. , 2007). COMP
has also been observed to bind with type II collagen, although the conditions under which binding
is favorable (2 mM Zn2+) were not present in this study ( = 1.5 nM). In our theoretical model,
ranged from 0.23 – 2.4 nM.
COMP levels have rarely been measured quantitatively in engineered cartilage constructs, thus
these results offer a novel finding that merits closer analysis. By day 45 the COMP content in the β3−
group was 0.09 ± 0.02 %ww, approaching native levels (native healthy/OA: ≈0.4 %ww; rheumatoid
arthritis: ≈0.1 %ww) (Di Cesare et al. , 1996). Despite this similarity, a strong correlation between
COMP levels and compressive mechanical properties was not observed (Figure 4.10C). Additionally,
COMP content did not show a strong correlation to construct growth (Figure 4.10G). Based on these
findings, COMP synthesis and distribution within engineered constructs may not be as critical as
GAG and collagen to the structural integrity and growth of engineered cartilage, suggesting that
models of GAG and collagen deposition would be more predictive of construct strength and growth
than models of COMP.
Pyridinoline, while not synthesized directly by cells, was also measured (Figure 4.5D, E). Pyridi-
noline is a mature cross-link connecting multiple collagen triple helices; these bonds spontaneously
form between hydroxylysine residues in the collagen triple helix (Eyre & Wu, 2005). Previous stud-
ies on engineered cartilage have reported that pyridinoline content typically falls below that seen
in native tissue (Yan et al. , 2009; Riesle et al. , 1998). This study presents the first quantitative
assessment of pyridinoline content in the [bovine chondrocyte]-[agarose gel] system. Results demon-
strate that the total pyridinoline content was below that typically seen in calf bovine cartilage (98
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nmol/g) while the ratio of pyridinoline to collagen within constructs was near native calf bovine
cartilage (0.46 mol/mol) (Williamson et al. , 2003b). The constructs in this study displayed a mod-
erate correlation between pyridinoline content and EY (Figure 4.10D); similar correlations have been
observed in native tissue (Williamson et al. , 2003b; Williamson et al. , 2003a; Yan et al. , 2009).
These results suggest that cross-linking occurs at the native levels relative to collagen and that
low construct pyridinoline content may suffer from low substrate (collagen) concentrations. There-
fore, engineered cartilage mechanical properties may benefit more from techniques used to increase
collagen content than by purely increasing cross-linking density.
Establishing computational models for optimizing nutrient distribution in large constructs
(Figure 4.9) may prove critical for optimizing the culture condition of anatomically-sized constructs.
Two critical requirements are to (a) develop a model of synthesis rates and retention of the matrix
and (b) identify which key nutrients control the synthesis of the ECM constituents. This study
now provides the matrix synthesis and binding parameters and glucose consumption rates for the
[agarose gel]-[bovine chondrocyte] system. As an example of the use of these parameters for compu-
tational growth models, we provide the model predictions of GAG distributions throughout a human
patella-sized construct, as was performed experimentally (Hung et al. , 2003; Hung et al. , 2004).
The similarities between the model simulations and experimental results suggest that these models
would have great predictive power for the optimization of culture conditions for these large con-
structs. Previously, our lab has demonstrated that the introduction of nutrient channels into large
constructs (∅10 mm) allows for the development of properties similar to small constructs with in-
creased nutrient availability (Bian et al. , 2009a). Future modeling work will optimize the culture
of such large-sized constructs with nutrient channels.
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Chapter 5 Matrix deposition is influenced by cell content more
than hyaluronan content
5.1 Abstract
The mechanism by which the cartilage matrix agglomerates is a complex process involving both
enzyme-mediated and spontaneous reactions as well as the slow diffusion of structural macro-
molecules. Modeling the kinetics of such a problem has been shown to be simplified by reversible
bining kinetics of the newly-sythesized soluble matrix and an available binding-site within the con-
struct scaffold and developing tissue. Our previous work has characterized these reversible binding
rates, however the relationship and evolution of a developing constructs with its matrix binding-site
availability is yet uncharacterized.
The previous work characterized the matrix binding constants (binding site densities and bind-
ing kinetics) for engineered cartilage. However, the binding site availability of matrix molecules is
expected to increase with tissue growth based on our preliminary experimental work suggesting that
matrix deposition continues nearly linearly; conversely, if the binding site density were constant,
matrix content would plateau. The aim of the present work is to experimentally relate potential
binding site partners with the overall deposition of matrix. We examined whether proteoglycan
and collagen deposition were dependent on hyaluronan content and cell content, as two likely ma-
trix binding site partners. Using constructs seeded with different cell densities, we measured and
correlated the cell, sulfated proteoglycan, collagen, and hyaluronan contents with small constructs
supplemented with sufficient media. Results suggested that cell seeding density correlates best with
the overall matrix deposition of both proteoglycans and collagen. The high correlations prompt the
use of construct cell density as a proxy for binding site density of both proteoglycans and collagens
in biochemical composition models.
5.2 Introduction
Growth modeling in the mixture framework requires information of the binding kinetics for de-
scribing matrix deposition. These kinetics require three parameters: 1) a forward reaction rate, 2)
a reverse reaction rate, and a 3) density of binding site density for the ligand to bind. We have
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previously determined the three parameters in Chapter 4 through quantitative methods to extract
both binding constants based on a constant binding site density. This binding site density, however,
is likely to change over culture and during growth. An evolution or proxy for the total construct
binding site density has not been determined.
In native cartilage, the salient binding partner with proteoglycans in both native and engineered
cartilage is hyaluronan, a long carbohydrate which interacts with extracellular receptors and ag-
grecan via the link protein (Watanabe et al. , 1997; Sandy & Plaas, 1989). Both link protein and
hyaluronan are associated with proteoglycan stability in native tissue. As a essential requirement of
biochemical deposition models is to predict the proteoglycan and collagen deposition, we wondered
whether modeling hyaluronan synthesis would be necessary for predicting matrix deposition.
In practice, a modeler will predefine an initial binding site density (we originally used 300 mM
as the GAG binding site density and 0.3 mM as the collagen binding site density based on the
study of Chapter 4 using small, 30 million cells mL−1 constructs). However, in our early attempts
to extend models to conditions of elevated cell density (up to 120 million cells mL−1), the available
binding site density at these original levels rapidly depleted and the continued matrix synthesis was
released into the media, an event not experienced in experimental culture.
Therefore, the current experimental study investigated the role of hyaluronan content on the
GAG and collagen content within small engineered constructs. As the insights would be directly
applied to our computational models of different cell densities, the influence of initial cell seeding
density on the hyaluronan content was examined.
5.3 Methods
5.3.1 Experimental culture
Small constructs (!3×0.8 mm) were cast as previously described (Nims et al. , 2014) with nominally
either 30, 60, or 120 million cells mL−1 using primary juvenile bovine chondrocytes. Constructs
were cultured in excess supply of media and cultured with 10 ng mL−1 TGF-β3 for the first 14 days
of culture.
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Figure 5.1: Biochemical (GAG, collagen, cells, hyaluronan) properties of small constructs grown
with sufficient media.
5.3.2 Biochemical assessment
After 35 days of culture, constructs were removed from culture and digested with proteinase K.
Digests were boiled to neutralize the proteinase K enzyme. Digests were then analyzed for cell
content, sulfated GAG, collagen, and hyaluronan using an enzyme linked immunosorbent assay
(HA ELISA, R&D Systems).
5.4 Results
Constructs grew well with the most growth occurring in the 120 million cells mL−1 (Figure 5.1).
Hyaluronan deposition was similar between the 60 and 120 million cell mL−1 groups. Cell content
in all groups increased with culture duration.
Correlation between the matrix constituents and cells were analyzed to gain insight into the best
correlates between GAG deposition and matrix constituents (Figure 5.2). Correlations are shown
between biochemical content for both current day and day-0 normalizations, as tissue swelling can
lead to differences in data interpeteation. Correlations were typically high between factors when
both were normalized to day-0 levels. For example, R2 = 0.85 between GAG (%day0-ww) and
cells (million cells/day-0 mL) while for the current-day normalizations R2 = 0.54 between GAG
(%ww) and cells (million cells/mL). To an even more extreme degree, R2 = 0.93 between collagen
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Figure 5.2: Biochemical correlations between total GAG content (normalized to day-0 and current
day wet weight), collagen (normalized to day-0 and current day wet weight), hyaluronan (normalized
to day-0 and current day wet weight) and cells (normalized to day-0 and current day wet weight).
The diagonal displays a histogram of sample distribution of each measure, the upper triangle displays
correlation coefficients and p-values (*: p<0.05, **: p<0.01, ***: p<0.001), and the lower triangle
displays the data correlations between two measures.
(%day0-ww) and cells (million cells/day-0 mL), while for the current-day normalizations R2 = 0.74
between collagen (%ww) and cells (million cells/mL).
5.5 Discussion
An open question in growth modeling is should the growth kinetics be described to allow the tissue
to evolve throughout culture and what constituents should the binding kinetics be related to for
modeling such growth. Here, we investigate whether hyaluronan content, a key binding partner
of proteoglycans in native cartilage, should be modeled as a proxy for the binding site availability
of GAG content. To this end, correlations between GAG and hyaluronan, cellular, and collagen
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content were examined in tissue constructs with different cell seeding densities.
GAG and collagen correlations with all constituents were high (Figure 5.2) when both correlated
variables are normalized to the referential (day-0) tissue wet weights, suggesting the influence of
swelling confounds the data interpretation here. Interestingly, cell content was strongly correlated
with both GAG and collagen deposition, with the highest correlation coefficients occurring between
the total cell content (normalized to day-0) and the total biochemical content (normalized to day-
0). Contrary to our original hypothesis that hyaluronan levels would most strongly correlate with
matrix deposition due to the presence of GAG binding sites on hyaluronan, cell density provided
the most remarkably robust correlations between all matrix deposition levels.
While this is likely due to a number of complex factors and interactions, including cell surface
receptors and increased cellular synthesis with higher cell densities, for modeling purposes we can
use this outcome to anticipate the GAG binding site availability through the current cell density
within the constructs.
Similarly, the availability of binding sites for collagen deposition is also a complex and evolv-
ing process. Collagen fibrils are often spontaneously formed within a developing tissue through
telopeptide interactions. This leads to the interesting prospect that collagen deposition begets more
availability for collagen deposition. Through this analysis, collagen content was strongly correlated
to cell content (R2 = 0.93). For modeling purposes, like the binding sites for GAG, collagen binding
sites can be related to the cell density of the local tissue.
The robustness of these correlations also suggests that increasing the cell density of tissues
(either through media additives supporting cell proliferations or increasing cell seeding density) will
enhance matrix deposition and growth within tissues. This relation, however, is contingent on the
adequate availability of media and nutrients. For this work, we used small tissue constructs in a
high media volume (3 mL per construct). This media supplementation level exceeds our standard
formulation as we attempted to minimize both glucose and TGF-β fluctuations between media
changes.
Overall, the work here provides strong evidence for using the cell density as proxy for the binding
sites available for both depositing GAG and collagen within our computational growth models and
experimental efforts towards increasing the cell seeding density of engineered tissues to enhance
matrix deposition.
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Chapter 6 TGF-β and glucose availability dictate the growth of
large, engineered cartilage constructs
6.1 Abstract
The goal of the present study was to developing matrix deposition models accounting for the complex
nutrient, cell, and matrix interactions occurring within growing, engineered cartilage. The previous
studies elucidated the nutrient demands (Chapter 2 and (Albro et al. , 2016; Cigan et al. , 2013)),
synthesis and binding kinetics of structural matrix proteins (Chapter 4), and the influence of cell
density for both of nutrient availability and matrix binding characterized (Chapters 3 and 5). While
the relation between glucose availability and matrix synthesis was established in our earlier works
(Cigan et al. , 2013), the dependence of TGF-β supplementation on matrix synthesis remains un-
known. In this work, we first establish a relationship between matrix synthesis and TGF-β supple-
mentation based on two studies using small [bovine chondrocyte]-[agarose gel] constructs seeding
with cell densities. As TGF-β dosing also had a strong influence on chondrocyte proliferation, we
further established a relationship between cell proliferation and TGF-β dose. Models featuring both
our previous work and the influence of TGF-β on matrix synthesis and cell proliferative were used
to simulate the growth of constructs from three of our earlier studies, all with different cell seeding
densities and construct geometries. Models reproduced the critical results of each study, and where
therefore validated. By capturing the salient results and characteristics of all three studies, the
validated models establish the complex and evolving roles of glucose and TGF-β availability, cell
density and proliferation, and matrix synthesis and deposition within models of engineered cartilage
growth. To extend these models for interrogating the channel density-cell seeding density space,
models were run for a range of channel densities and cell seeding densities and suggest a critical cell
seeding density necessary for nutrient channels to be beneficial.
6.2 Introduction
Despite significant progress in engineering small cartilage tissue constructs with native biochemi-
cal and mechanical properties, the engineering of larger, anatomically-sized constructs has proved
difficult. This has hindered the clinical translation of tissue engineered cartilage therapies to re-
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pair large, symptomatic osteoarthritis lesions. In particular, the most successful culture protocols
are typically performed on small engineered cartilage constructs (volume scales ≈10 µL and length
scales ≈1 mm) and often fail when translated to larger, more anatomically-relevant sized carti-
lage constructs (volume scales ≈100-1000 µL and length scales ≈10-100 mm). Nutrient limitations
within these larger tissues cause necrotic cores and severe matrix heterogeneities. The lack of a ro-
bust, homogeneous matrix is particularly detrimental for engineered cartilage as it compromises the
mechanical integrity of the tissue, producing constructs that would fail upon implantation within
the dynamically-loaded joint environment. Clinical adoption of engineered cartilage treatments
for osteoarthritis has therefore gained little traction with clinical trials predominantly focusing on
treating small focal lesions but with little overall success.
To address this shortcoming, several approaches have emerged in the field to improve the nutrient
availability and culture of large engineered constructs (Davisson et al. , 2002a; Buckley et al. , 2009;
Bian et al. , 2009a). In particular, our lab and others have supplemented nutrient channels into
critically large-sized constructs, enabling our recent engineering of an anatomically-sized cartilage
construct with native compressive mechanical properties (Cigan et al. , 2016c; Cigan et al. , 2016b;
Cigan et al. , 2014; Bian et al. , 2009a). This exciting result suggests that the most promising re-
sults achieved in small constructs can be scaled up to anatomically-sized constructs through the
judicious placement of nutrient channels. While employing nutrient channels in large constructs is
a proven strategy, determining the optimal arrangement and density of nutrient channels for each
culture system is a significant task to optimize between the matrix synthesis capacity (increased
with fewer channels) and nutrient availability (increased with more channels) of the tissue. Often,
these optimizations are left to resource and time intensive trial-and-error experiments. An attrac-
tive alternative for optimizing tissue culture conditions would be to use sophisticated computational
models of growth, informed by system-specific growth parameters, to provide an efficient strategy
for understanding the interplay between matrix deposition and nutrient availability.
Computational models of engineered tissue growth have proven instructive in modeling oxy-
gen and glucose availability and the roles of heterogeneous mechanical properties, but few
models have been developed with parameters taken entirely from a single system. System-
specific culture optimizations and insights for improving cartilage culture have not been pos-
sible (Nikolaev et al. , 2010; Obradovic et al. , 2000; Sengers et al. , 2004; Sengers et al. , 2005a;
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Sengers et al. , 2005b; Zhou et al. , 2008). To this end, computational predictions of nutrient avail-
ability within large, channeled constructs provided us early insight that increasing matrix synthesis
would require increased glucose supply, an outcome experimentally confirmed by increasing the me-
dia supply to constructs (Chapter 2 and (Nims et al. , 2015)). Importantly, this novel insight was
provided from simple models informed with system-specific growth parameters, highlighting the role
of computational models for improving culture conditions.
While models correctly instructed us on the beneficial role of enhanced glucose supply, they could
not predict the significant role of nutrient channels as was experimentally observed. This suggested
a more complex mechanism underlying engineered cartilage growth than glucose alone. Our recent
investigation demonstrated active TGF-β exhibits a high degree of non-specific binding in developing
tissue constructs and is rapidly internalized by resident cells, leading to significant heterogeneities
(Albro et al. , 2016). In Chapter 3 we further determined the individual binding characteristics
of agarose and cells with active TGF-β. Moreover, TGF-β exhibits differential biosynthetic and
proliferative effects on tissue constructs through a wide concentration range (Byers et al. , 2008),
suggesting that matrix heterogeneities may result from both TGF-β and glucose limitations. We
hypothesize that modeling both glucose and TGF-β, important constituents of modern engineered
cartilage culture protocols, will be necessary for developing functional growth models for predictive
modeling of the influence of nutrient channels in engineered cartilage.
This study aims to establish and validate comprehensive models of the growth of engineered
cartilage incorporating biosynthetic models of GAG and collagen based on the local availability
of glucose and TGF-β . These models are direct extensions from our prior characterization and
modeling studies and will, for the first time, develop matrix synthesis models of the complex nutrient
profile within developing tissues. We first develop, parameterize, and validate cell proliferation and
matrix synthesis models based on nutrient availability. Importantly, as recent experimental work has
demonstrated the importance of increasing the cell density within cartilage constructs to improve
tissue properties towards native contents, the models developed here are generalized and validated
across a wide range of cell seeding densities. This allows models to examine the complex interactions
between nutrient availability, cell density, and construct geometry.
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Figure 6.1: Overarching modeling schematic of experiments and modeling interactions.
6.3 Methods
The methods here reflect a union between experimental and computational procedures (Figure 6.1).
We first performed experimental parameter studies (PS) to provide data for fitting system-specific
growth relations required for the computational models. Models were fit to the experimental PS
through a set of growth parameters. These growth parameters were then tested and validated by
modeling experimental culture conditions not originally fit with the models. Lastly, models were run
through a construct geometry and cell density parameter space to gain insights on our engineered
cartilage culture system.
6.3.1 Experimental methods
Experimental protocols followed the well characterized cartilage engineering model of primary ju-
venile bovine chondrocytes embedded in a 2% agarose gel (type VII-A, Sigma) and cultured in a
chemically defined, chondrogenic media based on high glucose (25 mM) Dulbecco’s Modified Eagles
Media (hgDMEM). Constructs were cultured in a 37 C, 5% CO2 incubator under orbital rotation.
Unless otherwise noted, construct media were supplemented with 10 ng mL−1 active TGF-β3 for
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the first 14 days of culture. PS were first run on small constructs to estimate the growth parameters
necessary for fitting the computational models. Models were validated against many of recently
published experimental studies using alternate cell densities, construct geometries, and culture con-
ditions.
6.3.2 Parametric estimation studies on small constructs
Growth parameters were assessed from two parameter studies (PS) using small tissue constructs.
Both parameter study 1 (PS1: ∅3 mm × 0.8 mm constructs, initial cell seeding density 20 million
cells mL−1, 0.5 mL media per construct, 56 day culture) and parameter study 2 (PS2: ∅3 mm ×
2.34 mm constructs, initial cell seeding density 60 million cells mL−1, 1.5 mL media per construct, 28
day culture) focused on the influence of TGF-β dose on cellular proliferation and matrix deposition.
TGF-β was supplemented at either 0, 0.01, 0.1, 1, or 10 ng mL−1 to constructs over the first 14
days of culture. Cultures were maintained orbitally shaken to ensure adequate nutrient mixing
within the media bath. Cultured (PS1: day 56, PS2: day 28) and day 0 constructs were assayed for
DNA, GAG, and collagen as previously described (Farndale et al. , 1986; Hollander et al. , 1994;
McGowan et al. , 2002).
6.3.3 Lactic acid parametric studies
To determine the influence of lactic acid on growth, a parametric study was run (PS3) using the
same culture conditions previously described. Culture system and protocols were similar to those
described above with 10 ng mL−1 TGF-β supplementation for the first 14 days. A media-to-
construct volume ratio of 40 µL/µL was used (based on constructs seeded at 30 million cells mL−1)
and orbital culture was performed in an incubator with 5% CO2 at 37 C. Lactic acid (Sigma) was
added to fresh culture media at concentrations of 0, 5, 10, 15, 20, 30 and 40 mM. Day 0 and 28
constructs were assayed for DNA and GAG content.
6.3.4 Validation studies taken from the literature
Our previously published studies using the same culture system were used as the validation experi-
ments; culture conditions and results are summarized below. Unless otherwise noted, constructs in
these studies were supplemented with 10 ng mL−1 active TGF-β3 for the first 14 days of culture.
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6.3.4.1 Channel studies: TGF-β The first channel optimization study we performed
(Nims et al. , 2015) investigated the influence of media volume and construct geometry, testing
the growth of constructs parametrically using 5, 10, or 15 mL of media per construct and either 0,
3, or 12 nutrient channels (∅1 mm) within each ∅10 mm × 2.34 mm construct. Constructs were
seeded with 99 million cells mL−1 on day 0 and cultured on racks atop an orbitally shaken plate.
This system encouraged media flow within the channels and adequate mixing within the media
bath. The results demonstrated that increasing both channel density and media volume increased
cell, GAG, and collagen content.
Following this, a subsequent experimental study investigated whether increasing channel density
could further enhance growth. Constructs seeded with 45 million cells mL−1 and with 0, 12, 19,
or 27 nutrient channels were cultured for 56 days with 15 mL media per constructs, based on the
maximum growth conditions of the previous study. The results of this study demonstrated that the
12 and 19 channels configurations in a ∅10 mm × 2.34 mm construct optimized growth (matrix
deposition) compared to the 0 and 27 channel constructs.
6.3.4.2 Channel studies: no TGF-β To examine the role of TGF-ß in the growth enhance-
ments of channeled constructs, 0 and 12 channel configurations were cultured in ∅10 mm × 2.34
mm constructs as described above for 42 days, but without TGF-ß supplementation. Constructs
seeded with 60 million cells mL−1. This study did not show any differences in the 0 and 12 channel
growth conditions.
6.3.4.3 Quasi-one-dimensional studies To establish the role of active TGF-β in spatial ma-
trix deposition gradients, large constructs (∅6 mm × 3.2 mm) seeded with 60 million cells mL−1
were cultured on the bottom of dish (3 mL per construct), such that the only media-construct
interfaces were along the top and lateral faces of the construct. Constructs were cultured for 56
days with 0 or 10 ng mL−1 TGF-β supplementation over the first 14 days. After culture, a central
∅3 mm core of the construct was punched and divided into four equal slices for spatial biochemical
analysis (GAG and collagen). Using both experimental and computational methods, we validated
that TGF-β within this central core was available nearly entirely through transport from the top
surface of the construct, thus making the system “quasi-one-dimensional.” Results demonstrated
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little matrix deposition and heterogeneity within constructs not supplemented with TGF-β and a
high matrix heterogeneity in constructs cultured with TGF-β, with the highest matrix deposition
in the top (outer) slice.
6.3.5 Computer models
Models were developed using culture and construct-specific geometries and implemented with growth
kinetics and reactions. The framework ensures reactions are spatially dependent and run within
each finite element. Each reaction therefore is based on the local (elemental) concentrations of
glucose, TGF-β, lactic acid, and cell density.
6.3.6 Finite element geometries of culture conditions and geometries
Finite element models (FEM) were constructed using CUBIT (Sandia Labs) to simulate the culture
conditions and tissue geometries used in experimental culture and were modeled in a custom version
of FEBio (v. 2.6.0) (Figure 6.2). Models simulated the following culture conditions: a finite-sized,
well-stirred media bath surrounding the tissue construct. This bath supplied glucose and TGF-β
which were replenished during media changes; media changes also removed lactic acid and soluble
matrix which had transported into the bath. Growth reactions (nutrient consumption, matrix
synthesis, and matrix and nutrient binding as described below) occurred within the tissue construct.
Soluble metabolites (glucose, TGF-β, and lactic acid) and matrix (GAG and collagen) transport
(diffusion) occurred between the tissue construct and bath along the media-construct interfaces.
Bound nutrients, bound matrix, and cells were only present in the tissue construct. Symmetry was
employed where appropriate to reduce computational demand of the FEM.
Two critical FEM were employed here: 1) cylindrical constructs (CYL) and 2) channeled con-
struct units (CHU).
• 1) CYL were modeled as a single cylindrical construct (dimensions reflecting experimental
conditions) at the bottom of a media bath (bath volume reflecting experimental conditions),
with a media-construct interface along the lateral and top surface of the construct. CYL
(Figure 6.2A) models were axisymmetric, so a 3-degree construct slice was modeled.
• 2) CHU (Figure 6.2B, bottom) were modeled as a the symmetry reduced channeled construct
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Figure 6.2: Modeling schematic of experiments and modeling interactions.
to model a representative unit of a channeled construct that could be used to model specifi-
cally the growth of a large construct based on the inner regions away from the lateral edges.
CHU captured a 60 degree slice of the channel surrounding tissue based on axisymmetry of
the channel and symmetry of the representative units within the tissue. Axial symmetry was
employed to reduce models to one-half the thickness of the construct. The critical dimensions
for these CHU were the center-to-center spacing of channels (dependent on channel density),
construct thickness (constant to reflect the 2.34 mm thick constructs), and the channel diam-
eter (constant to reflect the ∅1 mm channel). The media-construct interface was along the
top and channel surfaces of the construct for CHU.
6.3.7 Modeling nutrient transport, consumption and matrix synthesis, binding
Growth reactions were modeled within the tissue construct material of the FEMs. Growth models
were based on our prior studies of glucose and TGF-β consumption and transport and GAG and
collagen synthesis and binding. TGF-β binding interactions with the individual tissue constituents
agarose and chondrocytes were extracted from the bulk mixture binding characteristics previously
reported (Chapter 3). Glucose and TGF-β consumption rates and GAG and collagen synthesis
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rates were normalized to a per cell basis such that consumption and synthesis were dependent on









As lactic acid was also used to investigate the role of product inhibition on cellular proliferation
and matrix synthesis, lactic acid was modeled as product of glucose metabolism following the
chemical reaction




where cla and cglu are the concentrations of lactic acid and glucose, respectively, Km is the Michaelis
constant for glucose, V glucell is the cellular consumption rate of glucose, ρ
cell is the local cell density of
the tissue, and a hat denotes the constituent’s molar supply. Experimentally, the concentration of
lactic acid was found to be critical for both matrix synthesis and cell proliferation and was adapted
into these models subsequently.
6.3.8 Cell proliferation
Cell proliferation was based on a logarithmic model where the specific growth rate, µ, was used to
stimulate proliferation (based on TGF-β, and cTGFβthresh = 1 pg mL























































The parameters for this reaction which must be gathered are KI and clathresh from the lactate dosing
study (PS3) and ka and c
TGFβ
thresh from a TGF-β dosing study (PS1 and 2).
6.3.9 Matrix synthesis
GAG and collagen synthesis was partitioned into two terms: a basal and TGF-β stimulated terms.
Basal synthesis was based on data, both our own and others, demonstrating that chondrocytes, in
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the absence of TGF-β stimulation, synthesize most matrix in over the 14 days of culture, before
reducing their synthesis rate (modeled here as 50% synthesis reduction in synthesis per cell after day
14). TGF-β stimulated synthesis was modeled as logarithmically dependent on the level of TGF-β
consumption. A minimum TGF-β consumption threshold was necessary to elicit matrix stimulation
and a maximum TGF-β consumption ceiling was modeled above which no further stimulation was
possible. Based on prior models of TGF-β stimulation, consumed TGF-β was normalized to an
average per cell level for modeling different cell seeding densities. Lactic acid inhibited matrix
synthesis based on empirical data in a similar manner to previously done (Zhou et al. , 2008).
Matrix binding site density (Nt), set to a constant in our original work (Chapter 4), was scaled
here based on cell density according to the ratio of NGAGt = 300 mM and N
COL
t = 0.3 mM per
30 million cells mL−1 (Chapter 5). This binding site density was modeled to increase with cell
proliferation at the same ratio. Binding rates for both GAG and collagen were taken from our
earlier work (Chapter 4) as constants that were only dependent on TGF-β administration and
release.
Matrix synthesis equations and formulation Like cellular proliferation, matrix synthesis was
based on a logarithmic model of consumed TGF-β (a product of the Michaelis-Menten kinetics of
soluble TGF-β with cells within the scaffold of the tissue.) The local consumed TGF-β content was













according to Michaelis-Menten kinetics were V TGFβcell is the per cell TGF-β internalization rate and
KTGFβm is the Michaelis constant for the reaction (taken from our earlier work to be 1 mM).
Using this measure of TGF-β consumption, matrix synthesis was calculated based on partitioning























where ĉGAGo is taken from our previous work (Chapter 4) and tthresh = 14 days.











































where ka is the matrix synthesis term, c
TGFβ
THRESH is the maximal TGF-β consumption and c
TGFβ
thresh is
the minimal TGF-β for matrix stimulation. As these are synthesis rates based on a cellular basis,












































Illustrative schematic trends of the ĉGAGstim and f(c
la) are included below.
6.4 Results
6.4.1 Experimental results
6.4.1.1 Parameter studies 1 and 2: TGF-β dosing influence TGF-β played a critical role
in the development of biochemical content in engineered cartilage through a large concentration
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Figure 6.3: Schematics of TGF-β stimulated matrix and lactic acid inhibition models.
range (four-orders of magnitude as measured here). In both PS1 and PS2, increasing TGF-β
supplementation levels increased the cell content (Figure 6.4). Cell content generally increased with
increasing levels of TGF-β with cellularity trending higher up to a TGF-β dosing of 1 ng mL−1.
Groups receiving 1 and 10 ng mL−1 had statistically similar cell contents. Similarly, small constructs
supplemented with 1 and 10 ng mL−1 significantly increased their GAG deposition compared to 0,
0.1, and 1 ng mL−1 supplementation groups. A TGF-β dose of 0 ng mL−1 produced little matrix
deposition. From preliminary studies, most of this GAG deposition occurred prior to day 14. The
physical growth of engineered constructs (as measured by the swelling ratio) was elevated in groups
with increased TGF-β supplementation, and highest in either the 10 ng mL−1 dose group (PS1) or
1 and 10 ng mL−1 dose group (PS2).
6.4.1.2 Parameter studies 3: Lactic acid influence Lactic acid treatment produced cellular
and biochemical growth differences over the 28 day culture (Figure 6.5). Cell content and tissue
swelling (swelling ratio) did not change from day-0 levels when media was supplemented with 40
mM lactic acid. Total cell content was unchanged from the untreated control (0 mM) with lactate
supplementation up to 20 mM.
GAG content varied complexly with lactate supplementation. When supplemented with 5 mM
lactate, constructs deposited significantly more GAG than all other groups. GAG deposition in the
0, 10, and 20 mM groups were similar. Cell density was significantly higher than day-0 levels for all
groups except the 40 mM supplementation group.
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Figure 6.4: Growth parameter study results to the influence of TGF-β dose. Parameter study 1: a,
c, and e; parameter study 2: b, d, and f. Data results in columns, model fits are diamonds.





ka 5.3×10−8 ncell µL−1 s−1














Table 4: Growth parameter fits of cell proliferation, matrix synthesis, and lactate inhibition.
6.4.2 Computational results
6.4.2.1 Parameter estimation Model fits to PS1 and PS2 produced close agreement when
using the study specific construct geometries, media bath volume, and cell seeding density to inform
growth rates (cell proliferation fits: rcellPS1 = 0.99; r
cell
PS2 = 0.94; GAG deposition: r
GAG
PS1 = 0.99;
rGAGPS2 = 0.99). Parameters gathered from the studies were both for cellular proliferation and GAG
synthesis (Table 4).
6.4.2.2 Validation The computational model growth parameters fit in the previous section
were first applied to the growth of the quasi-one-dimensional construct (Figure 6.6). Growth models
mimicked the heterogeneous deposition of GAG within TGF-β treated large constructs, where most
matrix deposition was evident in the top slice of the construct and little deposition was present in
the lower slices (rGAG1D = 0.92). Notably, there is a quantitative distinction between the deposition
profiles of the top two slices, with the model predicting GAG deposition at ≈12 %Day-0ww while
the experimental measurement was ≈5.6 %Day-56ww. The model further matched the matrix
deposition profiles of a large construct not treated with TGF-β, exhibiting a slight drop in matrix
binding between the bottom and top slices of the construct.
Validations of the channeled constructs were matched in both levels of cellular proliferation and
GAG deposition (Figure 6.7A, B). Comparing the models to the first channel study, using 0, 3, or 12
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Figure 6.6: Experimental and modeling predictions of the culture of a large, heterogeneous cartilage
construct. Quantitative results (left) for both TGF-β supplemented (left pane) and unsupplemented
(right pane). Histological and FEM graphical output results also compare well qualitatively.
channels seeded with 99 million cell mL−1 and 15 mL of media, computational models displayed an
increasing GAG and cell content (normalized to day-0 ww), as did the experimental results. The cell
proliferation model had a closer fit to the experimental data than the GAG synthesis. Quantitatively,
matrix synthesis models anticipated more GAG deposition than was measured experimentally.
Models of the second channel study changed the construct geometry to increase channel density
(0, 12, and 19 channels) while maintaining constant culture conditions (15 mL media per construct)
(Figure 6.7C, D). A lower cell seeding density (45 million cells mL−1) was used for this study.
Models again matched the trends in both cell proliferation and matrix deposition between the
different construct geometries. Experimentally, this channel study displayed an optimal density of
channels before which the deposition of matrix declines. In a similar manner, the system-specific
growth models matched this plateauing of matrix synthesis potential at elevated channel densities.
6.4.3 Modeling simulations
With the modeling fits and using the CHU FEM geometries, models were run with channel-to-
channel spacings from 4.33 mm (corresponding to the same spacing as three !1 mm channels in a
!10 mm construct) to 1.1 mm. Using a !1 mm channel geometry, the lowest channel-to-channel
spacing approaches 1 mm, although practically achieving this spacing would be experimentally
challenging. Cell seeding densities of 30, 45, 60, 75, 100, and 120 million cells mL−1 (Figure 6.8)
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Figure 6.7: Experimental and modeling predictions of the culture of a large-channeled tissue con-
structs of two previous studies constructs. GAG deposition results (a,c) and cellular proliferation
results (b,d) for both the 0-3-12 channel study (a,b) and 0-12-19 channel studies (c,d).
Figure 6.8: Model simulations of GAG deposition constructs with various channel-to-channel spac-
ings and cell densities.
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were used. These models displayed a peak in GAG deposition (normalized to day 0 tissue wet
weight) only when cell densities exceeded 75 million cells mL−1. Between 120 and 100 million cells
mL−1, the optimal channel-to-channel spacing shifted towards a less dense arrangement. At 60
million cells mL−1 and below, there was no optimal peak in matrix deposition with a trend towards
less GAG deposition as more tissue is removed with the increased channel-to-channel density.
6.5 Discussion
This study presents a comprehensive model of the growth of engineered cartilage using modern
tissue engineering technologies. To date, designing tissue engineering studies is largely based on
intuition and resource intensive iteration. As promising tissue engineered technologies come of
age and achieve success on small engineered tissue constructs using a variety of clinically-relevant
cell types, a transition to the clinic by creating large, anatomically-sized constructs for resurfacing
entire joint surfaces will begin to take place. For these studies, however, iterative experimental
tissue engineering strategies will become a prohibitive limitation to understanding how best to scale
culture protocols. Computational models, based on system-specific parameter studies, and validated
experimentally such that they exhibit the salient growth phenomena of engineered cartilage, may
be an essential tool for designing such large engineered tissues. Despite their necessity and utility,
to date, growth models have been limited in their scope and have not yet been used for guiding
successful culture protocols. The models we present here take advantage of our recent investigations
on the need for and transport of TGF-β, an essential stimulator of matrix synthesis in modern tissue
engineering systems.
In particular, parametric models fit the dose-dependence of TGF-β well (r = 0.99 for both
studies Figure 6.4) and cell proliferation within the engineered cartilage was identified to be TGF-β
dependent. Cell proliferation models also exhibited a high goodness of fit (r ≥ 0.94 Figure 6.4). An
important feature of these fitting experiments was the use of constructs with different cell seeding
densities and geometries. By developing models faithful to both experiments, we developed a set of
modeling relationships which may be applicable to a wide variety of experiments.
Based on the finding that cell density and proliferation was a strong variable dictating the
matrix deposition within tissue constructs (Chapters 3 and 5 and Figure 6.4), we were interested
as to what factors associated with increased cell density could influence matrix growth. Based on
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the literature of engineered cartilage development, we investigated lactic acid (Zhou et al. , 2008;
Sengers et al. , 2005b; Sengers et al. , 2005a; Obradovic et al. , 1999). The results here (Figure 6.5)
demonstrate that both cell proliferation and matrix synthesis are highly determined by lactic acid
and at a point, 40 mM as suggested previously (Zhou et al. , 2008), there is a complete inhibition of
matrix deposition. Lactic acid inhibition was therefore developed within both the cell proliferation
and matrix synthesis models based on this finding.
We then constructed models with FE geometries specific to the culture conditions of our studies
in the literature (Figure 6.2) for studies using either large, unchanneled construct or channeled
construct studies (Albro et al. , 2016; Cigan et al. , 2016c; Nims et al. , 2015). While these studies
featured a wide range of cell seeding densities, construct geometries, and culture conditions (presence
or absence of TGF-β), model predictions were well matched to the experimental outcomes of both
the quasi-1D study (Figure 6.6) and the two channel studies (Figure 6.7). All studies matched
the qualitative behavior of matrix expression. The quasi-1D model predicted the most matrix
deposition would occur in the top two peripheral slices of constructs supplemented with TGF-β
and no significant GAG content variations would be present in constructs not treated with TGF-β.
The channel models of constructs with 0, 3, or 12 channels using 99 million cells mL−1 predicted an
increasing trend in both GAG deposition and cell content with increasing channel density. Lastly,
the channel models of constructs with 0, 12, or 19 channels but at a lower cell density (45 million
cells mL−1) than the previous study predicted little change in both GAG deposition and cell content
with increasing channel density (no statistical differences in the experimental data was detected).
Despite these similarities in qualitative behavior, the quasi-1D study and 0-3-12 channel study
displayed quantitative discrepancies between experiments and computational predictions. While we
are not entirely sure of the nature of the discrepancy, it is important to note that these models did
not feature a physical expansion or swelling mechanism. Swelling could increase the path length for
diffusion of critical metabolites, reducing growth by either decreasing glucose or increasing lactic
acid concentrations. Additionally, as the quasi-1D experimental measurements were not relative
to day-0 wet weight, it is possible that allowing the models simulations to swell (which is likely
with the 12 %day-0 ww GAG deposition predicted, see Chapter 4). This swelling and matrix
dilution of the computational results would make the biochemical agreement of Figure 6.6 closer.
However, as all the model predictions captured the salient trends not previously understood or
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capable by computational models available to date, we accept these models as validated and propose
the quantitative differences result primarily from metabolic heterogeneities of the primary cells.
Validated models were then assessed to examine the complex interactions between tissue geom-
etry and cell seeding density (Figure 6.8). Interestingly, optimal channel densities were predicted
to exist for higher cell densities, while lower cell densities (below 75 million cells mL−1) displayed a
gradual decline in GAG deposition as the tissue channel density increased. This is particularly strik-
ing as the same behavior has been observed in our lab and others. When comparing the experimental
results of the 0-3-12 channel study using 99 million cells mL−1, there was a clear benefit to increased
channels (Nims et al. , 2015). Conversely, when we cultured 0-12-19 channel constructs with 45 mil-
lion cells mL−1, there was no clear benefit to nutrient channels and even a reduction in properties
(Cigan et al. , 2016c). Additionally, when other labs have cultured constructs with numerous chan-
nels with only 15 million cells mL−1, there was no benefit evidenced by the increased availability
of nutrients enhanced with channel supplementation (Buckley et al. , 2009; Sheehy et al. , 2011).
Together, these results make intuitive sense that nutrient channels only benefit tissue growth once
nutrition becomes diminished. For the construct sizes tested in vitro, this rarely occurs, even with
TGF-β nutrition, until the cell seeding density becomes prohibitively high. These models do suggest
a critical role in predicting optimal channel arrangements in large, anatomical constructs, which
may have tissue depths up to 7 mm (Hung et al. , 2003; Hung et al. , 2004).
There are several important advances in the computational models presented here which differ
from prior attempts to model engineered cartilage growth. Importantly, using glucose and TGF-β
allowed us to model modern tissue culture system where both nutrients are essential for and drive
growth. Glucose is often modeled as a proto-nutrient for engineered tissue growth and is essential for
cellular metabolism and viability. In our early attempts to engineer an anatomically-sized patella,
glucose deficiencies indeed led to heterogeneous matrix deposition.
Since the original culture of the patella over a decade ago, tissue engineering has increasingly
used chemically-defined media formulations including TGF-β supplementation to enhance matrix
synthesis in constructs. Building off of our recent investigations into the hindered transport of TGF-
β, the growth models developed here used TGF-β availability to predict cell proliferation and matrix
synthesis. Despite the diverse phenotypic responses TGF-β can elicit, a relatively simple relation
between TGF-β levels and cell proliferation and matrix synthesis proved sufficient for the model
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here. TGF-β signaling and the subsequent phenotypic responses, however, represent a complex
cascade mediated by a number of influences including intracellular signaling molecules (notably the
SMAD family), the concentration and duration of TGF-β exposure, and local cell density. Moreover,
direct relations between TGF-β signaling cascades and downstream phenotypic events have received
little attention in the literature. Phenotypic response studies have predominantly focused on studies
within the field of developmental biology (Dubrulle et al. , 2015). Models of adult cell responses are
still being validated and are based on modeling a gene regulatory network (GRN). GRN may prove
useful in modeling the phenotypic changes within cells which still exhibit some stemness and where
TGF-β exposure may influence more genotypic changes than cell proliferation and matrix synthesis
(Zi et al. , 2011; Dubrulle et al. , 2015).
As the models here are specific to agarose constructs seeded with primary bovine chondrocytes,
developing models for other clinically-relevant tissue culture systems will be required for optimizing
more translational systems. While mature cells are typically believed to have a depressed metabolism
and may not require the enhancements in nutrient availability provided by nutrient channels, recent
studies in fact suggest both mature canine cells and bovine mesenchymal stem cells in large con-
structs are nutrient-limited (Saxena et al. , 2016; Durney et al. , 2017; Nims et al. , 2017). Specifi-
cally for mature canine chondrocytes it is likely that different cellular signaling mechanisms may be
at play than in juvenile bovine chondrocytes. Therefore, higher levels of TGF-β may be necessary
to elicit similar levels of matrix synthesis, whereas juvenile bovine chondrocytes deposit similar
levels of matrix between 1 and 10 ng mL−1 TGF-β supplementation. Interestingly, the mechanism
by which juvenile bovine chondrocytes are stimulated after only a two-week TGF-β treatment is
still unknown. That mature chondrocytes (bovine, canine, and human) require continuous TGF-β
supplementation for maximal growth indeed suggests the internal cellular signaling is transient in
mature cells compared to the prolonged stimulation after the two-weeks of treatment in juvenile
chondrocytes (Cigan et al. , 2016a; Chung & Burdick, 2008; Farrell et al. , 2014; Ng et al. , 2009).
This study presents the first comprehensive computational model for optimizing and evaluating
modern tissue engineering culture featuring both glucose and TGF-β dependent growth and a
mechanism by which mechanical growth can be modeled spatially based on the simulated deposition
of GAG and collagen. This advance will be critical for our future culturing of patella-sized engineered
constructs by assessing optimal channel densities in these resource-intensive cultures. Our recent
90
advances in engineering large, channeled constructs provide the template by which these constructs
can be cultured to ensure adequate nutrient mixing and perfusion through the nutrient channels.
Our subsequent advances in culturing large constructs within a cage system to retain the tissue and
prevent deleterious construct swelling suggests that mechanical properties are further enhanced by
enhancing collagen maturity. Together, we are excited by these advances and other improvements
in the field towards a promising treatment for resurfacing damaged and denatured osteoarthritic
cartilage.
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Chapter 7 Varying the concentration of oxygen and inorganic
sulfate does not affect [juvenile bovine
chondrocyte]-[agarose gel] construct growth when
supplied with sufficient glucose and TGF-β
7.1 Abstract
The glucose- and TGF-β-dependent models of Chapter 6 displayed a high fidelity to the experimental
results of our earlier studies. Whether additional critical nutrients exist of this system has yet to be
determined. Perhaps most notably is the dependence of growth on oxygen as was suggested within
the literature and demonstrated with computational models. Additionally, the influence of sulfate
on tissue growth has not yet been characterized, but may be essential due to the high deposition
and synthesis of sulfated proteoglycans. To this end, the current study examines the influence of
oxygen and inorganic sulfate on the growth of small constructs using parametric studies of each
nutrient. Using glucose and TGF-β levels that we had previously classified as sufficient for cartilage
construct growth, we did not find that depletions of oxygen or inorganic sulfate negatively influenced
the growth of engineered cartilage constructs. This work suggest that differences in cell metabolism
heterogeneities, cell density, and tissue swelling and mechanics may influence the predictive ability
of computational models more than modeling additional nutrients.
7.2 Introduction
The nutritional demands of developing engineered cartilage are important to consider for optimally
designing culture protocols that ensure adequate nutrients are supplied to the resident chondrocytes
populations within large sized constructs. This is of great interest as the preponderance of engineered
cartilage systems produce supraphysiologic levels of GAG and synthesize subphysiolgic levels of
collagen. Uncovering simple nutrient alterations which can alter matrix synthesis would present a
convenient means by which the mechanics of engineered cartilage could be altered.
To this end, we have analyzed the nutrient demands of engineered cartilage using the [juvenile
bovine chondrocyte]-[agarose gel] system supplemented with TGF-β3 for the first 14 days of culture
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(Cigan et al. , 2013; Albro et al. , 2016). The salient findings suggest that glucose can be a limiting
dose-dependent nutrient, particularly in large constructs where nutrient gradients can develop from
both diffusion and consumption issues, and that TGF-β exhibits a steep dose-dependent alterations
in cellular proliferation and matrix synthesis. As TGF-β3 is readily internalized by chondrocytes it
has profound influence on tissue heterogeneity.
The chondrogenic media formulation, however, used here consists of 50 additional constituents
and inorganic salts which have not been extensively examined for their role in cartilage growth.
This section examines two of the previously unexamined nutrients in our culture system: inorganic
sulfate and oxygen.
Inorganic sulfate, SO−24 , plays a critical role in the sulfation of the negatively charged pro-
teoglycans within engineered and native cartilage (Rossi et al. , 1998). In cell culture, sulfate is
added through magnesium sulfate and is present in a concentration of 810 µM. As a cell culture
strategy to reduce sulfation, several studies have tried withholding inorganic sulfate from cell cul-
ture media to prevent GAG sulfation and alter the sizes and agglomeration of charged molecules
(Sobue et al. , 1978; Kato & Gospodarowicz, 1985). It is unclear how such a culture regime will
influence cartilage growth de novo.
Oxygen is a widely studied critical nutrient in engineered cartilage growth due to early evidence
that withholding gas exchange led to diminished chondrogenic growth in engineered constructs
(Obradovic et al. , 1999; Obradovic et al. , 2000; Heywood et al. , 2006b). Moreover, due to the
low oxygen content within the mature joint space, oxygen is thought to be a limiting nutrient al-
though chondrocyte viability is unlikely to be diminished by low oxygen tension (Stockwell, 1971a).
Atmospherically, oxygen is typically near 21% (normoxic) of the total gas content. Levels within
the native joint space are typically limited to 5% (hypoxic) although contents within the deep zone
of avascular cartilage can approach 0-1% (anoxic). In cell culture, oxygen content is limited by atmo-
spheric oxygen content and the solubility of oxygen into the cell culture media (Sengers et al. , 2005a).
Furthermore, once in solution, oxygen must diffuse to the construct, a process enhanced by stirring
or shaking the media (Sengers et al. , 2005a).
To this end, this study, parametrically varied the availability of sulfate and oxygen to examine
the influence of engineered tissue growth. All studies were performed with TGF-β3 supplementation




Small constructs (!3×2.3 mm) were cast as previously described (Nims et al. , 2014) using primary
juvenile bovine chondrocytes seeded nominally at 30 million cells mL−1. Constructs were cultured in
excess supply of media and cultured with 10 ng mL−1 TGF-β3 for the first 14 days of culture unless
otherwise noted (Byers et al. , 2008). The influence of each nutrient was assessed in independent
studies as follows.
7.3.2 Oxygen
Constructs were cultured either in a hypoxic chamber (5% oxygen, 5% CO2, balance N2: hypoxic)
or under normal conditions (21% oxygen tension, 5% CO2, balance (atmospheric) N2: normoxic).
Both the normoxic and hypoxic chamber groups were cultured with the same orbitally shaken
conditions. Media change was performed under atmospheric conditions. The hypoxic chamber was
then flushed for 3 min with sterile 5% CO2, 95% N2 gas before sealing until the subsequent media
change. Both normoxic and hypoxic groups were further supplemented with either 0, 0.1, 1, or 10
ng mL−1 TGF-β3 for the first 14 days of culture. Constructs were cultured for 35 days and received
1.5 mL media per construct per culture change.
7.3.3 Sulfate
Constructs were cultured in a chemically-defined media which lacked MgSO4, the source of exoge-
nous sulfate in culture media (inorganic salt-free high glucose DMEM: US Biologicals; inorganic
salts, dexamethasone, ascorbic acid, sodium pyruvate, L-proline: Sigma; ITS+ premix: BDBio-
science; antimycotic/antibiotic: Gibco (Lima et al. , 2007)). MgSO4 was added to create groups
with either 0 µM (0× group, relative to standard media), 81 µM (0.1× group), 405 µM (0.5×
group), or 810 µM (1× group) exogenous sulfate. MgCl2 was added to balance the Mg2+ concen-
tration between the groups. A control group was also cultured with standard high glucose DMEM
(control group; DMEM with inorganic salts: Invitrogen). Constructs were cultured for 6 weeks and
media were changed 3 times weekly (1 mL/construct/media change).
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7.3.4 Mechanical and Biochemical assessment
At the final time points of each study, constructs were removed from culture and tested me-
chanically for the unconfined equilibrium compressive modulus (EY ) before weighing samples for
a measure of the growth (via the swelling ratio). Samples were then digested with proteinase
K. Digests were then analyzed for cell content, sulfated GAG, and collagen as previously de-
scribed (McGowan et al. , 2002; Farndale et al. , 1986; Hollander et al. , 1994; Nims et al. , 2014;
Cigan et al. , 2016b).
7.4 Results
7.4.1 Oxygen
Day 0 cell seeding density of constructs was 39 ± 4 million cells mL−1. Tissue swelling (p<0.001)
and cell density (p<0.001) were higher in constructs grown under hypoxic conditions (Figure 7.1).
Conversely, hypoxic constructs had a significantly lower EY than normoxic constructs (p < 0.001).
Oxygen conditions resulted in no significant differences in total matrix deposition (GAG, p=0.32,
and collagen, p=0.817, when normalized to day-0 wet weight).
Similar to our previous studies of TGF-β dosing in engineered constructs, tissue swelling, GAG,
and collagen were similar between constructs supplemented with 1 and 10 ng mL−1 TGF-β, but
increased in properties from 0 to 1 ng mL−1.
Additionally, when normalized to day-35 tissue wet weight, oxygen supplementation did not play
a significant role in matrix content (data not shown).
7.4.2 Sulfate
Sulfate concentrations did not produce significant changes in EY , GAG, collagen, or cell density
(Figure 7.2). Tissues grew well even in the complete absence of inorganic sulfate and had equal
levels of negatively-charged GAGs as tissues grown with 1× and the standard culture media.
7.5 Discussion
Understanding the entire culture system and the growth limiting nutrients is critical for developing
faithful models of the salient growth kinetics at play within engineered cartilage. Our previous work
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Figure 7.1: Growth of constructs under normoxic and hypoxic conditions with different TGF-β
supplementation doses. Significance groupings at top of each chart indicate group-wise differences
(p<0.05). * denotes significant difference between normoxic and hypoxic groups at given TGF-β
dose (p<0.05, only for significant interaction ANOVA terms).
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Figure 7.2: Growth of constructs with different levels of inorganic sulfate (supplemented sulfate
levels were 0: 0 mM, 0.1: 81 µM, 0.5: 405 µM, 1: 810 µM, ITS: 810 µM using standard media, D0:
day 0). Significant differences (p<0.05) denoted by line.
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to implicate both glucose and TGF-β in the development of engineered cartilage has been success-
fully incorporated into our computational growth framework (Cigan et al. , 2013; Nims et al. , 2014;
Albro et al. , 2016). Questions still remained about the growth kinetics of tissue development par-
ticularly: 1) does oxygen, an integral partner in the metabolism of glucose, play a role in matrix
synthesis as originally found by Obradovic and colleagues (Obradovic et al. , 1999) and 2) can a
depletion of inorganic sulfate aid in the development of engineered cartilage through controlling the
ratio of sulfated proteoglycan to collagen.
Contrary to these earlier studies, and using a media supply previously found to supply adequate
glucose, neither oxygen nor inorganic sulfate played a significant role in matrix deposition.
Oxygen supply did play a complex role with TGF-β supplementation. In particular, despite total
matrix synthesis being similar between hypoxic and normoxic groups, cell densities were elevated
with hypoxic treatment as was total tissue growth and swelling. This swelling may have negatively
influenced mechanical properties as EY was lower in the hypoxic treatment.
As a point of interest: there were considerable changes in media coloration between the hy-
poxic and normoxic treatments. This is likely due to the alteration in metabolism between aerobic
and anaerobic processes. Anaerobic respiration (completed without sufficient oxygen) is a more
inefficient cellular process, producing 2 adenosine triphosphate (ATP: basic cellular energy carrier)
per glucose consumed and producing lactic acid as a byproduct. Conversely aerobic respiration
produces 36 ATP molecules per consumed glucose molecule. This suggests that in the absence of
oxygen, tissues may quickly run out of sufficient glucose for cellular processes and the production
of lactic acid and lowering of pH may be detrimental to tissue growth. However, with our strategy
of enhanced glucose supply through increased media volume, there may have been sufficient glu-
cose. Therefore, regardless of metabolic efficiency, energy production may not have been limited by
glucose availability and the added media may have helped to limit the lactic acid from decreasing
media pH to detrimental levels. Previous studies of the role of oxygen in tissue engineering rarely
report whether increased media supply was tested or the production of lactic acid.
Additionally, it is interesting that while there were no statistical differences of the interaction in
matrix synthesis or cell density, the cell density in groups without TGF-β suggests that a hypoxic
environment may aid in the viability of cells when not supplemented with proliferation-inducing
TGF-β. Indeed, the work and models of Chapter 6, cell proliferation of groups not receiving TGF-β
98
did decrease from day-0 levels. Using modern, TGF-β containing chondrogenic media formulations,
however, obviates and masks and potential cell viability loss with enhanced proliferation of cells.
Previous studies have shown that low sulfate concentrations can hinder GAG sulfation by chon-
drocytes, suggesting that free sulfate may be a critical nutrient required for growth of engineered
cartilage (Sobue et al. , 1978). This study investigated the influence of exogenous sulfate supple-
mentation on the growth and maturation of tissue engineered constructs in the model [bovine
chondrocyte]-[agarose gel] system. The results here illustrate that exogenous sulfate concentra-
tion is not a critical nutrient for the present tissue engineering system as neither the mechanical
nor the biochemical content was significantly influenced by the level of sulfate supplementation.
These results suggest that chondrocytes cultured with insufficient inorganic sulfate can metabolize
other sulfur containing molecules to synthesize the sulfate required for GAG sulfation. While this
stands in contrast to much of the earlier work on GAG undersulfation in low sulfate conditions,
several studies have examined the role of amino acid sulfur in GAG sulfation (Pecora et al. , 2006;
Rossi et al. , 1998). The present study was also conducted for a long duration (42 days) compared
with much of the earlier work (< 24 hours), suggesting that chondrocytes may need an extended
period before normal sulfated GAG production can be based primarily on amino acid catabolism.
The two sulfur-containing amino acids present in tissue culture media are cysteine (nonessential)
and methionine (essential), present at 402 µM and 201 µM, respectively. They therefore repre-
sent a large source of sulfur in the absence of inorganic sulfate ions. These results highlight that
previous measures of sulfate incorporation into sulfated GAG complexes that make up the ECM
of native and engineered cartilage may have neglected the role of amino acid metabolism. While
this mechanism may play only a minor role in GAG sulfation of chondrocytes with plentiful supply
of nutrients (superficial zone chondrocytes), amino acid metabolism may be more common where
sulfate concentrations are lower (middle and deep zone chondrocytes).
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Part II
Physical and Mechanical Growth Models and
Experiments
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Chapter 8 Experiments and models of the mechanism of physical
growth of engineered cartilage
8.1 Abstract
Part I established the biochemical growth kinetics of developing engineered cartilage. This insight
led to the culture of cartilage constructs in sufficient media. Only once media supply rates became
sufficient, tissue constructs began to exhibit a high degree of physical swelling. In fact, the exper-
imental portion of Chapter 3 displayed the greatest disparities in matrix synthesis only when the
examining the matrix synthesis relative to day-0 wet weight. As the success of engineered cartilage
is only possible with a mechanically robust tissue, the goal of this work was to investigate the mech-
anisms of tissue swelling and mechanical property development of engineered constructs using both
theoretical and experimental methods. To accomplish this, constructs with 120 million cells mL−1
were cultured for 105 days; during this culture, constructs grew to nearly 9× their day-0 size. We
identified that this high swelling is caused by the rapid proteoglycan synthesis which creates a strong
swelling pressure which the nascent collagen network fails to restrain due, in part, to the relatively
low synthesis of collagen. We developed computational models to further explain this growth using
a damage-based fiber material for collagens and a non-ideal Donnan swelling model for the proteo-
glycans. Models using the damage-able collagen material explained both the ongoing tissue swelling
and the plateau in mechanical properties of the tissue despite continued matrix synthesis, as seen
experimentally. We next experimentally investigated whether this “damaged” collagen was mea-
surable. Using the α-chymotrypsin solubilization assay, we measured a high degree (≈60 % ) was
susceptible to the solubilization assay. Together, models and experiments here suggest a mechanism
for understanding the complex physical growth phenomena in developing cartilage constructs.
8.2 Introduction
The adequate nutrition of large constructs has demonstrated a high level of matrix synthesis. The
disparities in matrix synthesis became physically evident in the experiments reported in Chapters
2 and 4; the former being due primarily to matrix synthesis mismatches resulting from differences
in nutrient supply and the latter due to matrix synthesis mismatches resulting from differences in
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TGF-β supplementation. The growth mechanism for these tissues, however, is unknown.
Without understanding the mechanism underlying a developing tissue’s mechanical properties,
mechanical growth models to date have been based on prior knowledge of the tissue’s growth en-
vironment (Nikolaev et al. , 2010; Khoshgoftar et al. , 2014). An incomplete understanding of the
growth within engineered cartilage limits the ability of computational models to assess the functional
implications of tissue geometries, culture conditions, and cell seeding densities.
Interestingly, despite the significant disparities in construct growth seen in the previous chapters,
there were no significant alterations in tissue mechanical properties. This is a surprising finding as
we typically assume that more matrix synthesis will directly enhance the mechanical properties of
the developing tissues. The experimental results of Chapter 2, however, suggest that both the tem-
poral matrix evolution and physical swelling of constructs will influence and alter their mechanical
development. While this is an intriguing prospect, without a more complete understanding of the
mechanisms underlying this swelling, it is unknown whether we can translate matrix synthesis into
enhanced mechanical properties.
To this end, the physiologic mechanisms governing native cartilage growth are vague. The
predominance of native cartilage growth studies have focused more on the biology of growth
than the physical growth mechanisms (Bland & Ashhurst, 1996; Clark, 1990; Craig et al. , 1987;
Doskocil, 1984). Mechanical growth studies, conversely, focus nearly entirely on morphometric
analyses with little regard for the underlying structural physics (Carter et al. , 2004). Interest-
ingly, from the combination of these studies we can glean that physical growth likely arises due
to the differential synthesis of matrix proteins, namely: high collagen and uncharged hyaluronan
synthesis levels early in development (prenatal) without significant cross-linking. Synthesized pro-
teoglycans become increasingly negatively charged (via sulfate groups) while collagen synthesis
slows from the high prenatal rates to very low levels. During this postnatal development, collagens
become increasingly cross-linked (Moriguchi & Fujimoto, 1978) and are relatively susceptible to sol-
ubilization via α-chymotrypsin, a marker of collagen turnover and instability (Bank et al. , 1997;
Bank & te Koppele, 1999; Riley et al. , 2002).
To further investigate whether a similar mechanism was at play in the newly developing engi-
neered constructs, we performed a coordinated experimental and modeling study whereby constructs
were first grown to produce a high degree of matrix deposition by using a developmentally physi-
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ologic cell seeding density. A theoretical damage framework was developed within mixture theory
to capture failure and damage during evolving tissue growth. The mechanical contributions of the
continuously synthesized collagen and proteoglycan molecules were independently featured to assess
whether such a framework and mechanism could explain the continued construct growth and ex-
pansion present over the extended culture durations of the samples and the plateauing of construct
mechanical properties.
8.3 Methods
8.3.1 Experimental construct growth
In this study, we opted to increase the cell seeding density to 120 × 106 cells/ml, to match native
levels in immature tissue (100 − 300 × 106 cells/ml (Jadin et al. , 2005; Klein et al. , 2007)). We
also increased media volume per construct to account for the nutrient needs of such elevated cell
numbers, consistent with our recent findings (Nims et al. , 2015). Finally, we extended the culture
duration to 105 days to provide more time for matrix synthesis, and included a CABC treatment
group with the digestion occurring from day 14 to 16 using 0.15 U/ml as per our previous protocol
(O’Connell et al. , 2014). Cylindrical constructs had an initial diameter of 3mm and height of
2.3mm. GAG, collagen and DNA content, and equilibrium compressive Young’s modulus, were
measured using standard protocols described in our previous studies (Nims et al. , 2015). Two-way
ANOVA (α = 0.05) was used to detect statistical differences (p ≤ 0.05) for the factors of treatment
(control and CABC) and time (14/16, 35, 56, 77 and 105 days for control/CABC), with n =4 to 6
samples per group; Turkey-Kramer correction was used for post-hoc testing of the means.
8.3.2 Theoretical model development
The models were constructed using a homogeneous material containing proteoglycan and collagen
constituents based on the experimental outcomes. Proteoglycan mechanics were governed by a non-
ideal Donnan equilibrium equation and collagen was composed of multi-generation, damageable
fibers, corresponding to each day of culture as described below.
8.3.2.1 Bond energy Consider an intact bond species b whose specific bond energy (bond
energy per mass) is given by ψb (F), where F is the deformation gradient of all solid constituents. Let
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ρb0 be the referential mass density (mass per volume in the reference, or undeformed, configuration)





b (F) represents the referential strain
energy density (strain energy density per volume in the reference configuration) when all bonds
are intact. When some of the bonds have failed, the current referential density of remaining intact


















Thus, the strain energy density of the damaged bond species has been scaled from Ψb0 by the
fractional ratio of remaining intact bonds to all the original intact bonds, ρbr/ρ
b
0. In this notation the
subscript 0 implies that all bonds are intact for that variable, whereas the subscript r implies that
only some of the bonds remain intact; for both subscripts, the corresponding variable is normalized
by the volume of the material in the reference configuration.
Now consider that bonds in that species have a probability of failure determined by a failure
criterion measure Ξb (F), where the definition of Ξb (F) follows the classical framework for damage
(Simo & Ju, 1987). In this study, it is proposed that the probability that intact bonds of species b




. The choice of
p.d.f. is based on a constitutive assumption, with the requirement that the p.d.f. be defined on the
appropriate interval for Ξb, e.g., the semi-infinite interval [0,∞[ when Ξb is a positive semi-definite









Let the failure measure be given by Ξbs = Ξ
b (F (s)) at a particular state of deformation
F (s), and let the maximum value of Ξbs over the history up until the current time t be given
by (Simo & Ju, 1987)
Ξbm = max
−∞<s≤t
Ξb (F (s)) .
Then, based on the formulation proposed in this study,















8.3.2.2 Thermodynamics To examine the thermodynamics of this process, consider that dam-
age represents a reaction that transforms intact bonds into broken bonds consisting of two or more
fragment species c,
[intact bond b] →
∑
c
[broken bond fragment c] .
The evolving referential density of broken fragments is ρcr, with ρ
c






0 when all bonds b have broken. In this reactive damage framework, it is assumed that
the specific strain energy of broken bond fragments is zero, ψc = 0, therefore the net free energy Ψr







a = Ψbr .
(This approach precludes the modeling of plasticity, where bonds may break and reform in a loaded
state.) The chemical potential µa of each species a = b, c may be evaluated from the standard
relation (Ateshian & Ricken, 2010),
µa (ρar ,F) =
∂Ψr
∂ρar
= ψa (F) ,
which shows that the chemical potential is equal to the bond specific free energy, with µb = ψb and
µc = 0. This equivalence between chemical potential and specific free energy occurs because of the
simplifying constitutive assumption that ψb is not a function of any of the bond densities ρar . (In
physical chemistry of solutions, this same assumption produces ideal solutions; we may thus describe
our bond mixture model as an ideal mixture.) The rate at which the intact bond density changes
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r is the referential mass density supply to b
from reactions with all other constituents in the mixture, such as the bond-breaking reaction; a
constitutive relation must be provided for ρ̂br. Similar expressions may be given for the broken




r = 0. As shown
previously in the context of mixture theory (Ateshian & Ricken, 2010), a reaction can proceed




a ≤ 0 .
Since µc = 0 for all c species, this inequality constraint reduces to ρ̂brψ
b ≤ 0, which further implies
that ρ̂br ≤ 0 (thus, Ḋ
b ≥ 0) since ψb is a positive semi-definite function of the strain. Thus,
the thermodynamic constraint simply states that intact bond species may break spontaneously
with loading (since their mass supply must be negative) but may not reform spontaneously in this
damage framework.
8.3.2.3 Damage Criterion As described in the prior damage mechanics literature





= Ξb (F (t))− Ξbm ≤ 0 ,








The damage criterion presents the following alternatives: ϕb < 0 if the current state of deformation
is below the current damage threshold, or ϕb = 0 and the deformation is receding from, or tangent
to, the damage (N : Ḟ ≤ 0), or increasing the damage (N : Ḟ > 0). Substituting this into the mass
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ϕb = 0, N : Ḟ > 0
0 otherwise
,






Based on this relation, the thermodynamic requirement, ρ̂br ≤ 0, and the damage progression condi-









is a monotonically increasing
function over the domain of Ξb.
8.3.2.4 Stress For a single bond species b, the state of stress may be evaluated from Ψr = Ψbr
using the usual relations of hyperelasticity, recalling that ρbr and F are independent state variables
















8.3.3 Failure Criterion Measure
The failure criterion measure Ξb (F) of a particular bond species b may be based on strain invariants,
strain energy density, stress invariants, or any other suitable, experimentally validated, measure.
Measures that are dependent on the material behavior, such as strain energy density and stress, are
based on the behavior of intact bonds, thus Ψb0 for the strain energy density, and T
b
0 for the Cauchy





Figure 8.1: Representative engineered cartilage construct from control group at day 105. Dashed
lines shows day 0 dimensions.
deemed appropriate for isotropic damage, which was used for this study. It is also possible to select
Ξb (F) = Ψb0 (F). For applications to biological tissue damage these criteria may be associated
with various mechanisms; selection of a specific criterion is dependent on the tissue’s constitutive
behavior and the applicability of different criteria must be guided by experimental data.
8.4 Results
8.4.1 Experimental construct growth
One of the most striking outcomes of this experimental study was the considerable tissue construct
volume growth or expansion from the size of the day-0 construct (Figure 8.1). The control group
specimens saw a nearly nine-fold increase in their wet weight (and volume) relative to day 0, while
CABC-treated specimens increased more than five-fold (Figure 8.2). Because of this very large
swelling ratio J , specifically defined as construct wet weight at a given time point normalized to the
day-0 construct ww, GAG and collagen compositional measures are reported using normalization
by current day wet weight (final day in culture) to produce conventional fractional measures (%ww,
Figure 8.3), and normalization by day 0 wet weight to assess total matrix synthesis (%D0ww,
Figure 8.4).
Using conventional measures, GAG content rose significantly above day 14/16 levels to nearly
7%ww by day 56 (p < 10−4), then dropped slightly by day 105 (Figure 8.3a); differences were
observed between control and CABC treatments only at day 14/16 (p < 10−3). Collagen content
rose significantly above day 14/16 levels to nearly 2%ww by day 56, then remained unchanged
until day 105 (Figure 8.3b); no differences were observed between control and CABC treatments
(p = 0.29).
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Figure 8.2: Swelling ratio J of engineered cartilage constructs, for control and CABC treatments
(bars). Different letters indicate significant differences across time points (p < 10−4) and asterisks
indicate significant differences between control and CABC at that time point (p < 10−4). Solid
curves represent the model fitted to control data (fit) and the prediction of CABC data (predict).
Figure 8.3: GAG and collagen content in engineered constructs, normalized to wet weight on final
day of culture (%ww). Different letters indicate significant differences across time points (p < 10−4
for GAG and collagen) and asterisks indicate significant differences between control and CABC at
that time point (p < 10−3 for GAG only).
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Figure 8.4: GAG and collagen content in engineered constructs, normalized to day 0 wet weight
(%D0ww). Different letters indicate significant differences across time points (p < 10−4 for GAG
and collagen) and asterisks indicate significant differences between control and CABC at that time
point (p < 10−4 for GAG and p < 10−3 for collagen).
Using day 0 normalization, GAG content increased nearly linearly with time (p < 10−4), reaching
54 %D0ww in the control group and 31 %D0ww in the CABC group at day 105 (Figure 8.4a).
Collagen content similarly rose nearly linearly with time (p < 10−4) to 15 %D0ww in the control
group and 10 %D0ww in the CABC group at day 105 (Figure 8.4b). From day 56 onward, GAG
(p < 10−4) and collagen (p < 10−4) content in the CABC group were smaller than control.
Total cell content per construct did not exhibit a monotonic trend, though significant differences
were found with time in culture (p < 10−4); the CABC group exhibited consistently lower cell
content than control (p < 10−4) (Figure 8.5). Fractional fluid content ϕw in constructs decreased
over time until day 35 (p < 10−4), then remained nearly constant until day 105 (Figure 8.6); at
most time points, CABC constructs had lower fluid content than controls (p < 10−4). Finally, the
compressive equilibrium Young’s modulus rose significantly above day 14/16 levels until day 35,
then remained statistically constant until day 105 (Figure 8.7). At two time points, EY was higher
in the CABC group compared to control (p < 0.01).
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Figure 8.5: Cells per construct as a function of time and treatment. Different letters indicate
significant differences across time points (p < 10−4) and asterisks indicate significant differences
between control and CABC at that time point (p < 10−4). On day 0, nominal cell content per
construct is 2 million.
Figure 8.6: Fractional fluid content ϕw in constructs, as a function of time and treatment. Different
letters indicate significant differences across time points (p < 10−4) and asterisks indicate significant
differences between control and CABC at that time point (p < 10−4). ϕw = 0.94 ± 0.02 on day 0.
Figure 8.7: Equilibrium compressive Young’s modulus Ey in constructs, as a function of time and
treatment (bars). Different letters indicate significant differences across time points (p < 10−4) and
asterisks indicate significant differences between control and CABC at that time point (p < 10−2).
EY = 12 ± 5 kPa on day 0. Solid curves represent the model fitted to control data (fit) and the
prediction of CABC data (predict).
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8.4.2 Damage in Growing Tissue Constructs
On first pass, results of this experimental study were substantially consistent with our past results
(Bian et al. , 2009b; Nims et al. , 2014), producing comparable GAG and collagen %ww levels and
compressive moduli, despite the fact that the cell seeding density was considerably higher. No
differences were found in the conventional GAG and collagen measures between control and CABC
treatments, though EY was significantly higher in the CABC group.
However, once we accounted for the swelling ratio, our interpretation of these results was con-
siderably refined: using a cell seeding density comparable to native juvenile tissue, it was in fact
possible to synthesize native levels of collagen in our tissue constructs (15 %D0ww in the control
group at day 105), indicating that the primary chondrocytes used in this culture system have not
lost their ability to produce sufficient collagen. However, the supra-physiological levels of GAG syn-
thesized over the same time period (54 %D0ww, compared to the native GAG content of 2.8%ww)
produced so much swelling, resulting from the excessive GAG deposition-induced swelling-pressure,
that the collagen content was diluted (2 %ww). It was experimentally evident that the swelling
was caused primarily by the GAGs (consistent with Donnan swelling theory (Overbeek, 1956)),
since lower GAG %D0ww levels in the CABC group (Figure 8.4a) produced a lower swelling ratio
(Figure 8.2).
The next intriguing outcome was that EY was higher in the CABC treatment than control,
even though %ww levels of GAG and collagen were not different, and %D0ww were in fact smaller
in the CABC group. Since GAG %ww usually correlates strongly with EY in tissue constructs
(Mauck et al. , 2002), this surprising outcome led us to the hypothesis that the large swelling ratios
observed in this study could in fact damage the collagen network, whose integrity is critical to
prevent uncontrolled swelling (since the agarose hydrogel breaks apart early in the growth process
based on visual inspection).
We hypothesized the following specific mechanism: GAG and collagen are synthesized continu-
ously during the growth process, at a nearly constant rate. The charged GAG produces a swelling
pressure that expands the tissue construct; this expansion is primarily resisted by the collagen net-
work that was synthesized since the start of culture until the current time. Collagen synthesized
at earlier times points is then subjected to more swelling than collagen synthesized most recently,
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under the assumption that collagen is incorporated into the network in a stress-free (unswollen)
state. Therefore, as time progresses, earlier generations of collagen are subjected to considerable
stretching (up to nine-fold swelling for the earliest collagen generation in this study. Figure 8.2),
causing them to become damaged. Only the most recent collagen generations remain intact or
nearly intact, providing some resistance to swelling while maintaining a regular construct shape
(Figure 8.1). At some time point during the culture (e.g., day 35 based on the data), the rate of
matrix synthesis and damage equalizes, such that GAG and collagen %ww, and EY , all reach a
plateau.
Based on our earlier study (Nims et al. , 2014), nearly 90% of synthesized GAG and 85% of
synthesized collagen is retained in the constructs throughout the culture period, therefore, in our
hypothesized mechanism, we expect that damaged collagen mostly remains in the construct, pos-
sibly contributing to the structural integrity when newly synthesized generations cross-link with
undamaged segments of those collagen fibrils.
Under this hypothesized mechanism, the CABC-treated constructs are subjected to less dam-
age in their earlier generations because of the reduced swelling resulting from the GAG digestion.
Therefore the collagen network in the CABC group has a higher tensile stiffness, which effectively
translates to greater resistance to compression from a swollen state as shown in our earlier studies
on native cartilage (Chahine et al. , 2004).
To validate this hypothesized mechanistic interpretation of our experimental observations, we
performed a theoretical analysis that captured its salient points. Cartilage constructs were modeled
as a mixture of collagen, charged GAGs, and an interstitial fluid containing water and monovalent
salt counter-ions (Na+ and Cl−). In this case, the mixture stress is
T = −pI+Te
where p is the interstitial fluid pressure, I is the identity tensor, and Te is the collagen matrix
stress. Under steady state conditions, when interstitial fluid flow and ion diffusion have subsided,
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where R is the universal gas constant, θ is the absolute temperature, Φ is the osmotic coefficient
describing the deviation from ideal Donnan law (Φ = 1 for ideal conditions), c∗ is the external NaCl
bath concentration, and cF is the fixed charge density arising from the GAGs. The parameter cF








where zGAG is the charge number and MGAG is the molar mass of GAG (zGAG = −2 and MGAG =
513 g/mol, recognizing that GAG content was measured using a DMMB assay with chondroitin
sulfate as the standard); ρT is the construct mass density (taken to be ρT = 1 g/ml), and ϕw is the
measured fractional fluid content. The only adjustable parameter in this relation is thus Φ.
The collagen matrix stress Te was evaluated using the multigenerational growth model formu-
lated in our earlier study (Ateshian & Ricken, 2010): Each generation of collagen was assumed to
be deposited in a stress-free reference configuration Xγ , coinciding with the current configuration at
the start of the generation, Xγ = χ (X, tγ), where χ is the motion, X is the reference configuration
of the first generation (start of day 1 in culture), and tγ is the time at the start of generation γ. The
deformation gradient of each generation is thus Fγ = ∂χ/∂Xγ and the collagen in generation γ is
subjected to strains calculated from Fγ . The construct swelling ratio is given by J = detF, where
F ≡ F(1) is the deformation gradient of the first generation. Though collagen synthesis is continu-
ous, a computational scheme employs finite time increments and we chose to have 105 generations,
corresponding to the start of each day in culture.
Each collagen generation γ was modeled using a fiber distribution with N = 210 fiber bundles




= 1/4π) reflecting the random arrangement
of collagen fibers evident in free-swelling tissue constructs. Each bundle was modeled using the
constitutive relation of the strain energy density with βf = 2 and ξf left as a single adjustable
parameter (same ξf value for all bundles and all generations). The log-normal c.d.f. was used to
describe the probability of damage in each bundle of each generation, with adjustable parameters
µc and σc (same values for all bundles). The failure criterion measure was the Simo criterion of the
fiber bundle calculated for each collagen generation using Fγ for that generation.
This model was implemented in the FEBio finite element environment to predict construct
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swelling and damage, and construct equilibrium compressive modulus under conditions equivalent to
the experimental testing protocol (unconfined compression at 10% strain). Using FEBio predictions,
the four adjustable material parameters, Φ, ξf , µc and σc, were fitted simultaneously to the mean
experimental results for swelling ratio J versus time in culture (Figure 8.2) and compressive modulus
EY versus time in culture (Figure 8.7), using control group data only (Φ = 0.5, ξf = 31 kPa,
µc = 0.08 (mJ/mm3)0.5 and σc = 1.7). These fits produced coefficients of determination R2J = 0.81
and R2Ey = 0.93, respectively. To validate the model, these optimal values were then used to predict




respectively (Figure 8.2 & 8.7).
The successful curve-fits of control group data, and faithful theoretical predictions of CABC
group data, provide a mechanistic validation of our hypothesis that growth is causing collagen
damage in our engineered tissue constructs. The fact that the model could predict an initial rise in
EY followed by a plateau (Figure 8.7), whereas the swelling ratio J rose continuously (Figure 8.2),
indicates that the onset of damage with growth can explain the observed responses.
The agreement between theory and experimental data sets (control and CABC groups) is also
evident in a scatter plot of J versus GAG %D0ww data, showing a strong correlation with the
theoretical model (Figure 8.8a). A scatter plot of EY versus GAG %ww from the control and
CABC groups here and our prior study of (Nims et al. , 2014) produces a moderate correlation
(Figure 8.8b).
8.4.3 Observable Damage
Based on the general agreement between experimental results and our hypothesized damage-mechanism
model of tissue growth, we investigated methods of measuring the damage directly and quantita-
tively. In 1997, Bank et al. introduced a simplified measurement of collagen fiber denaturation using
α−chymotrypsin, which reports the fraction of all collagen in that tissue that has been degraded
(i.e., whose triple helix is unwound) (Bank et al. , 1997). They demonstrated that this assay could
predict higher collagen degradation in cartilage from human osteoarthritic joints (10.4± 5.6%) ver-
sus normal tissue (2.1 ± 1.0%) suggesting that the technique would serve as a proxy for collagen
fiber damage.
We used this assay to assess damage in the control and CABC groups of the current study,
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Figure 8.8: Experimental and model responses for (a) swelling ratio J versus GAG %D0ww (R2 =
0.79), and (b) modulus Ey versus GAG %ww (R2 = 0.35).
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Figure 8.9: Fractional collagen damage measured using α−chymotrypsin digestion, as a function
of time and treatment (bars). Different letters indicate significant differences across time points
(p < 10−4) and asterisks indicate significant differences between control and CABC at that time
point (p < 10−2). Solid curves represent the fractional damage from the model fitted to control
data (fit) and the model prediction for CABC data (predict).
as well as damage in native juvenile bovine cartilage from which we harvested chondrocytes for
our tissue engineering studies. Native juvenile cartilage (n = 5 samples) exhibited 10.1 ± 0.9%
denatured collagen, consistent with the ∼ 14% value reported previously for young adult bovine
cartilage (Temple et al. , 2006). Engineered cartilage constructs exhibited damage that increased
over time, ranging from 38.9± 4.8% at day 14 to 53.9± 5.7% at day 105 for the control group, and
from 22.4±4.6% at day 16 to 63.8±4.4% at day 105 for the CABC group (Figure 8.9). A two-way
ANOVA for the factors of time in culture and treatment showed significant differences across all
factors (p < 10−4 for time, indicating a significant increase in damage over time; p = 0.002 for
treatment, indicating that damage was lower in the CABC group versus control on average; and
p < 10−4 for day×treatment, indicating that damage was lower in the CABC group only on day
14/16, Figure 8.9). These experimental results confirmed that damage did occur in tissue constructs,
well above the baseline level of denatured collagen found in native juvenile cartilage.
For comparison purposes, the fractional damage predicted from the model is also shown in
Figure 8.9). This damage was calculated by taking into account the multigenerational growth




over all N fiber bundles of generation γ was denoted by D̄γ , which
represents the damage in collagen generation γ; since each day produced a new generation, the
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The trend of this theoretical D̄ versus time in culture was consistent with the biochemical assay
results for both control and CABC groups, though the magnitudes did not match exactly (Fig-
ure 8.9). This qualitative agreement was similarly supportive of our hypothesis that growth and
swelling cause damage in the collagen matrix of engineered cartilage constructs. The fact that D
did not agree exactly with the measured collagen degradation was not surprising, since the model
did not propose an explicit constitutive relation between the fraction of collagen that is denatured
and the fraction of molecular bonds that are broken.
8.5 Discussion
The objectives of this study were to formulate a damage mechanics framework that employs observ-
able state variables, instead of internal hidden variables as in the prior literature, while recovering
the classical formulation for damage in isotropic materials; to show that this new framework was ap-
plicable to anisotropic materials without appealing to a tensorial damage measure; to demonstrate
its application to fibrous tissues with unidirectional or multi-directional fiber orientations; and to
use this framework to test the hypothesis that growth of cartilage constructs can lead to damage of
the synthesized collagen matrix.
Most biological tissues exhibit viscoelasticity, which significantly hinders the ability to assess
their damage exclusively from mechanical responses (except when the tissue exhibits gross failure).
Similarly, damage assays (e.g., biochemistry or Raman spectroscopy) are not always easy to interpret
on their own, as they may depend on complex interactions that are not fully understood. Using
observable variables to track damage implies that predictions from damage models may be validated
experimentally, and experimental damage measures may be interpreted mechanistically by validated
models. This combination of theory and experiments can enhance our confidence when testing
hypotheses, as demonstrated in the tissue engineering study presented here.
Though we have conducted cartilage tissue engineering studies for nearly two decades, we had
not initially suspected that newly synthesized extracellular matrix could rapidly become damaged
118
during the growth process. In retrospect, the first indication that excessive GAG swelling could
cause damage to engineered cartilage was reported in our earlier study, where constructs were
found to crack at their center (Bian et al. , 2009a), a one-time finding that we attributed to special
circumstances. In the current study no cracks were observed in the constructs, but the temporal
evolution of construct mechanical properties and swelling led us to hypothesize a more pervasive
collagen damage process that we proceeded to investigate more quantitatively.
Had we only performed the biochemical assay (using α−chymotrypsin digestion
(Bank et al. , 1997)), our results would have remained somewhat ambiguous since this assay
had not been previously used on engineered tissue constructs. Thus, the elevated levels of
denatured collagen found here (Figure 8.9) could have been attributed to the fact that newly
synthesized cartilage has relatively high levels of immature collagen that may be responsible for
these findings. (Indeed, it was somewhat surprising to us that healthy native juvenile and young
adult bovine cartilage exhibit between 10 and 14 % damage (Temple et al. , 2006), whereas healthy
adult human cartilage only exhibits 2% damage (Bank et al. , 1997).) It was the combination of
modeling and experiments that increased our confidence in the testing of our hypothesis.
The results of this study have significant implications for our ongoing cartilage tissue engineer-
ing efforts: Increasing cell seeding density to levels comparable to neonatal cartilage can produce
collagen synthesis that matches native levels; however, we must develop tissue engineering strategies
that prevent damage of newly synthesized collagens. This may be achieved by either preventing
excessive swelling during the growth process (e.g., suitably constraining the constructs without com-
promising access to nutrients), or reducing GAG synthesis in the early stages of tissue growth using
alternative strategies to CABC (e.g., siRNA to temporarily suppress aggrecan synthesis). These
alternative strategies are currently under consideration.
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Chapter 9 Predicting mechanical properties of heterogeneous
cartilage constructs
9.1 Abstract
With the fundamental mechanism underlying the growth of engineered constructs (Chapter 8) and
material models for the structural proteoglycan and collagen constituents, computational growth
models can be used to assess the mechanics of engineered cartilage tissues. Here, we use spatial
biochemical data from our previous study to assess the evolution and final spatial and average
mechanical properties of the tissue grown in our previous study to intentionally develop TGF-β
gradients (the quasi-1D study discussed in Chapter 6 and (Albro et al. , 2016)). Proteoglycan and
collagen content between days 0 and 56 were simulated to evolve through depositions of the material
models described in Chapter 8, such that by the day 56 of the growth simulation, a construct would
have the material model equivalents of the day 56 experimental levels of proteoglycans (via the
non-ideal Donnan material) and collagen (via the multigenerational damage-able fiber material).
Mechanical growth was simulated for the TGF-β treated and untreated constructs, with mechan-
ical properties elevated where TGF-β availability was highest. The average mechanical properties
of the experimentally cultured constructs were well matched to the average mechanical properties
of the predicted by the models (tested with a simulated unconfined compression test, as performed
experimentally). Together, the simulated spatial mechanical properties and close agreement of av-
erage mechanical properties to experimentally measured mechanical properties suggest the physical
growth phenomena proposed and fit in Chapter 8 is appropriate for predicting mechanical properties
of developing cartilage tissue constructs.
9.2 Introduction
With the ability to model the mechanical growth of constructs based on the developing biochemical
content, we tested the applicability of these models to the growth of the deliberately heterogeneous
growth of large tissue constructs from (Albro et al. , 2016). In that study, we cultured constructs
such that TGF-β availability within the construct was minimized and could be modeled within
the central core of the construct using a one-dimensional analysis. The histology from that study
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demonstrated profound matrix heterogeneities were present and that the modulus of the whole
construct was lower than that of small constructs cultured with TGF-β (≈ 400−800 kPa), although
spatial mechanical tests were not performed.
Using the models of tissue mechanics arising from the independent deposition of proteoglycans
and collagens we can, for the first time, examine the role heterogeneous matrix deposition has
in the development of spatially heterogeneous tissue properties (Chapter 8). To accomplish this,
we use the experimentally measured levels of spatial matrix deposition within 4 depth-wise layers
of the large tissue construct to providing the biochemical information for the development of the
mechanical properties. This informs both the spatial and spatially-averaged mechanical properties,
the latter of which we use to compare to the experimentally measured average modulus to validate
the fidelity of the model for predicting the growth of large tissue constructs.
9.3 Methods
9.3.1 Experimental culture summary
Large constructs (∅6 mm × 3.2 mm) seeded with 60 million cells mL−1 were cultured on the bottom
of a dish (3 mL per construct), such that the only media-construct interfaces were along the top
and lateral faces of the construct. Constructs were cultured for 56 days with 0 or 10 ng mL−1
TGF-β supplementation over the first 14 days. After culture, a central ∅3 mm core was punched
and divided into four equal slices for depth-dependent biochemical analysis (GAG and collagen).
These levels of GAG and collagen deposition would be used to inform the computational mechanical
models. TGF-β treated constructs developed a periphery rich in GAG and collagen deposition (see
(Albro et al. , 2016)) and an interior that presented little matrix. Constructs not supplemented
with TGF-β displayed little matrix deposition in all four slices of the construct.
9.3.2 Computational methods
9.3.2.1 Computationally simulating growth The depth-dependent and whole construct me-
chanical properties (equilibrium compressive Young’s modulus, EY ) were assessed computationally
for each of the samples in the active TGF-β and control (unsupplemented) groups (n=8 for each
group). Models were run in FEBio (http://www.febio.org, version 2.4.0), based on the models of
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Chapter 8, which provides a theoretical and computational framework to model the mechanical
growth (tissue swelling and compressive modulus development) of engineered cartilage based on the
biochemical content (GAG and collagen content).
Model geometry consisted of the ∅6 × 3.2 mm construct segmented with 24 radial elements and
four axial elements. Radial symmetry was enforced to reduce the computational power required for
simulations (3-degree slice). The engineered tissue was modeled as a solid mixture of a non-ideal
Donnan equilibrium swelling model (describing the behavior of negatively charged proteoglycans,
osmotic coefficient = 0.5) and a isotropic fiber distribution (describing the behavior of the collagens).
The fiber distributions were multigenerational, replicating successive generations of a deposited
collagen network. Additionally, these fiber generations could become damaged due to excessive
strain (due to the high deposition of GAGs), which our prior work has shown is necessary to
account for the growth patterns and mechanical behaviors of engineered cartilage constructs.
For each sample, the Donnan swelling term and fiber modulus within each slice was determined
from the sample- and slice-specific biochemical content. The Donnan model parameter of fixed-
charge density was taken directly from the GAG content (assuming 513 g mol−1 for chondroitin
sulfate). Solid volume fraction (for the FCD estimation) was approximated using a collagen and
proteoglycan true density of 1.4 g mL−1 and an agarose content of 2% (Khoshgoftar et al. , 2013b).
The experimental depth-dependent matrix content was normalized to day-56 wet weight, whereas
for computational simulations the matrix content was be normalized to day-0 wet weight. To
calculate the matrix content normalized to day-0 wet weight, we estimated the tissue swelling of
each slice by interpolation of the relation between tissue swelling and GAG normalized to day-0 wet
weight (Chapter 8, figure 8.8A). Relating material fiber modulus to collagen content was assumed
as directly proportional to the collagen content and fiber modulus of our previous validation study
(≈1.5% collagen and 0.028 MPa fiber stiffness, respectively). As presented in that work, the collagen
damage was based on Simo damage criterion according to a cumulative log-normal distribution
(threshold = 0.08 (mJ mm−3)0.5 and shape parameter σc = 1.5) (Simo & Ju, 1987).
9.3.2.2 Computationally simulating unconfined mechanical testing After simulating the
“growth” period over 56 days by increasing the fixed-charge density (as determined by the exper-
imental GAG content) and adding successive collagen generation deposition (determined by the
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experimental collagen content), the samples were “cored” to analyze the one-dimensional mechani-
cal properties by reducing the modulus and swelling of the annuli to leave only the inner ∅ 3 mm
section for simulating the mechanical testing.
Samples were first tared (5% displacement) before applying a 10% compression step, consistent
with our mechanical testing protocols. The whole-construct Young’s modulus was calculated as
the difference between pre- and post- compression normalized to the strain of the tissue. Spatial
modulus for each construct slice was calculated by normalizing the axial stress to prescribed axial
strain (Green-Lagrange strain, referential set to configuration after the “growth” prior to the tare
told).
Mechanical growth simulations were performed for each of the 6 constructs experimentally tested,
using each sample’s own depth-dependent biochemical content. As the predicted average compres-
sive modulus of each sample was also determined, we present the average mechanical properties
of the computational predictions as an average ± standard deviations, representing the averaged
values over all of the simulated samples within each group (TGF-β treated and untreated).
9.4 Results
The experimental results of (Albro et al. , 2016) showed that, due to TGF-β transport limitations,
tissues grow heterogeneously. Notably, TGF-β treated constructs developed ≈6 %ww GAG and
≈1.4 %ww collagen within the periphery (TGF-β exposed) of a construct and ≈2 %ww GAG and
≈0.3 %ww collagen within the interior (TGF-β depleted) of the same construct. If not treated with
any TGF-β constructs will develop ≈1.5 %ww GAG and ≈0.3 %ww collagen throughout.
Taking these levels of matrix synthesis, we simulated the growth and, similar to the biochemical
content, mechanical properties displayed spatial heterogeneity. The periphery of constructs exhib-
ited the most swelling and had an elasticity of ≈540 kPa, whereas the interior region of the same
construct, and a construct without TGF-β treatment had an elasticity of ≈20-100 kPa (Figure 9.1).
Model predictions replicated the experimental results of the bulk mechanical tests well (Figure 9.2).
In the TGF-β treated constructs, the experimental moduli of 50±10 kPa was not significantly differ-
ent than the model predictions of 59±16 kPa (p=0.25). In TGF-β unsupplemented constructs, the
experimental moduli of 10±6 kPa was significantly lower than the model predictions of 36±20 kPa
(p=0.02). TGF-β supplementation increased average tissue mechanical properties when compared
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Figure 9.1: Mechanical properties of heterogeneous constructs after the computational growth sim-
ulation.
for experiments (p<0.001) and growth model predictions (=0.02).
9.5 Discussion
The computational models presented in the previous chapter were tested here to assess their ca-
pability in simulating heterogeneous spatial mechanical property development and the implications
on bulk mechanical properties. Here, both large untreated and large TGF-β treated constructs
were tested with the computational growth simulations capturing the complex growth (swelling)
phenomena of the developing tissues and development of spatial mechanical properties.
These models rely only on the temporal evolution of mechanical properties as both the de-
veloping GAG content, driving the swelling, and the generational deposition of a damage-based
collagen material require the rates and timings of both biochemical constituents. Models could
therefore simulate the heterogeneous growth of constructs with measured heterogeneous matrix
content (Figure 9.1).
Model predictions were similar to experimental measurements of the average construct me-
chanical properties for tissues treated with TGF-β (Figure 9.2), although model predictions were
significantly different than experimental results in constructs not treated with TGF-β. This fact is
not unexpected as the material model fits were based on constructs treated with TGF-β (Chapter
8). TGF-β treatment enhances tissue functional properties synergistically when compared to the
influence of bulk biochemical content alone. For instance, in Chapter 4 (Figure 4.5A) we found a
doubling in GAG content between control (untreated) and TGF-β treated (and withdrawn) tissues
by day 45. This is distinct from the mechanical properties of the two groups on the same day (Figure
125
Figure 9.2: Experimental and model predictions of the average mechanical properties constructs.
* denotes difference in experiment and model prediction for TGF-β treatment (p<0.05). ◦ de-
notes significant increase in TGF-β treatment over control for given measure (experiment or model
prediction) (p<0.05).
4.4A), where the TGF-β treated and withdrawn constructs have a modulus an order of magnitude
higher than control constructs. On this basis, calibrating the material models to constructs not
treated with TGF-β would be necessary. However, given that all tissues grown with the intent
of attaining native mechanical properties are treated with TGF-β, such models would carry little
value.
Importantly, the similarity of the TGF-β treated model predictions to the experimental re-
sults and the overall differences between TGF-β treated and untreated samples provides a strong
validation of the mechanical models for simulations of the physical growth of engineered cartilage.
Additionally, these models stress the importance of both biochemical constituents in the gen-
eration of tissue mechanical properties and suggest a role for strengthening constructs by limiting
collagen damage and denaturation or reducing the swelling pressure of deposited GAG to improve
tissue mechanics. This is the topic of the following chapter and appendix A.
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Chapter 10 Constrained culture enhances functional tissue
properties through collagen stability and maturation
10.1 Abstract
When cultured with sufficient nutrient supply, engineered cartilage synthesizes proteoglycans rapidly,
producing an osmotic swelling pressure that destabilizes immature collagen and prevents the devel-
opment of a robust collagen framework, a hallmark of native cartilage. We hypothesized that me-
chanically constraining the proteoglycan-induced tissue swelling would enhance construct functional
properties through the development of a more stable collagen framework. To test this hypothesis,
we developed a novel “cage” growth system to mechanically prevent tissue constructs from swelling
while ensuring adequate nutrient supply to the growing construct. The effectiveness of constrained
culture was examined by testing constructs with both agarose and cartilage-derived matrix hydro-
gel (CDMH). Constructs were seeded with immature bovine chondrocytes and cultured under free
swelling (FS) conditions for 14 days with TGF-β before being placed into a constraining cage for
the remainder of culture. Controls were cultured under FS conditions throughout. Agarose con-
structs cultured in cages did not expand after the day 14 caging while FS constructs expanded to
8× their day-0 weight after 112 days of culture. In addition to the physical differences in growth,
by day 56, caged constructs had higher equilibrium (agarose: 639±179 kPa and CDMH: 608±257
kPa) and dynamic compressive moduli (agarose: 3.4±1.0 MPa and CDMH 2.8±1.0 MPa) than FS
constructs (agarose: 193±74 kPa and 1.1±0.5 MPa and CDMH: 317±93 kPa and 1.8±1.0 MPa
for equilibrium and dynamic properties, respectively). Interestingly, when normalized to final day
wet-weight, cage and FS constructs did not exhibit differences in proteoglycan or collagen content.
However, caged culture enhanced collagen maturation through the increased formation of pyridi-
noline crosslinks and improved collagen matrix stability as measured by α-chymotrypsin solubility.
These findings demonstrate that physically constrained culture of engineered cartilage constructs
improves functional properties through improved collagen network maturity and stability. We antic-
ipate that constrained culture may benefit other reported engineered cartilage systems that exhibit
a mismatch in proteoglycan and collagen synthesis.
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10.2 Introduction
To date, most engineered cartilage culture techniques produce constructs lacking the comprehen-
sive functional properties of native cartilage, such as equilibrium and dynamic moduli and failure
properties in compression and tension, as well as frictional and wear properties. The limitation to
growing functional replacement tissues for resurfacing osteoarthritic defects has hindered the clinical
translation of cartilage tissue engineering (Moisio et al. , 2009; Hung et al. , 2003). In particular,
native cartilage has a dense type II collagen fibrillar network that provides the tissue with a high
tensile modulus, and a negatively-charged glycosaminoglycan (GAG) ground matrix which imparts
a high fixed charge density and robust compressive properties to the tissue (Setton et al. , 1998;
Asanbaeva et al. , 2007; Hosseini et al. , 2014). The interaction between collagen and GAG gives
native cartilage unique compressive and tensile moduli as well as friction and wear properties ideally
suited for its physiologic function within the joint (Ateshian et al. , 2003; Soltz & Ateshian, 1998).
Current engineered cartilage culture protocols successfully develop native GAG content and com-
pressive moduli (Byers et al. , 2008); however, achieving native collagen content and tensile prop-
erties remains elusive (Huang et al. , 2012).
While the sub-physiologic functional properties of cartilage constructs are often attributed to
the low cellular metabolism of and biosynthesis by chondrocytes, we have recently shown that
chondrocytes seeded at the cell densities present in the developing joint can deposit native levels
of collagen, at the expense of producing supraphysiologic levels of GAG (DeGroot et al. , 1999;
Nims et al. , 2016). This rapid and excessive GAG synthesis and deposition results in a high degree
of tissue growth and swelling as negatively-charged GAG attracts ions and fluid from the sur-
rounding media bath, increasing the osmotic swelling pressure within the construct. As the nascent
collagen framework of engineered tissues provides only modest tensile stiffness (Huang et al. , 2012),
constructs volumetrically expand under this swelling pressure. This expansion continues through-
out culture as adequately nourished chondrocytes will continuously synthesize and deposit GAG.
In our earlier work this process resulted in constructs volumetrically growing nearly 800% in wet-
weight over 105 days in culture (Nims et al. , 2016). This study was also our first promising ev-
idence of constructs synthesizing native collagen contents, which reached 15 %/day-0 wet-weight
(%/D0-ww). This deposition, however, was effectively diluted due to the profound tissue swelling.
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Moreover, collagen solubility measured as the susceptibility of collagen to α-chymotrypsin digestion,
increased during culture. Increases in collagen solubility are associated with collagen destabiliza-
tion and remodeling phenomena, including collagen denaturation, immaturity, and damage, all
of which may weaken the bulk mechanical properties (Bank et al. , 1997; Thibault et al. , 2002;
Temple et al. , 2006). Therefore, while both GAG and collagen are necessary for obtaining native
cartilage functionality, high GAG deposition outcompetes and destabilizes the collagen network in
developing cartilage constructs, hindering their functional properties.
While the mismatch in GAG and collagen synthesis and deposition was originally ob-
served in agarose scaffolds, an open question is whether matrix deposition mismatches may
be scaffold-dependent. Differences in scaffold ultrastructure and pore size may lead to dif-
ferent rates of matrix deposition and retention. However, a review of engineered cartilage
systems suggests that GAG deposition exceeds collagen deposition in the majority of systems
and the matrix deposition ratios do not match mature cartilage in any system (Table 5)
(Vunjak-Novakovic et al. , 1999; Mauck et al. , 2002; Chung et al. , 2009; Byers et al. , 2008;
Ng et al. , 2009; Erickson et al. , 2012; Makris et al. , 2014a; Bhumiratana et al. , 2014;
Williams & Sah, 2010); thus while the field has been able to successfully promote chondro-
cyte matrix synthesis, engineered tissues are biochemically distinct from native cartilage. This
trend seems to be present across both scaffold and cell types, importantly suggesting translational
potential will continue to be limited in response to these matrix synthesis mismatches. The
field of cartilage tissue engineering has increasingly turned to extracellular matrix-based scaf-
folds to mimic the native cartilage environment (Kisiday et al. , 2002; Burdick & Prestwich, 2011;
Kim et al. , 2014; Rowland et al. , 2016; Beck et al. , 2016; Novak et al. , 2016); of these, cartilage-
derived and collagen-based scaffolds are widely used in both research and pre-clinical settings
(Huang et al. , 2016a; Rowland et al. , 2016). Although results are promising due to their high
initial matrix content, these scaffolds are prone to initial contraction and it is unclear whether they
can produce a functional collagen network.
We hypothesize that suppressing GAG-induced construct swelling and growth, while maintaining
nutrient access and matrix synthesis, can enhance collagen integrity and thereby lead to enhanced
functional properties in both agarose and cartilage-derived matrix hydrogel (CDMH) constructs. To
this end, we developed a constraint-based culture system (“cage”) that physically confines osmoti-
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Study Scaffold GAG level Collagen level COL:GAG ratio
Vunjak-Novakovic, 1999 3% PGA 4.5 %ww 3.75 %ww 0.83:1
Mauck, 2002 2% agarose 1.5 %ww 1.8 %ww 1.2:1
Chung, 2009 1:1 MeHA 2.5 %ww 0.83 %ww 0.32:1
Byers, 2008 2% agarose 4.6 mg 2.3 mg 0.5:1
Ng, 2010 2% agarose 4.27 %ww 1.06 %ww 0.25:1
Erickson, 2012 1% MeHA 4.8 %/ww 4.8 %/ww 1:1
Makris, 2014 Self-
assembled
1.45 %/ww 1.75 %/ww 1.2:1
Bhumiratana, 2014 Self-
assembled
75 µg/mg 95 µg/mg 1.26:1
Native cartilage
Williams, 2011 Native: 1-3
w.o. Bovine
45 mg/g 80 mg/g 1.77:1
Williams, 2011 Native: 1-2
y.o. Bovine
35 mg/g 180 mg/g 5.14:1
Table 5: GAG and collagen (COL) deposition levels and ratios from literature where both biochem-
ical contents are reported. Native biochemical content (bottom two rows) in juvenile and adult
bovine tissue are distinct from engineered tissues.
cally induced tissue growth and swelling. Cages were designed to mechanically restrain construct
growth within a fixed volume and shape, and provide sufficient nutrient access to the construct.
Cages integrated our previously reported tissue culture strategies for optimizing growth, namely the
introduction of construct nutrient channels perfused by orbital shaking of the culture system using
ample media (Nims et al. , 2015; Cigan et al. , 2014).
10.3 Methods
10.3.1 Cartilage-derived matrix hydrogel preparation
Hyaline cartilage was harvested from Yorkshire pigs weighing 40-50 kg immediately following eu-
thanasia under a tissue sharing protocol approved by the Columbia University Institutional Animal
Care and Use Committee. Hyaline cartilage was dissected free of connective tissue, rinsed in cold
sterile normal saline, and stored at -80 °C for at least 24 h.
Cartilage was sectioned to 1 mm thickness and serially washed in an orbital shaker in hypertonic
(2×) phosphate-buffered saline (PBS) for 15 min, 0.02 % trypsin for 15 min, and 3 % Tween-20
for 30 min. After each step, cartilage was washed in 2× PBS for 15 min. Cartilage sections were
snap-frozen in liquid nitrogen, milled into a fine powder, and lyophilized for 24 hours. Powdered
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cartilage was washed in 4 % sodium deoxycholate for 30 min, 2× PBS for 15 min, 0.2 mg mL−1
DNase I (Sigma D4527) for 24 hours, 0.1 % peracetic acid for 30 min, and sterile deionized water
for 30 min. The cartilage matrix slurry was then snap-frozen in liquid nitrogen, lyophilized for 24
hours, and stored at room temperature.
Dry cartilage matrix powder was digested as previously described (O’Neill et al. , 2013). Briefly,
1 g of lyophilized cartilage matrix powder was mixed with 0.1 g pepsin (Sigma P7012) in 0.01 M
hydrochloric acid and digested for 18 hours at room temperature (25 °C) under constant stirring.
Matrix digests were aliquotted and stored at -80 °C until use. Cells were encapsulated within
hydrogels by reconstituting the cartilage matrix digest with 0.1 M sodium hydroxide, 10× PBS,
and chondrocytes suspended in culture media to yield a cartilage matrix hydrogel with a final
concentration of 6 mg mL−1.
10.3.2 Construct casting and culture
Chondrocytes were isolated from juvenile (4-8 weeks old) bovine carpometacarpal joints and pas-
saged twice in monolayer culture as previously described (Cigan et al. , 2016b). Cells were released
with 0.05% trypsin and encapsulated in either agarose (Study 1) or CDMH (Study 2).
In Study 1, chondrocytes (120 million cells mL−1) were mixed 1:1 with type VII-A agarose
(Sigma) and poured into a glass and Teflon-backed mold with a pattern of pre-arranged pins such
that after punching ∅10 mm × 2.34 mm constructs, each construct possessed 12 × ∅1 mm nutrient
channels (Cigan et al. , 2014). In Study 2, chondrocytes (120 million cells mL−1) were mixed with
CDMH and gelled at 37 °C and 5% CO2 before biopsy punching ∅10 mm × 2.34 mm constructs.
Small agarose constructs (∅3 mm × 2.34 mm) were also cast as scaffold controls for the CDMH
constructs. Final nominal cell densities were 60 million cells mL−1 for Study 1 and the agarose
controls of Study 2, and 33 million cells mL−1 in the CDMH constructs of Study 2 prior to scaffold
contraction, as described below.
CDMH constructs were cast and initially punched without nutrient channels. Cellular contrac-
tion of the CDMH (Awad et al. , 2000) reduced the ∅10 mm × 2.34 mm constructs to approxi-
mately ∅4 mm × 0.8 mm after 14 days of culture. In a preliminary study using CDMH, the scaffold
contraction caused such a large increase in cell density that constructs exhibited severe matrix het-
erogeneities (Figure 10.1). Therefore, to provide adequate nutrient exchange in Study 2, a single
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Figure 10.1: Views of a preliminary study using the CDMH where no channels were used. After 60
days, growth and matrix heterogeneities were present, likely due to the high cell density present.
{A) top view, crack present (arrow). (B) side view, round growth visible, crack present (arrow).
(C) cross sectional view of construct, void interior present (arrow). (D) Safranin-O histology (4×).
Note cracking and void interior (arrow). (E) Picrosirius red histology (4×). Note cracking and
void interior (arrow). (F) Safranin-O histology (20×). High cell density post scaffold contraction is
evident.
∅1 mm channel was punched in the center of each ∅4 mm × 0.8 mm CDMH construct on day 14.
Constructs in both studies were cultured in standard chemically-defined chondrogenic media under
0.8 Hz orbital shaking, and the large agarose constructs of Study 1 were placed vertically in culture
racks to enhance nutrient access (Cigan et al. , 2014). Constructs received 10 ng mL−1 TGF-β3 sup-
plementation (R&D Systems) for the first 14 days of culture (Cigan et al. , 2013). As tissue growth
and expansion typically become significant after the 14-day TGF-β priming, constructs were di-
vided into free swelling (FS) and cage groups on day 14 (Byers et al. , 2008; Nims et al. , 2014).
Caged constructs were cultured for the remainder of the study within the cage while FS constructs
continued their culture unconstrained. Constructs were assessed in Study 1 on days 0, 14, 56, and
112 and in Study 2 on days 14, 56, and 85 (Figure 10.2A). Prior to cellular contraction CDMH
constructs lacked mechanical integrity and were therefore not tested immediately after casting on
day 0.
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Figure 10.2: (A) Study 1 (agarose) and 2 (collagen) overview including channeling, TGF-β3 supple-
mentation, caging, and construct time points. (B) Cage assembly diagram (left) and with construct
(right).
10.3.3 Cage components and manufacturing
Cages consisted of two faceplates abutting a single spacer and the assembly was secured with four
pairs of stainless steel screws and nuts (Figure 10.2B). Faceplates consisted of perforated stainless-
steel sheets (316, ∅0.625 mm holes, center-to-center spacing 0.094 mm, McMaster-Carr) to allow
media flow to the construct while preventing axial swelling. Spacers were made from an impermeable
biocompatible material (Study 1: polysulfone, Study 2: polytetrafluoroethylene) and construct seats
were sized to fit day 14 construct dimensions (Study 1: ∅10.5 mm × 2.34 mm; Study 2: ∅4 mm
× 0.8 mm) and prevent radial swelling. All materials were autoclaved before assembly. Cages were
assembled by placing constructs into the seats of the spacer and fastening faceplates to opposing
sides of the spacer. To promote nutrient transport, channels were aligned with faceplate perforations
and a ∅1 mm biopsy punch was passed through the faceplates and construct to ensure clear media
passage. Channels of the cage constructs became progressively occluded in Study 1 and were re-
cored once (day 58).
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10.3.4 Mechanical testing
Mechanical testing included measurements of compressive unconfined equilibrium modulus at 10%
compression (EY ) and compressive unconfined dynamic modulus (G∗) at 0.01 Hz and 1% strain
amplitude, as previously described (Cigan et al. , 2014).
10.3.5 Biochemical analyses
Biochemical analyses measured the matrix deposition of negatively-charged GAG using the
dimethylmethylene blue dye-binding assay (Farndale et al. , 1986) and collagen using the acid
hydrolysis-orthohydroxyproline (OHP) assay and a collagen:OHP conversion ratio of 7.6:1
(Hollander et al. , 1994; Cigan et al. , 2016b). Cell content was measured using the PicoGreen as-
say (Invitrogen) based on a ratio of 7.7 pg DNA cell−1 (McGowan et al. , 2002). Cell and matrix
concentrations were normalized to the current day wet-weight (%/ww) to provide a measure of
the current matrix content, and to the day-0 wet-weight (%/D0-ww) to provide a measure of total
matrix deposition (Nims et al. , 2015).
Soluble collagen content was measured following the protocol of (Bank et al. , 1997): sub-
punched ∅3 mm construct cores were desorbed of unbound collagen for 48 h at 4 °C under continuous
rotation in a 4 M guanidine HCl buffer solution (0.1 M TrisHCl, 10 µg mL−1 pepstatin-A, 1 mM
iodoacetamide, 1 mM EDTA, pH 7.3). Constructs were rinsed for 8 h in buffer at 4 °C before adding
a 0.5 mg mL−1 solution (0.5 mL per sample) of α-chymotrypsin (Sigma) and incubating for 16 h at
37 °C. α-chymotrypsin separates collagens into soluble and intact (bound) fractions corresponding
to their stability within the tissue. Aspiration of the incubation buffer isolates the soluble collagen
fraction, leaving the intact collagen fraction within the tissue pellet. The aspirant and pellet were
assayed with the OHP assay, and collagen solubility was calculated as
collagen solubility =
soluble collagen mass
soluble collagen mass+ intact collagen mass
.
The collagen crosslink pyridinoline (PYD) was measured with a PYD ELISA (Quidel) using the
construct acid hydrolysis digests (Nims et al. , 2014). PYD content is presented on a per tissue
wet-weight basis (nmol mL−1) and a per collagen basis (mol PYD/mol COL) assuming a collagen
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molecular weight of 285 kDa (Grant & Prockop, 1972).
10.3.6 Histology
Samples were fixed for 24 h in acid-formalin-ethanol and placed into 70% ethanol prior to section-
ing (5 µm slices) (Cigan et al. , 2016b). GAG was visualized with 0.01% Safranin-O staining and
collagen was visualized with 0.1% Picrosirius Red staining (Kelly et al. , 2006).
10.3.7 Statistics
Mechanical and biochemical data were assessed with a two-way ANOVA (α = 0.05, computed in R,
r-project.org) to determine statistical roles of culture duration (Day), culture group (Group; Study
1: FS versus cage and Study 2: FS versus cage versus agarose), and the interaction (Interaction;
duration × group). Tukey corrected post-hoc comparisons were made between groups exhibiting
significant differences (p≤0.05) according to the ANOVA. Significance differences between the factor
groups (Day, Group, Interaction) are noted within the corresponding figure (Figure 10.3, 10.5, 10.6,
and 10.7) where significant.
10.4 Results
10.4.1 Study 1: agarose constructs
Free swelling (FS) agarose constructs grew to 8× their original size after 112 days of culture, while
caged constructs swelled significantly less (2×, p<0.001), essentially maintaining the size they had
achieved prior to being placed in the cage on day 14 (Figure 10.3). FS constructs had dense Safranin-
O and Picrosirius Red staining in the periphery, but interior voids were present on days 56 and 112
(Figure 10.3). Caged constructs also exhibited rich Safranin-O and Picrosirius Red staining and
maintained tissue integrity on day 56, but by day 112 appeared less organized and interior tears
were evident.
Polarized light microscopy images showed no directed tissue ultrastructure in caged constructs,
but highly aligned collagen ultrastructure between the interior tissue void and construct periphery
of FS tissues, reminiscent of native cartilage (Figure 10.4).
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Figure 10.3: Agarose constructs: (A) Image of construct differences from free swelling (left) and
cage (right; front faceplate removed for construct viewing) on day 112. (B) Morphologic differences
in cage growth from top and side perspectives (FS side view only visualizes middle of construct). (C)
Swelling ratio differences between free swelling and caged constructs. Differences between groups
are noted where significant: ***p<0.001. * denotes differences between groups at same time point
(p<0.05). Note equal spacing on the x-axis. (D) Histological images (side view) of constructs
(Safranin-O displays GAG, Picrosirius displays collagen). Dashed lines are construct midlines and
separates Safranin-O and Picrosirius Red images; dotted lines are construct channels or pre-existing
channels; * are voids or tears in construct.
Figure 10.4: Polarized light microscopy images of agarose (A) free swelling and (B) cage construct
growth from after 112 days of culture. Collagen alignment was present in the free swelling constructs,
likely due to the high tissue swelling. Arrows point along construct periphery, + is interior void,
dotted lines surround a channel.
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Construct functional properties (Figure 10.5A-B) improved with culture duration before plateau-
ing after day 56 (p>0.40 for EY and G∗ between day 56 and 112), with both EY and G∗ higher
in caged constructs than FS constructs (p<0.001). GAG and collagen %/ww contents followed
similar temporal trends as mechanical properties and plateaued after day 56 (p<0.11 vs day 112,
Figure 10.5C-D). GAG content was significantly lower in caged constructs (p<0.004); meanwhile
collagen content was similar between the groups (p=0.17). In contrast, both GAG and collagen
matrix deposition (%/D0-ww) increased throughout culture and was significantly higher in FS con-
structs (p<0.001, Figure 10.5E-F). By day 14, constructs had deposited 4.8±0.2 %/D0-ww GAG
and 1.7±0.05 %/D0-ww collagen, after which time FS constructs continued to deposit matrix,
amounting to 66.6±3.1 %/D0-ww GAG and 14.8±1.7 %/D0-ww collagen by day 112 (p<0.001).
Caged constructs deposited less matrix once constrained, and matrix deposition did not change
after day 56 (p>0.98), holding at 14.7±2.6 %/D0-ww GAG and 3.4±0.3 %/D0-ww collagen. Cell
densities did not change significantly from day 0 levels (84±14 million cells mL−1) for caged con-
structs by day 112 (74±8 million cells mL−1, p=0.56) but decreased in FS constructs (44±2 million
cells mL−1, p<0.001) (Figure 10.5G-H). Conversely, total cell content was higher in FS constructs
(p<0.001) and increased throughout culture by cell proliferation (p=0.002). Total cell content in
caged constructs did not change with time (p=0.52).
PYD content was higher in cage culture than FS for both PYD concentration (p<0.001) and PYD
normalized to collagen (p<0.001) (Figure 10.5I-J). PYD content did not significantly change after
day 56 (p>0.34) similarly to collagen content. In particular, cage constructs exhibited 70% more
PYD when normalized to collagen content and 67% higher PYD concentration than FS constructs
on day 112. Collagen solubility increased between days 14 and 56 (p=0.003) and was higher in free
swelling constructs (p=0.03), suggesting collagen was more stable in cage constructs. Fluid volume
fractions (Figure 10.5L) changed throughout culture and were higher in cage constructs (p=0.011).
10.4.2 Study 2: cartilage-derived matrix hydrogel constructs
CDMH constructs grew significantly over the 85-day culture, (Figure 10.6A), with FS constructs
swelling significantly more (3.8×, p<0.001) than cage constructs (1.9× swelling) from their day
14 (post-contraction) wet-weight (Figure 10.6B). Adding a channel aided in nutrient availability
and the large interior voids seen in our preliminary work (Figure 10.1) were not present in Study
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Figure 10.5: Study 1, agarose constructs: mechanical and biochemical measures (A) EY , (B) G∗,
(C) GAG (%/ww), (D) collagen (%/ww), (E) GAG (%/D0-ww), (F) collagen (%/D0-ww), (G)
cell density, (H) total cell content, (I) PYD (nmol/mL), (J) PYD/collagen (mol/mol), (K) col-
lagen solubility, (L) construct water fraction. * denote differences between groups at same time
point (p<0.05); differences between groups are noted where significant. *: p<0.05, ** p<0.01,
***p<0.001. Note equal spacing on the x-axis.
139
Figure 10.6: CDMH constructs: (A) Morphologic differences (top and side profiles) of free swelling,
cage, and agarose constructs on day 85. (B) Swelling ratio differences between free swelling,
caged, and agarose constructs. Differences between groups are noted where significant: **p<0.01.
***p<0.001. * denotes differences between groups at same time point (p<0.05). Note equal spac-
ing on the x-axis. (C) Histological (top view) images of constructs (Safranin-O displays GAG,
Picrosirius displays collagen) on day 56. + is channel location, * are voids or tears in construct.
2; robust Picrosirius Red and Safranin-O staining was observed throughout the CDMH constructs
(Figure 10.6C). In particular, constructs grown in cages exhibited more uniform staining than FS
CDMH and agarose gels; CDMH displayed richer Picrosirius Red staining.
Caged growth enhanced EY over FS culture (p=0.007) and was similar to agarose control
constructs (p=0.99) (Figure 10.7A). G∗ was similar between all groups and peaked on day 56
(p=0.001) before returning to day 14 levels by day 85 (p=0.89) (Figure 10.7B). GAG content was
also similar between the culture conditions (p=0.52) and increased with culture duration (p=0.005)
(Figure 10.7C). Collagen content was higher in constructs with CDMH (p<0.03) and was elevated
in caged constructs, although not significantly so (p=0.06) (Figure 10.7D).
GAG and collagen deposition increased throughout culture (p<0.02) (Figure 10.7E-F). GAG de-
position was similar between caged CDMH and agarose constructs (p=0.39), which were both lower
than FS CDMH constructs (p<0.006), while collagen deposition was similar in the FS and caged
CDMH constructs (p=0.10) and increased through day 85 (p<0.014). Due to the initial contraction
at 14 days of culture, cell density in the CDMH constructs (350 million cells mL−1) was significantly
higher than the cell density in the agarose controls (50 million cells mL−1, p<0.001) (Figure 10.7G).
With subsequent construct swelling, cell density within CDMH decreased over culture such that by
day 85 the cell density in FS CDMH was similar to agarose constructs (p=0.97), though caged
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CDMH constructs still exhibited significantly higher cell density (p<0.05). Furthermore, total cell
content (cells normalized to day-0 wet-weight) did not change over the culture duration in CDMH
(p=0.15), indicating no active cell proliferation in this scaffold type (Figure 10.7H).
10.5 Discussion
Constrained cage growth of engineered cartilage reduced swelling (Figure 10.3C & Figure 10.6B)
and improved construct functional properties in both the agarose and cartilage-derived matrix
hydrogel (CDMH) constructs (Figure 10.5A-B & Figure 10.7A-B), supporting our hypothesis that
rapid GAG deposition can hinder the properties of developing engineered cartilage constructs. We
developed this strategy based on our prior observation that while cartilage constructs can synthesize
GAG and collagen to match native levels, chondrocytes synthesize GAG more rapidly than collagen
(Nims et al. , 2016).
Here, the mismatch in matrix deposition in FS constructs resulted in extreme tissue swelling and
growth (8× in agarose constructs, Figure 10.3C, and 3.8× in CDMH, Figure 10.6C) and disrupted
maturation of an intact collagen network (Figure 10.5I-K for agarose), thereby weakening the tissue
(Williamson et al. , 2003b) (Figure 10.5A-B for agarose; Figure 10.7A-B for CDMH). Cage culture
constrained swelling and excessive deposition of GAG and improved engineered cartilage functional
properties in constructs with both agarose (Figure 10.5A-B) and CDMH (Figure 10.7A-B).
Therefore, mechanical constraints against swelling can enhance functional properties by prevent-
ing excessive proteoglycan deposition (agarose: Figure 10.5E; CDMH: Figure 10.7E), a widespread
issue across engineered cartilage tissues (Table 5). However, cages also constrained total collagen
deposition (agarose: Figure 10.5F; CDMH: Figure 10.7F), so that concentrations of GAG and col-
lagen were similar in FS and caged constructs when accounting for the tissue swelling disparities
(agarose: Figure 10.5C-D; CDMH: Figure 10.7C-D).
The best mechanical properties achieved in this study were observed in caged agarose
(Figure 10.5A-B) and CDMH (Figure 10.7A-B) constructs on day 56. The equilibrium Young’s mod-
ulus in unconfined compression was EY =639±179 kPa for agarose constructs and EY =608±257 kPa
for CDMH constructs and the dynamic unconfined compression modulus at 0.01 Hz was G∗=3.4±1.0
MPa for agarose constructs and G∗=2.8±1.0 MPa for CDMH constructs. For comparison purposes,
we have previously measured EY =660±230 kPa and G∗=6.5±2.1 MPa in immature bovine carti-
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Figure 10.7: CDMH: mechanical and biochemical measures of Study 2 constructs (A) EY , (B) G∗,
(C) GAG (%/ww), (D) collagen (%/ww), (E) GAG (%/D0-ww), (F) collagen (%/D0-ww), (G) cell
density, (H) total cell content. * denote differences between groups at same time point (p<0.05);
differences between groups are noted where significant. *: p<0.05, ** p<0.01, ***p<0.001. Note
equal spacing on the x-axis.
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lage (Park & Ateshian, 2006). Therefore, EY in the best constructs matches the native level while
G∗ is half the native value. These findings are consistent with the observation that GAG levels in
this group of constructs (agarose: 8.0±0.7 %/ww; CDMH: 7.7±0.8 %/ww) are higher than native
cartilage levels (3.3±0.8 %/ww) while collagen content (agarose: 1.8±0.1 %/ww; CDMH: 2.9±0.2
%/ww) is lower than native levels (9.5±2.1 %/ww) (Basalo et al. , 2005). Proteoglycans are known
to enhance the compressive properties (Chen et al. , 2001; Guterl et al. , 2010), as manifested in
EY , whereas collagen enhances the tensile properties (Kempson et al. , 1973) and thus the dynamic
unconfined compression modulus G∗ (Park & Ateshian, 2006). Despite the increase in GAG content
from day 56 to 85, CDMH functional properties declined between these time points as did collagen
content (Figure 10.7A-D); unlike the agarose cage constructs, CDMH swelling ratio increased for
all groups between day 56 and 85, suggesting swelling was still possible in the CDMH constructs
due to heterogeneous construct sizing after cellular contraction (Figure 10.3B).
While matrix deposition was nearly constant in FS constructs throughout culture (nearly linear
rise in %/D0-ww for FS agarose constructs in Figure 10.5E-F starting on day 14 and CDMH
constructs in Figure 10.7E-F), net deposition ceased in caged constructs after day 56. However,
despite this dramatic difference in net matrix deposition, both FS and caged constructs had similar
matrix concentrations (agarose: ≈8.0 %/ww GAG and ≈1.9 %/ww collagen; CDMH ≈7.3 %/ww
GAG and ≈2.4 %/ww collagen). These two observations suggest a signaling role of the extracellular
matrix to control chondrocyte matrix synthesis. In FS constructs negative feedback cues may be
continually diluted by the swelling effect, promoting continuous matrix synthesis. Conversely, when
construct swelling is prevented, these signals concentrate and inhibit matrix synthesis. While the
nature of this signaling mechanism was not identified here, recent studies have implicated TRPV-4
channels in the transduction of extracellular environment signals to matrix synthesis modulation
(O’Conor et al. , 2014). TRPV-4 is responsive to the osmotic environment which is regulated by the
GAG %/ww concentration; thus, the observed plateau in GAG %/ww for both groups (Figure 10.5C)
would be consistent with this type of signaling mechanism.
Despite cessation of net matrix deposition, caged constructs developed higher PYD con-
tent and better functional properties. In effect, the 54 % increase in PYD between FS and
caged agarose constructs (Figure 10.5I-J) correlated with a threefold increase in EY and G∗ on
day 56 (Figure 10.5A-B) and a 10 % decrease in solubility (Figure 10.5K). This finding sug-
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gests that enhancing collagen maturity is critical to developing functional engineered cartilage
(Riesle et al. , 1998; Asanbaeva et al. , 2007). PYD and other intermolecular collagen crosslinks
form spontaneously between enzymatically (lysyl oxidase, LOX) formed residues on adjacent colla-
gen molecules (Siegel, 1974; Eyre et al. , 1984). The observation that collagen maturation is pro-
moted by constrained growth is strong evidence that the physical expansion of a growing engineered
tissue hinders the formation of PYD and prevents collagen maturation due to collagen content dilu-
tion. Makris et al. demonstrated that mechanical properties can be increased with increased PYD
content by treating self-assembled cartilage constructs with exogenous LOX (Makris et al. , 2014b).
However, even the highest LOX dose did not develop tissue matching the functionality of native
cartilage. In comparison to their study, the constrained culture approach of the current study in-
creased PYD content more than exogenous LOX supplementation alone. These results demonstrate
that collagen-collagen proximity needs to be maintained to enhance PYD kinetics in engineered
cartilage. Furthermore, the considerable enhancement in EY and G∗ between FS and caged groups
may not have resulted entirely from the increased PYD levels, since other types of crosslinks may
also exist in cartilage (Eyre et al. , 2010) that were not characterized here.
The constraint strategy employed here increased collagen stability and maintained cell viabil-
ity but did not improve collagen content, even though PYD of caged constructs matched native
levels in adult bovine cartilage (0.74-0.97 mol PYD/mol COL) (Williamson et al. , 2003a) when
normalized to collagen content. This deficiency in collagen content likely explains why tissue
construct G∗ remains below that of native cartilage. In previous work our lab and others di-
gested existing GAG using the enzyme chondroitinase ABC to temporarily increase collagen con-
tent relative to GAG. Though initially promising, these treatments proved deleterious to cellular
health and viability, stymieing further matrix synthesis (Bian et al. , 2009b; Natoli et al. , 2009;
O’Connell et al. , 2014). Therefore, while the constrained culture presented here will likely prove
critical in enhancing tissue functionality and collagen stability, the field of cartilage tissue engineer-
ing still requires strategies to enhance collagen content while maintaining cell viability.
The non-intuitive strategy of constrained growth only became evident after our extensive work
to enhance and optimize growth conditions utilizing native cell densities in young cartilage with suf-
ficient nutrient availability (Cigan et al. , 2016b; Nims et al. , 2016). Based on our recent studies
suggesting that cell densities approaching native levels of developmental cartilage produce superior
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quality cartilage, elevated cell densities were seeded in both agarose (89 million cells mL−1) and
collagen (250 million cells mL−1) scaffolds (Stockwell, 1979). Physiologic cell densities, while proven
effective for both juvenile bovine and adult human chondrocytes, require adequate nutrition to the
developing tissue. Tissue constructs of either high cell density or of anatomical dimensions, or
both, are particularly prone to nutrient scarcities and subsequent heterogeneous matrix deposition
and growth (Huang et al. , 2016b; Saxena et al. , 2016; Moutos et al. , 2016; Hung et al. , 2003).
We have previously directly demonstrated that both ample media and judiciously placed nutrient
channels can meet the high metabolic requirements of developing cartilage (Cigan et al. , 2016c;
Cigan et al. , 2016b; Cigan et al. , 2016a; Nims et al. , 2015). While the need for channels was pre-
viously demonstrated in an agarose scaffold system, this study suggests that channels can also
improve contracted collagen-based scaffold culture where the cell density reached remarkably high
levels. This suggests that channels may prove beneficial across other systems even with exceedingly
high cell densities. In particular, scaffoldless systems, which exhibit high cell densities, often dis-
play heterogeneous matrix deposition and growth, despite their small size and may benefit from
nutrient channel placement, similar to the collagen scaffolds constructs here (Huang et al. , 2016b;
Bhumiratana et al. , 2014; Hadidi et al. , 2015).
Cages were specifically designed to allow media transport through the nutrient channels. The
steel faceplates used here were adequate for the current study, but the selection of cage materials
will be dependent on the tissue culture system. In this study we placed the constructs in cages only
after 14 days of free swelling culture, coinciding with the termination of TGF-β supplementation.
We have previously shown that steel has a high binding affinity for active TGF-β, suggesting
that culture systems requiring continuous TGF-β supplementation will require different materials
(Albro et al. , 2016; Albro et al. , 2013).
This study demonstrated that cages may be used effectively for constraining the swelling of
engineered constructs resulting from high levels of matrix deposition. The primary benefits of this
cage system were to enhance mature crosslink formation and to better maintain the desired con-
struct dimensions, leading to better functional properties than free swelling controls. This approach
was shown to be effective using agarose as well as cartilage-derived collagen scaffolds. Therefore
this novel constrained culture approach holds promise for improving functional properties of large
anatomically sized constructs in a variety of tissue engineering systems (Cigan et al. , 2016b).
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Chapter 11 Conclusions and Future Directions
The work of this dissertation was to address the dearth of computational models of tissue growth,
specifically through developing both biochemical and mechanical models by which tissue engineering
protocols can be improved by both optimizing nutrient availability and enhancing the functional
properties during culture. The insights gained here by elucidating the critical nutrients of devel-
oping cartilage constructs, the dependence of cartilage growth on the nutrients, and the physical
mechanisms by which engineered cartilage grows has enhanced our fundamental understanding of
biological growth phenomena and has been fruitful in developing strategies by which tissue proper-
ties can be enhanced through engineering solutions. Moreover, the computational models developed
and validated have been instructive in the optimization of culture protocols and the interactions
between nutrient availability, construct geometry, and cell density of developing tissues.
11.1 Conclusions
11.1.1 Glucose and TGF-β supply are critical for engineered cartilage development
Chapters 2, 3, 6, and 7 establish the basis for understanding the complex role and interactions of
multiple nutrients within large, engineered cartilage constructs. In particular, glucose abundance
is critical for the growth of engineered cartilage and can be readily enhanced in culture through
additional media volume. Conversely, TGF-β is a transport limited nutrient which differentially
regulates the growth of constructs over a wide concentration range. Culture protocols, such as the
addition of different concentrations of TGF-β or the addition of more media for added glucose, can
be adapted depending on tissue geometry and cell seeding density, two critical factors we establish
for leading to heterogeneous TGF-β gradients and changes in media glucose depletion. The com-
putational models here were developed such that when coupled with finite element models specific
to the culture geometry and several system-specific growth parameters, many culture systems can
quickly be analyzed and optimized for culturing large-sized constructs. Perhaps most critical for
this optimization is establishing the relation between TGF-β dose and tissue growth due to the near
certainty that through either transport limitations (in large constructs) or cellular internalization
(in highly cellularized constructs) TGF-β availability will be critically limited within the interior of
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constructs.
Interestingly, based on the studies here that demonstrated juvenile bovine chondrocytes respond
to 1 and 10 ng mL−1 TGF-β similarly, channel supplementation can lead to reduced loads of
TGF-β being necessary for culture. This result was later confirmed in subsequent channel studies
using !10 mm constructs. This likely stems from the responsiveness of the juvenile cells to TGF-
β and therefore such insights will require a more complete understanding of each tissue system
before applying across systems. Regardless, taking care to ensure adequate glucose and TGF-β
availabilities is a proven strategy for enhancing large sized tissue constructs.
11.1.2 Elevated cellularities for improved tissue development
With the benefit of the insight of nutrient availability from the computational growth models,
Chapters 5 and 8 provided strong evidence for the improvements of tissue culture possible through
increased cell seeding densities when care is taken to ensure adequate nutrient supply. Prior evi-
dence in the literature that increased cell seeding densities improve tissue properties has been met
with studies which provide counter evidence, suggesting lower cellularities provide better results.
In this work we were able to achieve native collagen contents when constructs were seeded with
cellularities approaching those reached in native developing tissue constructs. This suggests that
engineering cartilage through biomimetic approaches of nutrient channels (to enable sufficient nu-
trient availability) and high cell seeding density (to improve matrix synthesis capacity) may benefit
the development of scaffolded engineered cartilage systems like the high cell seeding density of self-
assembled systems has aided the development of those systems. Furthermore, the analysis of chapter
5 suggests that increased cell densities in the presence of adequate nutrition may aid engineered
cartilage growth regardless of the scaffold system. Specifically, the presence of a high density of
cells may aid in the retention of matrix products and tissue development more than strategies and
systems targeting the retention of matrix products.
11.1.3 GAG and collagen synthesis mismatches drive tissue mechanics and swelling
While the functional properties of native cartilage have long been known to be imparted by the
mechanical composition of the tissue, in chapter 4, 8, and 9 we examined the growth mechanisms
of developing cartilage constructs. The impact of a high GAG synthesis and low collagen synthesis,
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once thought promising due to the abundance of matrix being deposited, was shown to be a sig-
nificant limitation to our culturing of functional tissue constructs. Specifically, the inability for our
tissue constructs to develop a functional collagen network as robust as the native collagen network
may be a widespread issue influencing the growth of engineered cartilage tissues. This is particularly
important as we hope to eventually engineered constructs which can be implanted to span the entire
joint surface, making achievement of native mechanical properties an essential task. Fortunately,
we identified that elevated GAG synthesis and depressed collagen synthesis is at the heart of this
tissue leads us to develop strategies specifically targeting this growth mismatch phenomena.
11.1.4 Quelling tissue swelling improves tissue functionality
Ultimately, strategies to enhance tissue functionality during growth will require strengthening or
reinforcing the nascent collagen framework. Chapter 10 presented a successful strategy for pre-
venting the deleterious swelling of the tissue constructs which results from the rapid deposition of
GAG by culturing constructs within a cage system to restrain the physical growth and swelling.
The cage system improved mechanical functional properties in both constructs using agarose and a
cartilage-derived matrix hydrogel scaffold systems. Cages achieved this functional improvement by
enhancing collagen stability and increasing the level of collagen pyridinoline crosslinking. Together,
this implies the mechanism of native growth may arise from delayed GAG synthesis early in de-
velopment which allows for sufficient collagen cross linking before the proteoglycan induced tissue
swelling. For improving the functionality of engineered constructs, cages proved useful and will help
additional systems which have achieved physiologic or supra physiologic levels of matrix synthesis.
11.1.5 Critical modeling approaches, relations, and takeaways
The ultimate goal of the models developed and validated here has been to truly test the predictive
outcomes of a comprehensive model, capturing the salient aspects of tissue growth. To achieve the
consistency required for quantitative agreement, we utilized the repeatable model system of juvenile
bovine chondrocyte encapsulated within an agarose gel, a system our lab has been characterizing
for over a decade. Importantly, our cell source has remained stable over these years and there
has been considerable overlap and training from researcher to researcher, thereby maintaining a
consistency in tissue harvest and culture protocols and limiting most heterogeneities to animal-to-
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animal differences of the primary cells. For the nature of the quantitative modeling work here, this
has allowed modeling fits, results, and predictions to be extended throughout all of our published
literature on the system.
To this point, and in an concerted effort to develop the most comprehensive engineered cartilage
models to date, we exclusively used our previously published data sets, covering a wide range
of culture conditions (media volumes and TGF-β supplementation levels), construct geometries,
and cell seeding densities, to validate the models developed here. The final product has not just
been a series of computational models but an insight of the different factors which can be altered
and their influence on the modeling relations put forth here. For example, changing the cell type
within a construct will change a number of the specific growth relations, but what will ultimately
dictate a construct’s success or failure is whether the cells will be able to receive adequate nutrition
(glucose and TGF-β) and synthesize adequate matrix (proteoglycans and collagens). To achieve
either of these goals, for instance, the density of channels may need to be altered with guidance
from computational models, which will subsequently required fitting experiments as purposed here.
Therefore, for any new system to be characterized for modeling, the critical relations of the
nutrient demands for the system are: the nutrient demands (i.e. glucose and, more influentially,
TGF-β) of the tissue, the transport of TGF-β within the cell-seeded scaffold, and the dependence
of matrix synthesis and deposition on TGF-β availability. To characterize the synthesis and binding
kinetics of matrix for a given cell type and within a given scaffold: measure overall matrix synthesis
and matrix release to the media, determine the relation and kinetics of matrix binding sites within
a tissue, and monitor overtime to determine if synthesis plateaus or remains constant in the pres-
ence of adequate nutrition. To establish models based on the number of cells within a construct:
establish the relations between nutrient requirements and consumption and matrix synthesis and
deposition rates for different cell densities. Lastly, to model growth of a system based on matrix
content, monitor the growth profiles (tissue swelling, mechanical modulus) over time and examine
whether increases in functional properties and swelling are correlated with matrix swelling; does
construct growth continue indefinitely or cease (when cultured with sufficient nutrition)? Can these
be correlated with additional matrix factors (pyridinoline, soluble collagen, hyaluronan)?
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11.2 Future Directions
11.2.1 Translation to clinically-relevant cell models
The work of this dissertation has drawn on our experience with juvenile bovine chondrocytes, cells
which are metabolically active and robust, even at low cell densities. Given the need for clinical
translation, a first step towards engineering large-sized constructs with adult and mature cell sources
would be developing an understanding of the unique nutritional requirements of mature cells which
are less metabolically active. Both glucose and TGF-β are still likely necessary to consider for
mature cells and our preliminary data on mature canine chondrocytes suggests increasing TGF-β
doses up to 50 ng mL−1 may be necessary for achieving homogeneous tissue properties even in
small engineered constructs (forthcoming: Nims et al. Transactions of ORS, 2017, see Appendix).
TGF-β doses of this magnitude in juvenile bovine cells have previously been shown to initiate more
catabolic activity than anabolic, therefore requiring more quantitative TGF-β dosing studies to
understand the role of matrix developing and synthesis in adult constructs.
Furthermore, it is interesting that despite achieving similar biochemical contents as juvenile
constructs, mature constructs often have much lower mechanical properties. Quantitative analysis
of the developing matrix content (cross links, hyaluronan) in adult constructs may provide structural
insights into how the mechanical models presented here can be extended and incorporate the physics
and phenomena important for more sensitive mature cells.
11.2.2 Patella constructs: application to canine and human
The direct application of these mature constructs is to treat large-sized defects within adult canine
(model system) and humans (clinical translation). With our ongoing work to characterize the
nutrient demands of mature engineered cartilage constructs, we can develop channels arrays within
anatomical shapes (Figure 11.1). As Chapter 10 highlights the novel use of a cartilage derived matrix
hydrogel, then the use of this strategy, proven effective for growing constructs when supplemented
with nutrient channels, for creating an anatomical construct will be an ongoing pursuit.
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Appendix A Silencing ribonucleic acids for altering chondrocytes
gene expression
A.1 Introduction
One of the major findings of this dissertation was that non-native matrix synthesis and deposition
rates can negatively influence the mechanical functionality of engineered cartilage. Therefore, in the
present aim we try to use gene silencing techniques to knockdown protein expression of molecules
and protein which contribute to the formation of fixed charges within the extracellular matrix, the
driver of the high osmotic swelling pressure which develops. While siRNAs were able to knockdown
mRNA expression, protein expression was not different than control constructs.
A.2 Introduction
One of the ongoing challenges in tissue engineering is developing strategies to control matrix com-
position for engineering tissues with biochemical and biomechanics properties to match the native
tissue. As previously discussed, cartilage tissue engineering technologies suffer from excess proteo-
glycan (GAG) synthesis and little collagen and synthesis. Strategies that enhance the collagen to
GAG synthesis ratio are likely to enhance the mechanical competency of the tissue.
One potential strategy for decreasing GAG synthesis is silencing RNA (siRNA), a technique
for specifically targeting the destruction of gene sequences and inhibiting the protein translation of
deleterious proteins. siRNAs stimulate in intracellular complex which specifically targets comple-
mentary mRNAs and degrades them, preventing future peptide translation and eventual synthesis
of the target protein. As siRNAs work solely within a cell targeting specific, complementary mRNA,
they’re believed to be safe for clinical applications and their activity eventually diminishes as cellular
proliferation reduces their concentration to below effective levels. To this end, siRNA technologies
have been used in several clinical trials to exhibit the synthesis of disease modifying proteins
In chondrocytes, GAG synthesis and sulfation is a well coordinated biochemical pathway, thereby
presenting numerous targets by which we may be able to alter GAG synthesis or decrease GAG
sulfation. In particular, two possible sites for this action would be 1) decreasing the overall synthesis
the aggrecan core protein (the predominant proteoglycan in cartilage) and 2) decreasing the enzymes
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gene target sense sequence (5’→3’) antisense sequence (5’→3’)
aggrecan (var 1) CCUUUGACGUGAGCGUAGAtt UCUACGCUCACGUCAAAGGca
aggrecan (var 2) CCUUUGACGUGAGCGUAGAtt UCUACGCUCACGUCAAAGGca
xylotransferase 1 GCAUAAAACUGUACAGAAAtt UUUCUGUACAGUUUUAUGCat
xylotransferase 2 CCAGGUUCAUCAAGAAACAtt UGUUUCUUGAUGAACCUGGag
Table 6: siRNA sequences for Bos taurus.
involved in the sulfation of proteoglycans (xlyotransferases).
In this study we investigated the growth of engineer constructs under the treatment of specifically
targeted siRNAs for inhibiting both the synthesis of aggrecan and the sulfation of GAG. Ultimately
we’re interested in decreasing the synthesis of proteoglycan proteins, but as siRNA efficiency is
measured by mRNA down regulation, we use both RT-qPCR and standard biochemical assays to
associate how effective siRNA treatments were.
A.3 Methods
A.3.1 Experimental methods
For these studies, chondrocytes were plated in two-dimensions until reaching 90% confluence as
previously described (Cigan et al. , 2016b). At this level, fetal bovine serum supplemented media
was removed and cells were washed with sterile PBS. Transfection agent (siRNA + Lipofectamine
3000, described below) in Optimem-reduced serum media was applied to chondrocytes for 6 hours
in static incubator culture. Cells were then washed for transfection agent and lifted (0.05% trypsin)
before casting into constructs as previous described (Nims et al. , 2014). Small constructs were cast
for all studies.
A.3.2 Gene knockdown
Transfection was performed by mixing the target siRNA (Invitrogen) with Lipofectamine as advised
by the manufacturer in OptiMem media. This transfection media was applied to plated cells for 6
hours before immediate cell lifting and construct casting or PCR analysis.
siRNAs for aggrecan (two variants: siACAN1 and siACAN2) and xylotranferase 1 and 2 (
siXYL1 and siXYL2, respectively) were transfected to chondrocytes. Details of siRNA sequences is
found in Table 6.
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Figure A.1: Gene knockdown of siACANs.
A.3.3 PCR
Gene expression of ACAN knockdowns was assessed via qRTPCR following the procedure listed on
our lab’s protocol server. Briefly, cells were lysed and RNA was isolated using trireagent. Nano
drop testing confirmed high purity RNA which was maintained at -80 degrees to prevent degrada-
tion in between steps. RNA underwent RT-PCR in a thermocycler before assessing gene activity
(normalized to the housekeeper GAPDH) with qPCR (Jacob’s lab).
A.3.4 Biochemical assessment
At both early and late time points, constructs were assessed for mechanical and biochemical prop-
erties as previously described (Cigan et al. , 2016c; Hollander et al. , 1994; Farndale et al. , 1986;
McGowan et al. , 2002).
A.4 Results
Gene assays indicated that siACAN1 and siACAN2 displayed a high level of (>80%) gene knockdown
(FigureA.1). Interestingly this gene knockdown did not significantly influence biochemical content
of constructs after 35 days of culture (Figure A.2).
Conversely, the application of si-xylosidetransferase had a large impact on the mechanical devel-
opment of constructs (Figure A.3). However, when normalized to cell content, biochemical proper-
ties of the constructs were unaffected only influenced by siXYL2, but this treatment also negatively
impacted the collagen content of the constructs.
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Figure A.2: Protein expression of siACANs.
Figure A.3: Protein expression of siXYLs.
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A.5 Discussion
Gene silencing is an attractive and reversible methodology to alter gene expression of engineered
tissues. However, despite the promise, our results here suggest that altering the phenotype is
a complicated process by which juvenile bovine chondrocytes. Interestingly, the xylotransferase
activity diminished both tissue mechanics and biochemical output. So, while the siACAN response
was not strong enough to elicit a phenotypic response, the siXYL response negatively impacted
overall cell activity. This is not desirable and is similar to our recent investigations into the role of
chondroitinase ABC (O’Connell et al. , 2014).
Recent studies have further demonstrate the disconnect between mRNA expression and a cell’s
phenotypic response (Cote et al. , 2016), suggesting that more investigation on this subject. Such
advances would benefit the control of engineered cartilage and other tissues mechanics during
growth.
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Appendix B Heterogeneity of engineered cartilage constructs
using adult canine chondrocytes is reduced with
higher TGF-β concentrations
B.1 Abstract
Based on the bulk of this dissertation, it is understood the importance of TGF-β for juvenile
bovine chondrocyte constructs. In application for future work, this study examines the role of
TGF-β in a adult canine chondrocyte system. Adult chondrocytes are one of the most common
cell sources for engineered cartilage constructs. Without understanding the TGF-β requirements of
these cells, engineering anatomic functional cartilage constructs will likely suffer from heterogeneous
and incomplete matrix synthesis. This work investigates the interactions of cell density and TGF-
β supplementation on engineered cartilage functional properties and identifies parameter sets for
optimizing nutrient channel placement in large constructs seeded with adult canine constructs for
our preclinical studies.
B.2 Introduction
Prior cartilage tissue engineering studies using immature bovine chondrocytes have shown that
TGF-β supplementation is a key nutrient for controlling matrix synthesis and deposition, as it
exerts both mitogenic and biosynthetic influences when administered at a wide range of concentra-
tions (Van der Kraan et al. , 2002). Recently, we have shown that active TGF-β concentrations are
highly heterogeneous within large cartilage constructs, due to cellular internalization and extracel-
lular binding interactions, leading to similarly heterogeneous matrix synthesis (Albro et al. , 2016).
Optimally spaced nutrient channels within large constructs significantly mitigated this heterogene-
ity, allowing us to engineer more consistent constructs up to 40 mm in diameter, using TGF-β3 at
1 ng mL−1 (Cigan et al. , 2016b).
Though juvenile chondrocytes are a convenient cell source for developing tissue culture strate-
gies, adult chondrocytes are more clinically applicable for engineered cartilage constructs. Yet,
relatively little is known about the metabolic requirements needed to optimize culture conditions
when using adult chondrocytes. This incomplete understanding limits the engineering of functional
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anatomic cartilage constructs due to heterogeneities in matrix deposition. To address this lim-
itation, this study evaluated the mitogenic and functional influence of TGF-ß3 on adult canine
chondrocyte-seeded constructs. While our long-term goal is to produce anatomic constructs for im-
plantation, the present work determined the responses of smaller tissue constructs to 1, 10 and 50
ng mL−1 TGF-β3 to test the hypothesis that matrix heterogeneities exist in mature canine chon-
drocyte seeded cartilage constructs and is ameliorated with additional TGF-β supplementation.
Furthermore, since prior work with both juvenile bovine chondrocytes and adult human chondro-
cytes has shown a strong influence of growth with increasing cell seeding density (Nims et al. , 2016;
Cigan et al. , 2016a), in this study we seeded constructs with 30, 60, or 90 million cells mL−1. Upon
culturing for 28 days, matrix heterogeneity became visually evident, so construct heterogeneity was
assessed with spatial mechanical properties testing.
B.3 Methods
Engineered cartilage constructs were cast and punched (! 3 mm × 2.34 mm) using third-passage
adult canine chondrocytes (3 dogs, tibial plateau and glenoid) in a 2% agarose gel with an initial cell
seeding density of 30, 60, or 90 million cells mL−1. Chemically defined media were supplemented
with TGF-β3 throughout culture (Kelly et al. , 2006). Constructs with 30 and 90 million cells mL−1
were supplemented with 1 and 10 ng mL−1 TGF-β3 and constructs with 60 million cells mL−1 were
supplemented with 1, 10, and 50 ng mL−1. Constructs were cultured for 28 days. Equilibrium
compressive modulus (EY ), dynamic modulus (G* at 0.01 Hz), and spatial mechanical properties,
were measured as previously described (Cigan et al. , 2014).
For spatial mechanical characterization, constructs were diametrically halved, treated with cal-
cein AM and imaged on a confocal microscope (2× objective) under axial loading. VIC2D (Cor-
related solutions) was used to analyze the images and extract strain fields. A MATLAB script
averaged the axial strains in 9-platen-to-platen bins after cropping the outer 20% of the construct
diameter, to produce a quasi-one dimensional analysis through the construct thickness. Spatial
tissue modulus was computed by normalizing the tissue stress at 15% nominal bulk tissue strain to
the spatial strain maps.
Histological samples were sectioning (5 µm) and staining for collagen (Picrosirius red) and
live/dead images were taken after an additional 28 days of culture (day 56) for long-term viability
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Figure B.1: Gross images (A, arrow is translucent center, scale = 3 mm) and strain maps (B, arrow
is platen loading) of 60 million cell/mL and 1, 10, and 50 ng mL−1 TGF-β.
assessment. Two-way ANOVA examined the influence of cell density, TGF-β concentration, and
their interaction and were run in R (v. 3.3.0). ANOVA examined EY in the center depth-wise bin.
B.4 Results
B.4.1 Morphology
After 28 days of culture, growth of the canine constructs was dependent on both cell density and
TGF-β3 concentration. Constructs supplemented with 1 ng mL−1 TGF-β3 were visually more
translucent within the construct center versus constructs treated with 10 ng mL−1 and 50 ng mL−1
(Figure B.1).
B.4.2 Mechanical properties
For all cell seeding densities, the 1 ng mL−1 TGF-β dose produced the lowest bulk EY (average of
all 1 ng mL−1 samples 189±31 kPa, p<0.001, Figure B.2A) and G* (0.68±0.14 MPa, p<0.001, not
shown). Cell density alone did not play a significant role in either EY or G*; 50 ng mL−1 produced
similar EY (p=0.69) to the 10 ng mL−1 group but had a higher G* (2.1±0.1 MPa versus 1.8±0.2
MPa, p=0.005). In contrast to the bulk mechanical properties, spatial mechanical properties exhib-
ited significant differences with TGF-β dose and cell density. For the 1 ng mL−1 dose, the center
minimal EY averaged 44±14 kPa for all cell densities, although there was less spatial heterogeneity
with increased cell density (Figure B.2C). For the 10 ng mL−1 dose, the center bin had the highest
spatial EY for the 30 million cell mL−1 group (733±395 kPa) and was significantly higher than the
center bin EY for the 90 million cell mL−1 group (107±25 kPa, p=0.005) (Figure B.2D). Within
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Figure B.2: A. Bulk construct EY . B. Spatial EY of 60 million cell mL−1 group with 1, 10, and 50
ng mL−1 TGF-β. C. 1 ng mL−1 TGF-β on 30, 60, 90 million cell mL−1 constructs spatial EY . D.
10 ng mL−1 TGF-β on 30, 60, 90 million cell mL−1 EY .
Figure B.3: Picrosirius red (top) and live/dead viability staining (bottom) images from 60 million
cells mL−1 cultured with 1, 10, or 50 ng mL−1 TGF-β. Arrow is cell sparse region.
the 60 million cell mL−1 constructs, increasing TGF-β concentration significantly increased the core
EY from 46±14 kPa for 1 ng mL−1 dosing, to 317±17 kPa for 10 ng mL−1 dosing, to 1078±342
kPa for 50 ng mL−1 dosing (Figure B.2B).
B.4.3 Histology
Histological images for both GAG and collagen showed preferential matrix deposition in the periph-
ery of the construct for the 1 ng mL−1 and 10 ng mL−1 constructs and homogeneous deposition
within constructs treated with 50 ng mL−1 TGF-β (Figure B.3, top). Cell viability was maintained
throughout constructs supplemented with 10 and 50 ng mL−1 TGF-β (Figure B.3C).
B.5 Discussion
This study investigated the interactions between cell seeding density and TGF-β concentration
when using adult canine chondrocyte-seeded engineered constructs, critical factors in the culture
of engineered cartilage but yet untested in such a combinatorial manner. In contrast to many
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studies utilizing juvenile bovine chondrocytes, adult canine chondrocytes produced heterogeneously
deposited matrix despite the small size of the tissue constructs used here. Bulk mechanical tests of
tissue constructs produced near native EY and G* functional properties for adult canine cartilage
(EY ~250 kPA and G*~2.6 MPa (Ng et al. , 2009)) with 10 ng/mL TGF-β across all cell densi-
ties. More sensitive spatial testing and histology revealed TGF-β transport limitations produced
low functional properties in the center of the construct when cell density was elevated, or with
insufficient TGF-β supplementation. Histological images confirmed that matrix content was largely
confined to the construct periphery even for TGF-β doses up to 10 ng mL−1, suggesting that severe
matrix heterogeneities would be present as construct size increases in efforts to resurface larger-
sized tissue defects. This finding contradicts the standard notion that adult cells are typically less
metabolically active in vitro and may require fewer nutrients than juvenile cells. TGF-β availability
and heterogeneities should be considered must be taken into consideration even when culturing
adult chondrocytes, as the TGF-β threshold required for synthesizing matrix may be higher than
it is for juvenile cells.
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